|
Managed Care Regulations by State
(Click on each state to link to go to the
listing)
Alabama | Alaska
| Arizona | Arkansas
| California | Colorado
| Connecticut | Delaware
District of Columbia | Florida
| Georgia | Hawaii
| Idaho | Illinois
| Indiana | Iowa |
Kansas
Kentucky | Louisiana
| Maine | Maryland
| Massachusetts | Michigan
| Minnesota
Mississippi | Missouri
| Montana | Nebraska
| Nevada | New
Hampshire | New Jersey
New Mexico | New
York | North Carolina
| North Dakota | Ohio
| Oklahoma | Oregon
Pennsylvania | Rhode
Island | South Carolina | South
Dakota | Tennessee | Texas
| Utah
Vermont | Virginia
| Washington | West
Virginia | Wisconsin | Wyoming
Note: Usually excluded, even from provisions
with very broad scope, are workers’ compensation-related plans,
long-term care plans, disability income plans, and single-disease
and similarly restricted plans. The key criterion for determining
whether an entity will be regulated as an HMO is typically prepayment.
The key criterion for determining whether an entity will be regulated
as a managed care organization, where state laws relate to such
entities, is adoption of restrictions or incentives affecting choice
of provider (although some states, e.g., Montana, exclude PPOs and
other networks “operated in a fee-for-service indemnity environment”
from the definition of managed care plan) (Mont. Code Ann. 33-36-103(15)).
Alabama
Link to Alabama Legislature: http://www.legislature.state.al.us/misc/links/links.html
Consumer/Patient Protections
Access
*Ala. Admin. Code r. 420-5-6-.06 (1998) – standing referrals – HMOs
must have a system in place to ensure that enrollees receive medically
necessary referrals.; in those cases in which a health condition
of ongoing or chronic status has been established and the need for
specialized care has been determined, the referring physician may
authorize in advance a number of visits to a specialty physician
so that the enrollee may proceed directly to the specialty physician
without first meeting with the referring physician (without incurring
increased financial liability).
Ala. Code § 27-94-4 (1997) – OB/GYNs – health benefit plans
(inclusive term) must permit OB/GYNs to serve as PCPs and allow
patients direct access to OB/GYNs for specified services.
Complaints/UR
Ala. Code § 27-21A-10 – complaints – HMOs are required to establish
a complaint system (typical of HMO model act-type provisions that
require HMOs to establish a complaint system and get regulatory
approval but do not set timeframes, etc.).
Ala. Admin. Code r. 420-5-6-.08(1998) – grievances – HMOs are to
have three levels of review, with notice of right to appeal at each
stage; HMO is to specify time limits, no more than 45 days, for
disposition of grievances at each level of review.*
HMO Protections
Ala. Code § 27-21A-23 – vicarious liability – HMOs authorized
by the state are deemed not to be engaged in the practice of medicine
and no person participating in the arrangements of an HMO other
than the actual provider of services or supplies to enrollees shall
be liable for negligence, misfeasance, nonfeasance or malpractice
in connection with the furnishing of such services and supplies.
Selected Benefit Mandates (examples;
not intended to be exhaustive):
Ala. Code § 27-1-10.1 (1997) – off-label uses of drugs – any
insurance policy that provides coverage for drugs is required to
provide coverage for off-label use of drugs (not restricted to cancer)
Ala. Admin. Code r. 420-5-6-.04 (1998) –
basic services – HMOs are required to provide “basic health services,”
which include emergency care (defined term, although no reference
to prudent layperson), etc.
+The state health agency is expected to issue
regulations that establish tighter timeframes for handling grievances,
etc., shortly.
Return to Top of Page
Alaska
Link to Alaska Legislature: http://www.legis.state.ak.us/folhome.htm
Consumer/Patient Protections
Complaints/UR
1998 Alaska Sess. Laws Ch. 60, Sec. 5 (adding § 21.86.150(i)(3))
– denials of coverage – HMOs may not deny health care coverage unless
the enrollee has been examined by at least 2 physicians.
1998 Alaska Sess. Laws Ch. 60, Sec. 5 (adding § 21.86.150(j))
– denials of benefits – HMO UR decisions about medical necessity
may only be made by a provider in the relevant specialty or subspecialty
after consultation with covered person’s provider.
Disclosure
1998 Alaska Sess. Laws Ch. 60, Sec. 5 (adding § 21.86.150(i)(1))
– gag clauses – HMOs may not “cause, request, or knowingly permit”
the imposition of limits on provider communication with patients
regarding health care services (includes criticism of the HMO).
Prohibition on Incentives
1998 Alaska Sess. Laws Ch. 60, Sec. 5 (adding § 21.86.150(i)(4))
– incentives – HMOs may not “cause, request, or knowingly permit”
financial incentives to be given or offered to a provider for denying
or delaying health care services.
Return to Top of Page
Arizona
Link to Arizona Legislature : http://www.azleg.state.az.us/
Consumer/Patient Protections
Complaints/UR
Ariz. Rev. Stat. Ann. §§ 20-2530 to 20-2539 (West 1997)
– independent review – applies to all health care insurers (inclusive
definition), with an ERISA preemption caveat for self-funded plans;
does not create a private right of action ; requires insurers to
have at least 4 levels of review: an expedited medical review, an
informal reconsideration, a formal appeal process, and an external
independent review; reviewers must have certain qualifications;
timeframes are specified for each level of review; IR decisions
are subject to judicial review; the insurer pays the IR fees.
Disclosure
Ariz. Rev. Stat. Ann. § 20-1076(A)(6) (West 1997) – incentive
disclosure – health care services organizations must provide a concise
description of any incentives or penalties intended to encourage
plan providers to withhold services or minimize or avoid referrals
to specialists; does not create a private right of action; parallel
provisions for small employer plans at § 20-2323(h)(6).
Ariz. Rev. Stat. Ann. § 20-1076(A)(5) (West 1997) – formulary
disclosure – other disclosure items include information concerning
formularies.
Ariz. Rev. Stat. Ann. § 20-118 (West 1997) – gag clauses –
“no person” may restrict or prohibit, by means of policy or contract,
good faith communication between provider and patient concerning
health care needs, treatment options, health care risks or benefits
(same language is repeated in sections governing specific types
of insurers, e.g., § 20-1061 (health care services organizations),
§§ 20-827, 20-833 (hospital and other service corporations),
§ 20-934 (benefit insurers).
Emergency Care
Ariz. Rev. Stat. Ann. § 20-2803 (West 1997) – emergency care
– health care services plans (inclusive term) must cover an initial
medical screening exam and any immediately necessary stabilizing
treatment required under EMTALA without prior authorization; for
necessary follow-up care, prior authorization is deemed granted
unless a request is denied within a reasonable period of time; certain
kinds of follow-up care must be covered unless the plan makes alternative
arrangements for the patient’s care.
Nondiscrimination
*Ariz. Rev. Stat. Ann. § 20-1057 (West 1997) – discrimination
– health care services organizations must provide specified basic
health care services and may not cancel a plan because of a health
status-related factor or frequency of utilization of basic health
care services of an enrollee or group of enrollees.
Selected Benefit Mandates
Ariz. Rev. Stat. Ann. § 20-826 (West 1997) – home health services
- hospital and other service corporations must pay benefits for
any home health services prescribed by a physician in lieu of hospital
services (also §§ 20-1402, 1404 for group and blanket
disability insurance).
Ariz. Rev. Stat. Ann. § 20-826 (West 1997) – post-mastectomy
breast reconstruction – applies to hospital and other service corporations
that cover mastectomies (also § 20-1057 for health care services
organizations, §§ 20-1402, 1404 for group and blanket
disability insurance).
Note: § 20-1061 makes health care services organizations subject
to the statutory provisions concerning unfair trade practices and
frauds.
Return to Top of Page
Arkansas
Link to Arkansas Legislature: http://www.arkleg.state.ar.us/lpbin/lpext.dll
Consumer/Patient Protections
Access
*Ark. Code Ann. § 23-99-408 (Michie 1997)– continuity of care
– applies to insurers restricting providers; new patient who is
being treated by nonparticipating provider for a current episode
of an acute condition may continue that treatment as an in-network
benefit until earlier of end of treatment episode and 90 days; patient
whose provider is terminated may continue to receive care as an
in-network benefit until earlier of end of treatment for acute condition
and 90 days.
Ark. Code Ann. § 23-99-406 (Michie 1997) – OB/GYNs – health
insurers must permit direct access.
Complaints/UR
Ark. Code Ann. § 23-99-410 (Michie 1997) – grievances – applies
to all managed care plans; no specific timetables or kinds of review,
simple “prompt and meaningful review” in cases of denial with “prompt”
notice in writing of the outcome with “specific findings” relating
to the grievance.
Disclosure
Ark. Code Ann. § 23-99-407 (Michie 1997) – gag clauses – no
participating provider may be “prohibited, restricted or penalized
in any way” in connection with disclosure of any health care information
(extends to UR processes and financial incentives).
Ark. Code Ann. § 23-99-413 (Michie 1997) – formularies –health
insurers must provide to prospective policyholders, policyholders
and covered persons, upon request, among other things, information
concerning the existence of formularies and prior approval requirements
for prescription drugs, and criteria by which providers are evaluated
for participation (also available to providers upon request).
Emergency Care
Ark. Code Ann. § 20-9-309 (Michie 1997) – emergency care –
prudent layperson standard, no preauthorization required.
Formularies
*Ark. Code Ann. § 23-99-409 (Michie 1997) – nonformulary drugs
– applies to insurers using formularies; each insurer must have
a written procedure whereby covered persons can obtain “without
penalty and in a timely fashion,” specific drugs and medications
not included in the formulary when the formulary’s equivalent has
been ineffective or causes or can be expected to cause an adverse
reaction.
Selected Benefit Mandates
Ark. Code Ann. § 23-79-147 (as amended by SB 151, 1999 Ark
Legis. Serv.) – off-label uses of drugs – applies to any insurance
policy that provides coverage for prescription drugs; limited to
use for the treatment of cancer; standard qualifications concerning
backing in the medical literature.
Ark. Code Ann. § 23-99-405 (Michie 1997) – post-mastectomy
breast reconstruction – applies to health insurers that cover mastectomies.
Ark. Code Ann. §§ 23-79-601 to 607 (Michie 1997) – diabetes
– applies to all health insurance policies (inclusive term); requires
coverage of self-management training and medically necessary equipment,
supplies and services.
Return to Top of Page
California
Consumer/Patient Protections
Access
Cal. Health & Safety Code § 1367 (West 1998) – continuity
of care/referrals – admonition that health care service plans (=
entities that cover services in return for a prepaid or periodic
charge) furnish “services in a manner providing continuity of care”
and ready referral to other providers “as may be appropriate consistent
with good professional practice.”
*Cal. Health & Safety Code § 1373.96 (West 1999) – continuity
of care – plans must, at enrollee request, cover continuing treatment
by a terminated provider for an acute condition, serious chronic
condition, or pregnancy (does not apply to voluntary departure or
termination for cause, and provider must agree to certain terms);
for an acute or serious chronic condition, must cover services for
up to 90 days or longer if necessary for a safe transfer as determined
by the plan in consultation with the terminated provider, consistent
with good professional practice; serious chronic condition defined
as “a medical condition due to a disease, illness, or other medical
problem or medical disorder that is serious in nature, and either
persists without full cure or worsens over an extended period of
time or requires ongoing treatment to maintain remission or prevent
deterioration” (parallel provisions for life and disability insurers
are at Cal. Ins. Code § 10133.56).
*Cal. Health & Safety Code § 1374.16(a) (West 1999) – standing
referrals/specialists as PCPs – plans must have a procedure that
provides for a standing referral to a specialist if the PCP determines
in consultation with the specialist, if any, and the plan medical
director/designee that an enrollee needs continuing specialist care;
may involve treatment plan that limits visits or period of time;
plan must have a procedure that provides for referral to a specialist/specialty
care center for the purpose of coordinating the enrollee’s health
care, where a condition or disease requires specialized medical
care over a prolonged period of time and is life-threatening, degenerative,
or disabling (determination of medical necessity is made by the
PCP in consultation with specialist/center if any and the medical
director/designee); may involve treatment plan; after the referral
is made, the specialist is authorized to provide services within
the area of expertise in the same manner as the PCP, subject to
the terms of any treatment plan; determinations must be made within
3 b.d. of receipt of request and all necessary information, and
referral must be made within 4 b.d. of submission of treatment plan,
if any, to the medical director/designee; obligation to make OON
referral only where there is no appropriate IN specialist (as determined
by the PCP in consultation with the medical director).
Cal. Health & Safety Code § 1367.69 (West 1998) – OB/GYNs
– plans must permit OB/GYNs to serve as PCPs (direct access is mandated
under 1998 Cal. Legis. Serv. § 1367.95 (West)).
Complaints/UR
Cal. Health & Safety Code § 1367 (West 1998) – noninterference
– the section on administrative capacity contains a requirement
that a plan “be able to demonstrate to the department that medical
decisions are rendered by qualified medical providers, unhindered
by fiscal and administrative management.”
Cal. Health & Safety Code §§ 1368, 1368.01 (West 1998)
– grievances – plans must establish system; some timeframes specified,
and recourse to department permitted after 60 days in the process;
a status report if not a resolution required within 30 days.
Cal. Health & Safety Code § 1368.02 (West 1998) – ombudsman
– the commissioner is to establish a toll-free number and designate
an ombudsperson.
Cal. Health & Safety Code § 1368.1 (West 1998) – expedited
review – a plan that denies coverage to an enrollee with a terminal
illness must provide certain information within 5 business days
and provide the enrollee with the opportunity to attend a conference
within 30 calendar days.
Cal. Health & Safety Code § 1370.2 (West 1998) – reviewer
qualifications – plans must insure that reviewers of contested claims
have appropriate qualifications.
Cal. Health & Safety Code § 1370.4 (West 1998) – independent
review – plans must provide IR for enrollees with terminal conditions
seeking non-standard therapies that would be covered but for plan
determinations that they are experimental; does not apply to Medi-Cal
beneficiaries; costs are borne by the plan; timeframe is 30 days
or 7 days for expedited review; a majority decision is binding on
the plan and an even split is deemed a decision in favor of coverage
(parallel provisions for life and disability insurers are at Cal.
Ins. Code § 10145.3).
Disclosure
Cal. Bus. & Prof. Code §§ 2056, 2056.1 (West 1998)
– gag clauses/nonretaliation – no person may penalize a physician
or surgeon for principally for advocating for medically appropriate
health care or prohibit or discourage a physician or surgeon from
communicating to a patient information in furtherance of medically
appropriate health care; medically appropriate health care in a
hospital is defined by the medical staff, consistent with the applicable
legal standard of care; plans and their contracting entities may
not include provisions in their contracts that interfere with the
ability of a licensed health care provider to communicate with a
patient regarding his or her health care, including communications
regarding treatment options, alternative plans, or other coverage
arrangements (but may prohibit solicitation for alternative coverage
for the primary purpose of securing financial gain).
Cal. Health & Safety Code § 1367.10 (West 1998) – incentive
disclosure – plans that affect choice of provider must disclose
the basic method of reimbursement and whether financial bonuses
or incentives are used.
1998 Cal. Legis. Serv. § 1367.22 (West) – formulary disclosure
– plans must disclose current list of formulary drugs to members
of the public upon request.
Cal. Health & Safety Code § 1373.96 (West 1999) – continuity
of care – a description of how to request continuity of care must
be included in the evidence of coverage and disclosure form after
7/1/99.
Cal. Health & Safety Code § 1363 (West 1999) – matrix –
beginning 7/1/99, plans in individual or small group markets must
display information in uniform benefits and coverage matrix that
includes category descriptions with corresponding copayments and
limitations (includes prescription drug coverage, DME, mental health,
chemical dependency, home health).
Emergency Care
Cal. Health & Safety Code § 1371.4 (West 1998) – emergency
care – plans, with some exceptions, cannot require preauthorization
for emergency care so long as emergency services are legally mandated
without regard to ability to pay, unless the enrollee did not require
emergency care and reasonably should have known that (no preauthorization
for ambulance services per 1998 Cal. Legis. Serv. § 1371.5
(West), also linked to enrollee’s reasonable belief).
Formularies
*1998 Cal. Legis. Serv. § 1367.24 (West) – nonformulary drugs
– plans that cover prescription drugs must establish an “expeditious”
process by which providers may obtain authorization for medically
necessary nonformulary drugs.
*1998 Cal. Legis. Serv. § 1367.22 (West) – maintenance drugs
– plans that cover prescription drugs may not exclude a drug previously
approved for coverage for the enrollee’s medical condition if the
provider continues to prescribe it (eff. 7/1/99).
Prohibition on Incentives
Cal. Bus. & Prof. Code § 511, Cal. Health & Safety
Code § 1348.6 (West) – no contract between a plan and a licensed
health care practitioner, or subcontract between a practitioner/group
that contracts with a plan or insurer and another practitioner/group,
shall contain an incentive plan that includes a specific payment
made to a licensed health care practitioner as an inducement to
deny, limit or delay specific, medically necessary, and appropriate
services covered under the contract and provided with respect to
a specific enrollee or group of enrollees with similar medical conditions
(does not prohibit incentive plans that involve general payments
or shared-risk arrangements that are not tied to specific medical
decisions involving specific enrollees/groups with similar medical
conditions, and payments are deemed confidential information) (parallel
provisions for life and disability insurers are at Cal. Ins. Code
§ 10175.5).
Consumer Participation
Cal. Health & Safety Code § 1369 – policy – plans must
establish procedures to permit members to participate in establishing
the public policy of the plan.
Provider Protections
Cal. Bus. & Prof. Code § 510 (West 1998) – nonretaliation
– any retaliation against a health care practitioner principally
for advocating for appropriate health care is declared against public
policy (see also § 2056).
Selected Benefit Mandates
Cal. Health & Safety Code § 1367.21 (West 1998) – off-label
uses of drugs – plans that provide coverage for prescription drugs
cannot exclude off-label use of drugs; limited to life-threatening
conditions; Medi-Cal plans are exempt.
Cal. Health & Safety Code § 1367.18 (West 1998) – orthotic/prosthetic
devices – most plans must cover.
Cal. Health & Safety Code § 1367.19 (West 1998) – special
footware – most plans must cover.
1998 Cal. Legis. Serv. AB 2003/Ch. 790 – dental – plans required
to cover general anesthesia and associated charges for dental treatment
of certain groups, including those with developmental disabilities,
when treatment must be rendered in a hospital or surgery center
due to the physical or mental condition of the patient.
Cal. Code Regs. tit. 10, § 1300.67 – basic services – health
care services plans must provide basic health care services, including
medically appropriate home health services. (See also AB 1899,
1999 Legis. Serv. ch. 1026).
Return to Top of Page
Colorado
Consumer/Patient Protections
Access
*Colo. Rev. Stat. Ann. § 10-16-704(2) – OON referrals – where
no participating provider is available to provide a covered benefit,
the carrier must arrange for a referral to a provider with the necessary
expertise and ensure that the cost to the covered person is equivalent
to that for an in-network referral.
*Colo. Rev. Stat. Ann. § 10-16-705(4) – continuity of care
– if a managed care plan terminates a provider without proper notice,
the plan must permit covered persons to continue receiving care
for 60 days from the termination date.
*Colo. Rev. Stat. Ann. § 10-16-704(9) – access plan – for each
managed care network the carrier must develop an access plan that,
among other things, describes the carrier’s efforts to address the
needs of covered persons with physical and mental disabilities (among
other groups).
Colo. Rev. Stat. Ann. § 10-16-107 – OB/GYN – managed care plans
must either allow women direct access to a participating OB/GYN
or CNM or not unreasonably withhold a referral when requested.
Complaints/UR
Colo. Rev. Stat. Ann. § 10-16-705(14) – preauthorization –
provider contracts must state that the sole responsibility for obtaining
preauthorizations rests with the participating provider who recommends
or orders a service.
Colo. Code of Reg. § 4-2-17 – UR/review decisions – applies
to all health plans that base decisions concerning claims on UR;
for prospective review, determination within 2 b.d. of obtaining
all necessary information, with notice of an adverse determination
within 1 b..d of decision; for concurrent review, determination
within 1 b.d., with notice of an AD within 1 b.d. (service continued
without liability to covered person until notice given); content
of notice specified, including instructions for initiating appeal
and requesting statement of clinical rationale; may request reconsideration;
covered person may designate representative to exercise rights.
Colo. Code of Reg. § 4-2-17 – UR/appeals – first level appeals
must be evaluated by a physician in consultation with appropriate
clinical peer(s), in each case with no involvement in initial AD,
and decision must be rendered and notice given within 20 b.d. of
request; notice must include credentials of reviewers, medical rationale
and reference to evidence used as basis for decision, and description
of process for requesting second level appeal; second level appeal
must involve a panel with at least 3 people, the majority of whom
were not previously involved and are health care professionals with
appropriate expertise (also no direct financial interest in outcome
and not plan employees), with meeting within 45 days of receipt
of request, and 15 b.d. advance notice with opportunity for covered
person to appear, or if not practical for geographic reasons, opportunity
to communicate via appropriate technology at carrier expense, plus
provision of all relevant information not confidential or privileged
upon request; covered person has right to attend, present, submit
supporting material, ask questions, and be assisted or represented
by another (notice must advise of these rights); written decision
within 5 b.d. of meeting, with notice that includes right to contact
insurance commissioner’s office and telephone number and address.
Colo. Code of Reg. § 4-2-17 – UR/expedited appeals – where
standard review procedures would seriously jeopardize the life or
health of the covered person or jeopardize his/her ability to regain
maximum function, decision must be made as expeditiously as the
medical condition requires, but in no event more than 72 hours after
review is commenced (must be provided for all requests concerning
follow-up to emergency care).
Emergency Care
Colo. Rev. Stat. Ann. § 10-16-704(5) – emergency care – managed
care plans cannot deny benefits for emergency services based upon
failure to comply with notification provisions where the medical
condition prevented timely notification.
Colo. Code of Reg. § 4-2-17(VI)(G) – UR/ER – adopts prudent
layperson standard for establishing necessity of emergency services,
situations in which prior authorization cannot be required, necessity
of obtaining care from OON provider (if prudent layperson would
have reasonably believed that use of contracting provider would
result in delay that would worsen emergency).
Provider Protections
Colo. Rev. Stat. Ann. §§ 10-16-121, 10-16-705(11) – nonretaliation
– carriers’ contracts must contain a provision stating that neither
the provider nor the carrier shall be prohibited from protesting
or expressing disagreement with a medical decision, policy or practice,
and that the carrier shall not terminate the contract because the
provider expresses disagreement with a decision to deny or limit
benefits or assists a patient in seeking reconsideration or discusses
with any patient any aspect of the patient’s medical condition or
treatment options or plan policy provisions or recommends a health
plan based on personal knowledge of the patient’s health needs (but
can prohibit maliciously critical comments and terminate for material
misrepresentation); carriers are prohibited from penalizing providers
for good faith reports to regulators or discussions of financial
arrangements with patients.
Return to Top of Page
Connecticut
Link to Connecticut Legislature: http://prdbasis.cga.state.ct.us/BASIS/TSPBKCP/LIN1/PUB/MSF
Consumer/Patient Protections
Access
Conn. Gen. Stat. Ann. § 38a-530b – OB/GYNs – group health carriers
must permit direct access to OB/GYNs and may permit OB/GYNs to serve
as PCPs.
Complaints/UR
1997 Conn. Legis. Serv. P.A. No. 97-99 § 14 – grievances –
general requirement that MCO have one and inform enrollees about
it.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 20 – independent review
– any enrollee or provider with enrollee consent may appeal a denial
to the commissioner, but only after exhausting internal MCO or URO
mechanisms; the filing fee is $25 (waivable); the decision is binding.
Conn. Gen. Stat. Ann. §§ 38a-226-38a-226d – UR standards
– sets timeframes for UR, specifies content for notices, qualifications
for reviewers, and types of appeals that must be provided, including
expedited review for emergency or life-threatening situations; prohibits
financial incentives based on number of denials.
Disclosure
1997 Conn. Legis. Serv. P.A. No. 97-99 § 12 – gag clauses –
MCO contracts with providers may not prohibit discussion of any
treatment options with patients, or disclosure of compensation methods
to an enrollee who inquires.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 8 – UR disclosure
– MCOs must provide enrollees and potential enrollees with a plan
description including the number of UR denials and the number upheld
and reversed on appeal (must also include enrollee satisfaction
information). (Procedures for maintaining confidentiality
must also be described.)
1998 Conn. Legis. Serv. amendment to P.A. No. 97-99 § 8 – formulary
disclosure – plan descriptions must also describe the use of drug
formularies or any limits on the availability of prescription drugs
and the procedure for obtaining information on the availability
of specific drugs covered.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 13 – report cards
– consumer report cards are to be distributed by the commissioner
of insurance beginning 3/15/99.
Emergency Care
1997 Conn. Legis. Serv. P.A. No. 97-99 § 26 – emergency care
– adopts prudent layperson standard.
Conn. Gen. Stat. Ann. § 38a-525a – emergency care – group health
policies may not direct an enrollee to obtain approval before calling
9-1-1 in a life or limb threatening emergency (enrollee belief).
Provider Protections
*1997 Conn. Legis. Serv. P.A. No. 97-99 § 7 – provider profiling
– MCOs that measure provider performance must make allowances for
the severity of illness or condition of the patient mix and for
patients with multiple illnesses or conditions, must share the documentation
with regulators, and must inform enrollees and providers of their
methodology upon request.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 9 – nonretaliation
– MCOs are prohibited from retaliating against providers for assisting
enrollees with appeals.
Selected Benefit Mandates
Con. Gen. Stat. Ann. § 38a-518b – off-label uses of drugs –
applies to group health policies, limited to cancer.
Con. Gen. Stat. Ann. § 38a-520 –home health services – applies
to group health policies, includes medical social services.
Miscellaneous
1997 Conn. Legis. Serv. P.A. No. 97-99 § 21 – compliance with
laws – MCOs must conform to all applicable state and federal antidiscrimination
and confidentiality statutes and have written confidentiality policies
and procedures.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 11 – coinsurance payments
– coinsurance payments must be calculated based on the lesser of
provider/vendor charges and or the amount payable by the MCO.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 10 – no limitation
of action – MCOs may not limit causes of action or contract rights
otherwise possessed by enrollees by contract.
1997 Conn. Legis. Serv. P.A. No. 97-99 § 27 – mental health
parity – group health insurance policies must provide coverage for
biologically-based mental or nervous conditions at least equal to
coverage for medical or surgical conditions. (dealt with in separate
legislation in most other states)
Return to Top of Page
Delaware
Consumer/Patient Protections
Access
*Del. Reg. § 69.305 – continuity of care – except in cases
where termination was due to unsafe practices, MCOs must assure
continued coverage of services at the contract price for up to 120
days [from notice? termination?] in cases where it is medically
necessary for the enrollee to continue treatment with the terminated
provider.
Del. Code Ann. tit. 18, §§ 3342, 3556 – OB/GYNs – insurers
must permit OB/GYNs to serve as PCPs if certain conditions
are met and must allow direct access to OB/GYNs.
Del. Reg. § 69.402 – access plan – MCOs must annually submit
to the insurance department policies and procedures for measuring
and assessing the adequacy of the network.
Del. Reg. § 69.402(B) – OON providers – MCOs shall make acceptable
service arrangements with the provider and enrollee if the appropriate
level of service is not available at no extra cost to the enrollee.
Complaints/UR
Del. Reg. § 69.403 – UR/general standards – protocols must
be periodically reviewed and updated, and with the exception of
internal or proprietary quantitative thresholds, be readily available,
upon request, to affected providers and enrollees; compensation
to persons providing UR services shall not contain direct or indirect
incentives to make inappropriate decisions, e.g., compensation may
not based on the quantity or type of adverse determinations rendered;
all determinations must be made by appropriately qualified staff,
and all determinations to deny or limit an admission, service, procedure
or extension of stay must be rendered by a physician and must made
in accordance with clinical and medical criteria and standards and
take into account the individualized needs of the enrollee.
Del. Reg. § 69.404 – UR/appeals – three stages (informal internal,
formal internal, and formal external); correspond to Colorado in
terms of general parameters, except for stage 3, external review;
stage 1 timeframes are 72 hr. maximum for expedited appeals (imminent,
emergent or serious threat to health), 5 b.d. for others; in stage
2, enrollee has right to attend, present, submit supporting material,
etc., and timeframe is 72 hr. maximum for expedited review, 30 days
from receipt of request for others (with extension for reasonable
cause).
Del. Reg. § 69.404 – UR/independent review – MCO charged with
maintaining formal external review process, with review meeting
within 45 days of request; includes provision for enrollee to attend/communicate
via appropriate technology at MCO request, and rights similar to
stage 2, with written decision within 5 b.d. of meeting.
Del. Reg. § 69.404(A)(3) – UR/MCO-appointed representative
– at any stage of the appeal process, upon enrollee request, the
MCO must appoint a member of its staff with no direct involvement
in the case to represent/assist the enrollee, and the appealing
enrollee must be notified of this right.
Disclosure
Del. Code Ann. tit. 18, §§ 3303, 6407 – gag clauses –
health insurance policies/HMO contracts may not contain any provision
prohibiting health care providers from giving patients information
regarding diagnoses, prognoses, and treatment options.
Emergency Care
Del. Reg. §§ 69.1, 69.402(C) – emergency care – adopts
prudent layperson standard in definition of emergency medical condition;
MCOs may not require prior authorization for treatment of such a
condition (= screen and stabilize); emergency and urgent care services
must include 24x7 medical and psychiatric care and out of area care
for urgent or emergency conditions where the enrollee cannot reasonably
access IN services.
Nondiscrimination
*Del. Reg. § 69.307 – nondiscrimination – no MCO may cancel
or refuse to renew an enrollee solely on the basis of his/her health;
pre-existing condition clauses may not extend longer than 12 months
from enrollment.
Prohibition on Incentives
Del. Reg. § 69.307 – incentives – incentives to a provider
to provide less than medically necessary services are prohibited.
Provider Protections
Del. Code Ann. tit. 18, §§ 3339, 6408 – nonretaliation
– insurers/HMOs may not refuse to contract with or compensate providers
solely based on their good faith communication with patients concerning
the insurer’s products or services.
Del. Reg. § 69.307 – nonretaliation – MCOs may not penalize
providers for good faith reports to state authorities re threats
to patient health or welfare.
*Del. Reg. § 69.401(C) – nondiscrimination/selection criteria
– professional selection criteria shall not be established in a
manner that would allow an MCO to avoid high-risk populations by
excluding providers because they are located in geographic areas
that contain populations or providers presenting a risk of higher
than average claims, losses or health services utilization, or that
would exclude providers because they treat or specialize in treating
populations presenting a risk of higher than average claims, losses
or health services utilization.
Return to Top of Page
District of Columbia
Consumer/Patient Protections
Disclosure
D.C. Code Ann. § 35-4506(h) – gag clauses – HMO contracts with
providers may not interfere in discussions between patient and provider
concerning treatment options; carrier contracts with providers must
require providers to discuss treatment options with patients; HMOs
may not retaliate against providers solely based on discussion of
treatment options with patients.
Provider Protections
D.C. Code Ann. § 35-4506(h) – nonretaliation – HMOs may not
retaliate against providers solely based on discussion of treatment
options with patients.
Return to Top of Page
Florida
Consumer/Patient Protections
Access
*Fla. Stat. Ann. § 641.51(5) – OON referrals – HMOs and prepaid
plans must have a policy to determine when referrals to out-of-network
“specially qualified providers” should be provided to address “unique
medical needs.”
*Fla. Stat. Ann. § 641.51(6) – standing referrals – HMOs and
prepaid plans must have policies and procedures for the provision
of standing referrals to subscribers with chronic and disabling
conditions which require ongoing specialty care.
*Fla. Stat. Ann. § 641.51(7) – continuity of care – HMOs and
prepaid plans must allow subscribers with life-threatening or disabling
and degenerative conditions (plus pregnancy) to continue care for
60 days with a terminated provider.
Fla. Stat. Ann. § 641.19 - OB/GYNs – HMOs must permit participating
OB/GYNs to serve as PCPs.
Fla. Stat. Ann. § 641.31(33) – dermatologists – HMOs that offer
dermatological services must provide direct access to participating
dermatologists for office visits and minor procedures and testing,
within certain limits.
Complaints/UR
Fla. Stat. Ann. § 641.511 – grievances – one year window for
submission of grievances to HMOs/prepaid plans; 30-day window for
internal appeal of adverse determinations; minimum requirements
for grievance procedures include provision of a toll-free number,
expedited review for grievances classified as urgent, and development
of a procedure for assisting individuals who are unable to submit
a written grievance; 60-90 day timeframe for action on standard
reviews, shortened to 72 hours for expedited review; service continued
without liability to subscriber until notice in the case of concurrent
review; subject to administrative sanctions for noncompliance; no
independent review until internal review is completed, but subscriber
may submit a copy of grievance to agency at any time.
Fla. Stat. Ann. § 408.7056 – independent review – state regulatory
agency is to implement a consumer assistance program that includes
a review panel that meets periodically to consider cases not resolved
through plans (HMOs, PPOs) internal grievance procedures; the panel
consists of agency and insurance department staff, which may contract
for medical expertise; focused on instances of violation of law;
parties have opportunity to appear before panel and panel must notify
them that it has transmitted its recommendations to the agency within
30 days after the meeting; the agency sends a response to the parties
within 30 days of its receipt of a recommendation.
Fla. Stat. Ann. § 641.60 – consumer assistance – establishes
statewide managed care ombudsman committee.
Disclosure
Fla. Stat. Ann. § 641.54 – disclosure – HMOs and prepaid plans
must provide information concerning the following upon request:
the authorization and referral process, determinations of medical
necessity, prescription drug benefits, policies and procedures respecting
confidentiality, the decision making process regarding experimental
treatments, and policies and procedures for addressing the needs
of NESPs, etc.
Fla. Stat. Ann. § 641.315(8) – gag clauses – HMOs contracts
with providers may not contain any provision restricting communication
with patients regarding medical care or treatment options.
Fla. Stat. Ann. § 641.3903(13) – misrepresentation – HMOs may
not knowingly mislead potential enrollees as to the availability
of providers.
Emergency Care
Fla. Stat. Ann. §§ 641. 19, 641.31(12), 641.513 – emergency
care – HMOs may not require prior authorization for emergency care
or deny payment based on failure to give notice prior to or within
a certain time period; HMOs must use the state definitions for emergency
condition (which includes concept of reasonable expectation), etc.
(§ 627.6472 covers insurance policies with exclusive provider
provisions).
Nondiscrimination
*Fla. Stat. Ann. § 641.3903(12) – discrimination – HMOs may
not engage or attempt to engage in discriminatory practices that
discourage participation on the basis of actual or perceived health
status of Medicaid recipients.
Selected Benefit Mandates
Fla. Stat. Ann. § 641.31(26)(a) – diabetes – HMOs and prepaid
health plans must cover “all medically appropriate and necessary”
equipment, supplies, and services used to treat diabetes.
Fla. Stat. Ann. § 641.31(27) – osteoporosis – HMOs must cover
“medically necessary” diagnosis and treatment of osteoporosis for
high-risk individuals.
Fla. Stat. Ann. § 641.31(32) – post-mastectomy breast reconstruction
– applies to HMOs that cover mastectomies.
Fla. Stat. Ann. § 641.31094 – bones and joints in the facial
region – applies to all HMOs that cover surgical procedures involving
bones and joints.
Fla. Stat. Ann. § 627.4236 (West 1998) – bone marrow transplants
– insurers and HMOs that cover cancer treatment may not exclude
coverage for BMTs recommended by the referring and treating physicians
as experimental if the particular use is accepted within the appropriate
oncological specialty and according to rules developed by the state
administrative agency.
Fla. Stat. Ann. § 627.4239 – off-label uses of drugs – applies
to all insurers; limited to treatment of cancer.
Miscellaneous
Fla. Stat. Ann. § 641.28 – remedies – in any civil action brought
to enforce an HMO contract, the prevailing party is entitled to
recover attorney’s fees and court costs.
Insurance Protections (examples below;
these provisions do not address problems with managed care per se;
many states have similar provisions)
*Fla. Stat. Ann. § 641.31073 – discrimination – HMOs that offer
group coverage may not establish rules for eligibility based on
health status, medical condition, claims experience, receipt of
health care, or disability (but may limit the amount, level or nature
of benefits for similarly situated individuals); premium variations
are permitted, so long as they apply to all similarly situated individuals.
(relation to HIPAA?)
Fla. Stat. Ann. § 641.31 – dependent children - general insurance
protections include provisions that require HMOs to (a) cover newborn
children, to include necessary care for congenital defects, etc.
and (b) provide continuing coverage (beyond age limits) for children
who are incapable of self-sustaining employment by reason of mental
or physical handicap and dependent.
Return to Top of Page
Georgia
Consumer/Patient Protections
Access
*Ga. Code Ann. § 33-20A-9(2) – nonformulary drugs – MCOs that
use formularies must have a written procedure that allows patients
to obtain nonformulary drugs “without penalty and in a timely fashion”
where the formulary’s equivalent (a) has been ineffective in treating
the patient or (b) causes or is reasonably expected to cause an
adverse reaction.
Ga. Code Ann. § 33-24-59 – OB/GYNs – direct access provision
applicable to insurers, HMOs, etc.
Complaints/UR
Ga. Code Ann. § 33-20A-5(3) – grievances – MCOs must provide
a “prompt and meaningful” hearing for denials, with non-medical
director physician representation on the hearing panel; if the outcome
is adverse notice must include specific findings.
Ga. Code Ann. § 33-20A-31 – independent review – threshold
determination whether treatment sought reasonably appears to be
covered; enrollee must have received notice of an adverse decision
or a determination that the proposed treatment is excluded as experimental;
in the case of an experimental exclusion, the enrollee must have
a terminal condition or the enrollee’s ability to regain or maintain
maximum function must be impaired by withholding the treatment (in
the judgment of the treating physician) and the treating physician
(who is board certified or eligible and qualified to treat the condition)
certifies that there is no standard treatment available more beneficial
than the proposed treatment and that scientifically valid studies
using accepted protocols published in peer reviewed literature demonstrate
that the proposed treatment is likely to be more beneficial for
the enrollee than available standard treatment and the treatment
would be covered but for the determination that it is experimental;
at least $500 must be at stake; the MCO is required to pay for the
independent review; eligible enrollees must be given instructions
on how to request review; the IRO decision is final and binding
on the MCO; 72 hour expedited review available, otherwise 15 b.d.+;
conflict of interest rules apply.
Ga. Code Ann. § 33-20A-31 – IR/medical necessity – for purposes
of IR, defined as care based upon generally accepted medical practices
in light of conditions at the time of treatment which is (A) appropriate
and consistent with the diagnosis and the omission of which could
adversely affect or fail to improve the eligible enrollee’s condition;
(B) compatible with the standards of acceptable medical practice
in the U.S.; (C) provided in a safe and appropriate setting given
the nature of the diagnosis and the severity of the symptoms; (D)
not provided solely for the convenience of the eligible enrollee
or the convenience of the provider; and (E) not primarily custodial
care, unless that is a covered benefit.
Ga. Code Ann. § 33-20A-31 – IR/experimental – in making a determination
as to whether a treatment is experimental, the expert reviewer must
determine whether the treatment has been approved by the FDA or
whether medical and scientific evidence (defined term) demonstrates
that the expected benefits of the proposed treatment would be greater
than the benefits of any available standard treatment and that the
adverse risks of the proposed treatment will not be substantially
increased over those of standard treatments; for either determination,
the reviewer must apply prudent professional practices and assure
that at least two documents support the decision.
Disclosure
Ga. Code Ann. § 33-20A-5(1) – incentive disclosure – MCOs must
disclose limited utilization incentive plans to enrollees and prospective
enrollees upon request (parallel provision covering HMOs only at
§ 33-21-13(c); parallel provision covering insurers, HMOs,
and private health benefit plans at § 31-11-82).
Emergency Care
Ga. Code Ann. §§ 33-20A-3, 33-20A-5, 33-20A-9(1) – emergency
care – applies to all managed care plans; prudent layperson standard;
if judged necessary by the provider, services may be initiated without
prior authorization and MCOs and private health plans must pay (parallel
provision relating to HMOs only at § 33-21-18.1).
Prohibition on Incentives
Ga. Code Ann. § 33-20A-6 – incentives – MCOs may not use financial
incentive programs that directly compensate providers for providing
less than medically necessary and appropriate care, but capitated
payment arrangements consistent with the intent of this section
are not prohibited.
MCO Liability
Ga. Code Ann. § 51-1-48 (West 1999) (HB 732) – negligence –
any person or entity that administers benefits or reviews claims
under a managed care plan must exercise ordinary diligence to do
so in a timely and appropriate manner in accordance with the practices
and standards of the profession of the health care provider generally;
any injury or death to an enrollee resulting from a want of such
ordinary diligence is a tort from which recovery may be had against
the MCO offering the plan (but no punitive damages).
Provider Protections
Ga. Code Ann. § 33-20A-7 – nonretaliation – no health care
provider may be penalized for discussing medically necessary or
appropriate care with or on behalf of his or her patient.
Selected Benefit Mandates
*Ga. Code Ann. § 33-24-59.1 – clinical trials – any plan that
provides major medical coverage for dependent children must cover
the routine patient care costs incurred in connection with a dependent
child’s participation in an approved clinical trial for the treatment
of children’s cancer.
Ga. Code Ann. § 33-24-59.2 – diabetes – managed care plans
and other major medical policies or plans must offer coverage.
Miscellaneous
*Ga. Code Ann. § 33-20A-5(3) – QA – MCOs must have a QA program
that includes mechanisms to detect both underutilization and overutilization
of services. (General mandates to have some kind of QA program are
common, undoubtedly part of model HMO act.)
Return to Top of Page
Hawaii
Consumer/Patient Protections
Complaints/UR
1998 Hawaii Sess. Laws Act 178 § 6 – independent review – after
exhausting all internal review and appeal procedures, an enrollee
may appeal an adverse decision to a 3-member review panel appointed
by the commissioner (an MCO representative and a provider, both
uninvolved, and the commissioner or his/her designee).
Disclosure
*1998 Hawaii Sess. Laws Act 178 § 4(b) – disclosure of treatment
options – providers in managed care plans must discuss all treatment
options with an enrollee and ensure that persons with disabilities
have an effective means of communication with the provider and other
members of the managed care plan.
1998 Hawaii Sess. Laws Act 178 § 4(d) – gag clauses – managed
care plans may not impose any prohibition or negative treatment
upon a provider for disclosing any information regarding treatment
options or care.
Emergency Care
1998 Hawaii Sess. Laws Act 246, §§ 431.10A-, 432.1-, 432D-
– emergency care – prudent layperson standard; health plans must
cover emergency services without prior authorization (out of network,
if a prudent layperson would have believed that the time required
to reach a participating provider placed him/her in danger, etc.).
Miscellaneous
1998 Hawaii Sess. Laws Act 178 § 10(b)(5) – confidentiality
– a managed care plan shall ensure confidentiality of records and
shall not disclose individually identifiable data or information
pertaining to the diagnosis, treatment, or health of any enrollee,
except as provided under law.
1998 Hawaii Sess. Laws Act 178 § 8 – remedies – exclusive enforcement
by the commissioner.
Return to Top of Page
Idaho
Consumer/Patient Protections
Access
Idaho Code § 41-3915(2) – OB/GYNs – MCOs must allow members
direct access to OB/GYNs and permit OB/GYNs to serve as PCPs.
Complaints/UR
Idaho Code § 41-3918 – grievances – MCOs must provide “reasonable”
procedures to assure “prompt” review.
Idaho Code § 41-3930 – UR standards – MCOs must adopt criteria
that are “based on sound patient care and scientific principles”
and “sufficiently flexible to allow deviations” when justified,
and procedures for timely review by clinical peers; MCOs must respond
to requests for prior authorization for non-emergency services within
2 business days.
Disclosure
Idaho Code § 41-3914(1) – formularies – MCOs must provide to
enrollees and make available for inspection by public on annual
basis, among other things, a statement as to whether the MCO includes
a limited formulary and a statement that the formulary will be made
available to any prospective member upon request.
Emergency Care
Idaho Code §§ 41-3903(7), 41-3930(2) – emergency care
– MCOs may not require prior authorization for emergency services
(definition incorporates prudent layperson standard).
Nondiscrimination
*Idaho Code § 41-3915(3) – discrimination – MCOs may not cancel
the enrollment of a member or refuse to transfer a member from group
to individual basis for reasons relating to health status. (check
for this kind of HIPAA-related provision in other states)
Prohibition on Incentives
Idaho Code § 41-3928 – incentive prohibition – MCOs may not
employ incentive plans that includes specific payments to providers
as an inducement to deny, limit, or delay specific, medically necessary,
and appropriate covered services provided with respect to a specific
member or group of members with similar medical conditions; incentive
plans that involve general payments and shared risk agreements not
tied to specific medical decisions involving specific members or
groups of members with similar medical conditions are not prohibited.
Consumer Participation
Idaho Code § 41-3916 – policy and operation – MCOs must establish
a mechanism to provide members an opportunity to participate in
matters of policy and operation.
Provider Protections
Idaho Code § 41-3927(4) – contract terms – MCOs may not require
that a provider deny a member access to services not covered by
the plan, etc.
Idaho Code § 41-3927(5) – nonretaliation – MCOs may not refuse
to contract with or compensate providers solely because they have
communicated in good faith with patients regarding the MCO’s products
as they relate to the needs of the patients; MCOs may not penalize
providers practicing in conformity with community standards solely
for advocating on behalf of patients.
Illinois
Consumer/Patient Protections
Access
215 Ill. Comp. Stat. Ann. 125/5-3.1, 5/356r – OB/GYNs – HMOs and
other insurers that use PCPs must allow a woman to designate an
OB/GYN to whom the woman has direct access.
Complaints/UR
215 Ill. Comp. Stat. Ann. 125/4-6 – complaints – HMOs must have
“reasonable procedures” for complaint handling; when a complaint
is received by the dept. of insurance, notice is sent to the HMO,
which has 21 days to respond.
215 Ill. Comp. Stat. Ann. 125/4-10 – independent second opinions
– HMOs must offer review by an unaffiliated physician with the same
class of license as the PCP in the event of a dispute between the
PCP and HMO regarding the medical necessity of a covered service
(with a nonretaliation provision attached).
Selected Benefit Mandates
*215 Ill. Comp. Stat. Ann. 125/4-5 – organ transplants – HMOs may
not deny reimbursement for an otherwise covered expense incurred
in an organ transplant procedure solely on the basis that the procedure
is experimental [i.e., experimental or investigational] unless the
Office of Health Care Technology Assessment has determined that
the procedure is experimental or there is insufficient data to determine
whether it is clinically acceptable.
215 Ill. Comp. Stat. Ann. 125/4-6.3, 5/370r – off-label uses of
drugs – applies to HMOs and all group policies that cover prescribed
drugs, limited to cancer treatment.
Return to Top of Page
Indiana
Consumer/Patient Protections
Access
*Ind. Code Ann. § 27-13-36-5 (West 1998) – OON referrals –
when a PCP determines that a service is needed and the HMO determines
that the type of service is covered and is not available in-network,
the PCP and HMO must refer the enrollee to an appropriate out-of-network
provider “within a reasonable amount of time and within a reasonable
proximity”; payment to the provider is the lesser of the UCR charge
for the area or an agreed amount, with the enrollee responsible
only for the deductible or copay applicable to in-network care;
contract terms penalizing PCPs making this kind of determination
are prohibited.
*Ind. Code Ann. §§ 27-13-37-2, 27-13-37-3 (West 1998)
– standing referrals/specialists as PCPs – HMOs must develop a system
to allow enrollees to use appropriate participating providers to
manage their condition when their PCPs determine that this is warranted
by the condition, for as along as warranted; contract terms penalizing
PCPs making this kind of referral are prohibited; eff. 7/1/99 enrollees
must be given a choice of appropriate participating providers when
a referral is made.
*Ind. Code Ann. §§ 27-13-36-6, 27-13-36-11 (West 1998)
– continuity of care – HMO contracts with providers must require
the provider to continue to treat an enrollee for up to 60 days
after termination at the enrollee’s election; HMOs must develop
standards for continuity of care following enrollment.
Ind. Code Ann. § 27-8-24.7-5 (West 1998) – OB/GYNs – insurers
including HMOs must permit OB/GYNs to serve as PCPs.
*Ind. Code Ann. § 27-13-36-10 (West 1998) – access plan – HMOs
must demonstrate to the commissioner that they have an access plan
to meet the needs of enrollees, including the vulnerable and underserved
and NESPs.
*Ind. Code Ann. § 27-13-36-3 (West 1998) – proximity – HMOs
that cover specialty medical services and mental and behavioral
health services must demonstrate to the department that offered
services are located within reasonable proximity to subscribers
(eff. 7/1/99).
Complaints/UR
Ind. Code Ann. § 27-13-37-5 (West 1998) – second opinions –
HMOs must allow an enrollee to obtain a second opinion from an appropriate
participating provider upon request.
Ind. Code Ann. §§ 27-13-10-5 to 27-13-10-13 (West 1998)
– grievances – HMOs must accept grievances orally or in writing,
offer a toll-free number (capable of handling the languages of the
major population groups served), and offer assistance with filing;
procedures must include standards for timeliness, under normal circumstances
not to exceed 20 business days from the filing date; members of
panels that review appeals must be qualified and free of direct
conflicts, appeals must be resolved not later than 45 days after
the filing date, and grievance resolution notices must contain specified
information.
*Ind. Code Ann. §§ 27-13-39-2, 27-13-39-3 (West 1998)
– experimental treatments – HMOs must disclose limits on coverage
for experimental procedures, drugs, etc., including processes for
making determinations and criteria; HMOs must provide enrollees
denied services notice of the basis of denial and the right to appeal;
in an emergency or where the enrollee’s condition is life-threatening
the HMO has 72 hours to complete a review.
Ind. Code Ann. § 27-13-39-1 (West 1998) – technology assessment
– HMOs must have procedures to evaluate technologies and their applications
for coverage that include review of information from regulatory
bodies and published scientific literature and involve appropriate
professionals in the decision making process.
Disclosure
Ind. Code Ann. § 27-13-15-1 (West 1998) – gag clauses/nonretaliation
– HMO contracts with providers may not prohibit disclosure of incentives
to limit services or treatment options and may not penalize providers
for disclosure.
Emergency Care
Ind. Code Ann. §§ 27-13-1-11.7, 27-13-36-9 (West 1998)
– emergency care – HMOs must pay for emergency care without prior
authorization and without regard to contractual relationships, based
on prudent layperson standard.
Formularies
*Ind. Code Ann. § 27-13-38-1 (West 1998) – formularies/nonformulary
drugs and devices – HMOs may use formularies, but only if (a) the
formularies are developed, reviewed, and updated in consultation
with and with the approval of a committee with a physician majority,
and (b) there is an expeditious process for an enrollee to obtain
a medically necessary and appropriate nonformulary drug or device
without prior HMO approval and without penalty or additional cost-sharing;
HMOs may not void or refuse to renew a contract because a provider
prescribed a drug or device as provided.
Miscellaneous
Ind. Code Ann. § 27-13-7-14.8 (West 1998) – mental health parity
– HMO contracts may not impose aggregate lifetime limits or annual
limits on coverage of services for mental illness if similar limitations
are not imposed on coverage for other conditions (does not apply
after 9/29/2001).
Ind. Code Ann. § 27-13-29-1 (West 1998) – DTPA – HMOs are subject
to laws concerning unfair or deceptive acts or practices to the
extent not in conflict with laws regulating HMOs. (standard
for most states)
Return to Top of Page
Iowa
Consumer/Patient Protections
Disclosure
Iowa Admin. Code r. 191-40.22(514B) – gag clauses – HMOs may not
prohibit providers from, or punish providers for, discussing treatment
options with patients, advocating for patients in UR or grievance
processes, or reporting the HMO to regulators in good faith (roughly
parallel provisions for PPOs at r. 191-27.2(514F) and 191-27.4(514F).
Emergency Care
Iowa Admin. Code r. 191-40.20(514B), 191-40.21(514B) – emergency
care – prudent layperson standard adopted; HMOs may not deny reimbursement
for emergency services solely on the grounds that services were
performed by a noncontracted provider (parallel provisions for PPOs
at 191-27.8(514F).
Consumer Participation
Iowa Code Ann. § 514B.7 – policy and operation – HMOs must
establish a mechanism to allow reasonable representation of enrollees
in matters of policy and operation.
Iowa Admin. Code r. 191-40.4(514B) (1998) – governance – “reasonable
representation” requires that not less than 30 percent of the governing
board members be enrollees who are not providers or associated with
a provider; enrollees must be given the opportunity to nominate
representatives.
Return to Top of Page
Kansas
Consumer/Patient Protections
Access
*Kan. Stat. Ann. § 40-4607 (1997) - standing referrals – health
insurers (inclusive definition) must have a plan by which an insured
with a life-threatening, chronic, degenerative or disabling condition
or disease requiring specialized medical care over a prolonged period
of time may receive a referral to a qualified specialist who will
coordinate specialty care.
*Kan. Stat. Ann. § 40-3230 (1997) – continuity of care – HMOs
must continue care with a terminated provider for up to 90 days
where “continuation of such care is medically necessary and in accordance
with the dictates of medical prudence” and the enrollee has special
circumstances such as a disability or life-threatening illness.
Complaints/UR
Kan. Stat. Ann. § 40-3228 (1997) – grievances – HMOs are given
certain timeframes, but the timeframe of 20 working days for the
completion of an investigation appears to be infinitely extendable
by the HMO.
Disclosure
Kan. Stat. Ann. § 40-4603 (1997) – gag clauses – health insurers
may not prohibit or restrict providers from discussing/disclosing
any medically appropriate health care information or from advocating
on behalf of insureds in UR or grievance processes.
Emergency Care
Kan. Stat. Ann. §§ 40-3229, 40-4603 (1997) – emergency
care – HMOs may not base denials solely on failure to receive prior
authorization; health insurers may not deny coverage for care warranted
by symptoms or for a screening exam and stabilizing treatment, regardless
of authorization.
Prohibition on Incentives
Kan. Stat. Ann. § 40-4605 (1997) – incentive prohibition –
health insurers may not employ compensation arrangements with providers
that may directly or indirectly serve as an inducement to reduce
or limit the delivery of medically necessary services with respect
to an insured; capitation payments and other risk-sharing provisions
are not considered inducements.
Return to Top of Page
Kentucky
Consumer/Patient Protections
Access
*1998 Ky. Acts ch. 496, § 28(1) – OON referrals – managed care
plans must demonstrate that they offer an adequate number of accessible
specialists and subspecialists, and when the specialist needed for
a specific condition is not represented, enrollees have access to
nonparticipating providers without prior plan approval. (new
section of subtitle 17A of KRS Ch. 304)
Complaints/UR
1998 Ky. Acts ch. 496, § 34 – UR standards – managed care plan
medical directors must ensure that (a) UR denials of medical services
based on medical necessity are made by a physician and (b) a procedure
is implemented whereby physicians have an opportunity to review
and comment on protocols.
1998 Ky. Acts ch. 496, § 43 – ombudsman – office created in
the consumer protection and education division.
Emergency Care
1998 Ky. Acts ch. 496, §§ 25, 28(4), 59 – emergency care
– managed care plans must cover emergency-room screening and stabilization,
both in- and out-of-network, without prior authorization for use
consistent with the prudent layperson standard.
Nondiscrimination
1998 Ky. Acts ch. 496, § 45 (amending § 304.14-130) –
discrimination – plans will not be approved if they exclude or provide
terms of coverage for HIV/AIDS that are different than those that
apply to any other medical condition or, as to an individual policy,
if the benefits provided are unreasonable in relation to the premium.
Provider Protections
*1998 Ky. Acts ch. 496, § 30(1) – profiling – selection or
participation standards based on the economics or capacity of a
provider’s practice must be adjusted to account for case mix, severity
of illness, patient age and other features that may account for
higher-than or lower-than-expected costs; plans may not use criteria
that would allow an insurer to avoid high-risk populations by excluding
providers because they treat or specialize in treating populations
presenting a risk of higher-than-average claims, losses, or health
services utilization.
Selected Benefit Mandates
Ky. Rev. Stat. Ann. §§ 304.17A-135, 304.38-1936 – breast
cancer/HDC – health benefit plans (inclusive term) and HMOs that
provide benefits for treatment of breast cancer by chemotherapy
must also provide coverage for HDC with ABMT or SCT, which may not
be considered experimental.
Ky. Rev. Stat. Ann. § 304.38-1937 – TMJ – health care services
contracts that cover treatment of skeletal disorders must all cover
medically necessary procedures for TMJ and related disorders.
1998 Ky. Acts ch. 438, § 1 – off-label uses of drugs – applies
to all health benefit plans; limited to cancer; includes proviso
that HMOs are not required to cover any drug excluded from a formulary
for a reasons other than lack of FDA approval for the specific indication.
(new section of subtitle 17A of KRS Ch. 304)
1998 Ky. Acts ch. 476 § 1 – diabetes/outpatient supplies –
applies to all health benefit plans issued or renewed after 4/9/98;
coverage mandated for equipment, supplies, outpatient self-management
training and education, and medications; “private third-party payors
may not reduce or eliminate coverage due to the requirements of
this section.” (new section of subtitle 17A of KRS Ch. 304)
Miscellaneous
1998 Ky. Acts ch. 496, § 44 (amending § 304.17A-150) –
marketing – unfair trade practices include encouraging individuals
or groups to refrain from applying for coverage because of health
status, claims experience, etc.
Return to Top of Page
Louisiana
Consumer/Patient Protections
Access
La. Rev. Stat. Ann. §§ 22:215.17, 2:2027, 40:2206 (West
1998) – OB/GYNs – HMOs, PPOs, etc. may not limit direct access to
(participating) OB/GYNs for routine gynecological care.
Complaints/UR
La. Rev. Stat. Ann. § 22:2021 (West 1998) – UR standards –
applies to HMOs; general directive that requirements and guidelines
“shall not fall below the appropriate standard of care and shall
not impinge upon the independent medical judgment of the treating
health care provider”; timeframes include 2 working days for decision
in urgent need cases (5 for elective cases); failure to timely approve
or disapprove a request constitutes authorization; accreditation
is evidence of compliance.
La. Rev. Stat. Ann. § 22:2022 (West 1998) – grievances – applies
to HMOs; general; accreditation is evidence of compliance.
Disclosure
La. Rev. Stat. Ann. §§ 22:215.18 (West 1998) – gag clauses
– MCOs may not include provisions in their provider contracts that
interfere with the ability of a provider to communicate with a patient
regarding his/her health care; provisions that prohibit providers
from soliciting for alternative coverage arrangements for the primary
purpose of securing financial gain are not affected.
Emergency Care
La. Rev. Stat. Ann. § 22:657(D)(2) – emergency care – MCO requirements
concerning prospective evaluation are inapplicable to an emergency
medical condition, defined to incorporate a prudent layperson standard
(per (G), an enrollee who does not receive payment within 30 days
of claim submission can sue to collect a penalty of double the amount
of benefits due plus attorneys fees).
Prohibition on Incentives
La. Rev. Stat. Ann. §§ 22:215.19, 22:2018, 40:2207 (West
1998) – incentive prohibition – MCOs, etc. and their contracting
entities may not include provisions in their contracts with providers
which include an incentive or specific payment made directly to
a provider or provider group as an inducement to deny, reduce, limit,
or delay specific, medically necessary, and appropriate services
provided with respect to a specific insured or groups of insureds
with similar medical conditions; incentive plans that involve general
payments, such as capitation payments, or shared-risk arrangements
that are not tied to specific medical decisions involving a specific
insured or groups of insureds with similar medical conditions are
not prohibited. 40:2232?
Provider Protections
La. Rev. Stat. Ann. §§ 22:215.18 (West 1998) – nonretaliation
– MCO retaliation against a provider solely on the basis of a medical
communication is prohibited (also restrictions on lodging complaints
with govermental bodies and patient advocacy).
Selected Benefit Mandates
*La. Rev. Stat. Ann. §§ 22:2004.1, 40:2208 (West 1998)
– interpreters – HMOs and PPOs must provide coverage for expenses
incurred by any hearing impaired enrollee for services performed
by a qualified interpreter/transliterator (other than a family member)
in connection with medical treatment or diagnostic consultations.
La. Rev. Stat. Ann. §§ 22:215.22, 22:2027, 40:2209 (West
1998) – breast reconstruction – HMOs, PPOs, etc. that cover mastectomies
must cover reconstructive surgery.
La. Rev. Stat. Ann. § 22:215.20 (West 1998) – off-label uses
of drugs – applies to all categories of insurers/plans that cover
cancer treatment; limited to treatment of cancer.
Miscellaneous
La. Rev. Stat. Ann. § 46:153.3(3) – Medicaid/formulary – the
department shall not establish a drug formulary that restricts by
any prior or retroactive approval process a physician's ability
to treat a patient with a prescription drug that has been approved
and designated as safe and effective by the FDA (inclusion of drugs
for cosmetic purposes and nonprescription drugs, anorexic drugs,
drugs used solely for the treatment of infertility when prescribed
for that purpose, cough and cold preparations, and minor tranquilizers
is not mandatory).
Return to Top of Page
Maine
Consumer/Patient Protections
Access
Me. Rev. Stat. Ann. tit. 24-A, § 4303(1) – access – carriers
(broad definition) offering managed care plans must provide members
reasonable access to services in accordance with standards developed
by the super.
Code Me. R. Ch. 850, § 7 – access – HMO applications for certification
must include an access plan; access plans must include a description
of the HMO’s basis for determining that the network is sufficient
to meet basic health care services and how enrollees with special
needs (mental retardation, mental illness, behavioral and/or emotional
disturbances and developmental delays and disabilities) will be
identified.
Code Me. R. Ch. 850, § 7(B)(6) – access – in any case where
the HMO has an insufficient number or type of participating provider
to provide a covered benefit, the carrier must ensure that the covered
person obtains the covered benefit at no greater cost than if the
benefit were obtained from a participating provider, or make other
arrangements acceptable to the super.
Code Me. R. Ch. 850, § 7(C), (D) – access – specific standards
for geographic accessibility and appointment and wait times.
Code Me. R. Ch. 850, § 7(F) – coordination of care – HMOs are
not required to provide coverage for OON services more new enrollees
if they are transferred to network providers without unreasonably
disrupting ongoing care or treatment; HMOs must maintain a written
plan for continuity of care in event of contract termination including
60 days notice to affected enrollees and provision for enrollees
with special needs/at special risk.
Me. Rev. Stat. Ann. tit. 24, § 2332-G, tit. 24-A, §§
2847-F, 4241 – OB/GYNs – parallel provisions for HMOs and other
carriers; must permit qualified OB/GYNs to serve as PCPs; all group
plan contracts must cover an annual exam from a physician or certified
nursepractitioner or midwife without prior PCP approval.
Complaints/UR
Me. Rev. Stat. Ann. tit. 24-A, § 4303(4)(A) – grievances –
carriers must have a grievance procedure that meets standards developed
by the super. and includes timelines (no particular timeline mandated),
provision of a written statement with reasons upon conclusion of
the process, and decision making by individuals non previously involved
in making the decision subject to the grievance.
Code Me. R. Ch. 850, § 89 – grievances – 2 levels of review;
timeframe of 20 working days for 1st level (with possibility of
extension), and 50 working days for 2nd level; right to appear in
person at 2nd level, and majority of panel must be clinical peers
not previously involved.
Me. Rev. Stat. Ann. tit. 24-A, § 4303(4)(B) – independent second
opinion – in any appeal under the grievance procedure in which a
professional medical opinion regarding a health condition is a material
issue in the dispute, the aggrieved party is entitled to an independent
2nd opinion paid for by the plan from a participating provider of
the same specialty (if none exists, a nonparticipating provider);
applies to all carriers.
Me. Rev. Stat. Ann. tit. 24-A, § 4304 – UR – carriers must
respond to provider requests for prior authorization of nonemergency
services with an answer or request for further information within
2 business days; carriers may not retrospectively deny payment for
a previously approved service.
Code Me. R. Ch. 850, § 8 – UR – UR programs must use documented
clinical review criteria that are (a) based on published sound clinical
evidence and (b) evaluated periodically to ensure ongoing efficacy;
compensation may not be based on the quantity of adverse determinations
rendered or include other incentives to render inappropriate review
decisions; UREs must make initial determinations and give notice
of them within 2 working days of obtaining all necessary information
(1 working day for concurrent reviews); requirements for notices
include statement of clinical rationale including criteria, phone
number for assistance.
Code Me. R. Ch. 850, § 8(G) – appeals – appeals must be evaluated
by appropriate clinical peer/s who were not involved in initial
determination (unless appeal presents new information); notice of
decision must be given within 20 working days; where standard timeframe
would seriously jeopardize the life or health of a covered person
or jeopardize the covered person’s ability to regain maximum function,
a decision must be communicated no more than 72 hours after initiation
of appeal, with continuation of service paid for by the insurer
until notice in the case of concurrent review of emergency services
or a previously authorized admission or course of treatment.
Disclosure
Me. Rev. Stat. Ann. tit. 24-A, § 4301 – incentive disclosure
– carriers must provide prospective enrollees with a general description
of methods used to compensate providers, including capitation and
methods in which providers receive compensation based upon referrals,
utilization or cost criteria.
Me. Rev. Stat. Ann. tit. 24-A, § 4302(1)(H) – formularies –
carriers must provide prospective enrollees (and members of the
public upon request) and current enrollees annually with a description
of the plan that includes procedures enrollees must follow to obtain
drugs subject to a formulary, if any; a description of any formulary
and any cost sharing; enrollees may request additional information
related to specific drugs that are not on the formulary.
Me. Rev. Stat. Ann. tit. 24-A, § 4303(3) – gag clauses – carriers
offering managed care plans may not restrict a provider from disclosing
information regarding the treatment or the decision of any plan
to authorize or deny services or benefits.
Emergency Care
Me. Rev. Stat. Ann. tit. 24, § 2302-B, tit. 24-A, §§
2749-B, 2847-A – emergency care – policies may not include a provision
permitting the insurer to impose a penalty for failure to notify
the insurer of a hospitalization for emergency treatment.
Code Me. R. Ch. 850, §§ 5, 8(H) – emergency care – carriers
must cover emergency services necessary to screen and stabilize
a covered person and may not require prior authorization if a prudent
layperson acting reasonably would have believed that an emergency
condition existed; OON services to screen and stabilize if a prudent
layperson would have reasonably believed that use of a network provider
would result in a delay that would worsen the emergency; preauthorization
may not be retracted absent fraud etc.
Code Me. R. Ch. 850, § 7(E) – emergency care – specialized
standards must be utilized for evaluating the need for urgent or
emergency services for infants and children and for individuals
with chronic conditions.
Nondiscrimination
Me. Rev. Stat. Ann. tit. 24-A, §§ 2846, 4229 – HIV/AIDS
– exclusion of HIV/AIDS from coverage, or coverage under more restrictive
termsthan for other diseases, is prohibited.
Provider Protections
Me. Rev. Stat. Ann. tit. 24-A, § 4303(3) – nonretaliation –
carriers offering managed care plans may not discipline a provider
for advocating for medically appropriate health care.
Selected Benefit Mandates
Me. Rev. Stat. Ann. tit. 24, § 2320-F, tit. 24-A §§
2745-E, 2837-F, 4234-D – off-label uses of drugs/cancer – parallel
provisions for each category of insurer/plan; applies if contract/plan
covers prescription drugs; limited to drugs used in the treatment
of cancer.
Me. Rev. Stat. Ann. tit. 24, § 2320-G, tit. 24-A §§
2745-F, 2837-G, 4234-E – off-label uses of drugs/HIV or AIDS – parallel
provisions for each category of insurer/plan; applies if contract/plan
covers prescription drugs; limited to drugs used in the treatment
of HIV or AIDS.
Me. Rev. Stat. Ann. tit. 24, § 2320-C, tit. 24-A, §§
2745-C, 2837-C, 4237 – breast reconstruction – all forms of individual
and group coverage subject to HMO regulation and individual policies
that cover mastectomies must also cover reconstructive surgery.
Me. Rev. Stat. Ann. tit. 24, § 2320-D, tit. 24-A, §§
2745-D, 2837-D, 4238 – medical food coverage – HMOs and individual
policies must provide coverage for formula and medical food products
for persons with inborn errors of metabolism (coverage for low-protein
food products may be capped at $3,000).
Me. Rev. Stat. Ann. tit. 24, § 2332-F, tit. 24-A, §§
2754, 2847-E, 4240 – diabetes supplies – HMOs must provide coverage
for equipment and self-management training to treat diabetes if
certified as medically necessary by a treating physician or qualified
specialist.
Miscellaneous
Me. Rev. Stat. Ann. tit. 24-A, §§ 2749-C, 2843 5-C – mental
illness – individual and group health policies must provide benefits
for the treatment and diagnosis of specified categories of mental
illness under terms and conditions no less extensive than for physical
illnesses.
Return to Top of Page
Maryland
Consumer/Patient Protections
Access
Md Code Ann., Health-Gen. § 19-705.1(d) – special needs plan
– HMOs must have a written plan that, among other things, identifies
any special groups of members that have unique health problems and
describes community health resources and how they will be used.
Md Code Ann., Ins. § 15-112(i) , Health-Gen. § 19-706
– continuity of care – applies to all carriers (broad term); PCPs
who have been terminated must continue to provide services to enrollees
receiving services from them for at least 90 days after the termination
notice (if enrollees request continuation after receiving notice
of the termination), and carriers must pay for these services at
the contract rate.
Md Code Ann., Ins. § 15-816, Health-Gen. § 19-706 – direct
access to OB/GYNs – insurers, service benefit plans and HMOs must
classify an OB/GYNs as a PCP or, if the OB/GYN declines, allow a
woman direct access for routine gynecological care if the care is
medically necessary and the OB/GYN communicates/confers with the
PCP
Complaints/UR
Md Code Ann., Ins. §§ 15-10A-01, 15-10A-02 – grievances
– carriers must establish a grievance process that includes an expedited
procedure for “emergency cases” (definition to be established by
IC) that provides for decision within 24 hours; otherwise the carrier
has 30 working days to render a decision in prospective cases; content
of notice of adverse decision is specified, e.g., specific factual
bases for decision in clear, understandable language, reference
to specific criteria and standards (use of generalized terms specifically
prohibited); carrier cannot escape responsibility by delegating
UR function.*
Md. Code Ann., Ins. §§ 15-10A-02(d), 15-10A-03, 15-10A-05
– independent review – complaints may be filed the IC without exhausting
internal review processes if the complaint demonstrates a compelling
reason (IC to identify circumstances); otherwise, member/provider
may file complaint for review of a grievance decision within 30
days of receipt; carriers must provide any information requested
by the IC no later than 7 days after receipt of request; expedited
procedure for emergency cares to involve decision within 24 hours,
otherwise timeframe for review is 30 working days for pending cases
and 45 working days for retrospective cases; carriers have the burden
of persuasion that their adverse decisions and grievance decisions
are correct; qualifications for reviewers specified.
Md. Code Ann., Ins. §§ 15-10B-01 et seq. – private review
agents – also regulated; final determinations on appeals must be
made by a physician or panel with a physician who is not compensated
in a manner that provides a financial incentive directly or indirectly
to deny or reduce coverage; notice content requirements similar
to those for internal review; 10C concerns certification of medical
directors.
Md. Code Ann., Ins. §§ 15-10A-02(f) – ombudsman – health
advocacy unit will assist consumers with filing a grievance, and
carriers must notify members of availability of service in response
to initial contact about an adverse decision.
Md. Code Ann., Ins. § 15-10A-04(c)(3) – criteria – it is an
independent violation if the IC, in consultation with an independent
review organization, medical expert, the department, of other appropriate
entity, determines that the criteria and standards used by an HMO
to conduct UR are not (i) objective; (ii) clinically valid; (iii)
compatible with established principles of health care; or (iv) flexible
enough to allow deviations from norms when justified on a case by
case basis.
Md Code Ann., Ins. § 15-122, Health-Gen. § 19-706 – experimental
treatments – carriers must (a) disclose definitions of “experimental
medical care”; (b) establish or contract to provide a systematic,
scientific process to follow for evaluating emerging medical and
surgical treatments to ensure that subscribers have access to the
latest appropriate treatments, to include a comprehensive literature
and data review and input from qualified, independent physicians
and other recognized experts; (c) base coverage decisions on the
consensus of opinion from its own analysis and knowledge provided
via the required process.
Disclosure
Md Code Ann., Ins. § 15-121, Health-Gen. § 19-706 – incentive
disclosure – enrollment sales materials must include disclosure
in layman’s terms of reimbursement methodologies used to reimburse
physicians and the distribution of each $100 received in premium
dollars, including the proportions for direct medical care expenses
and for plan administration.
Md Code Ann., Ins. § 15-116, Health-Gen. § 19-706 – gag
clauses – carriers may not prohibit health care providers from discussing
with anyone any information that is necessary or appropriate for
the delivery of health care services (does not affect prohibition
of tortious interference with contract).
Emergency Care
Md Code Ann., Health-Gen. §§ 19-701, 19-712.5, 19-716
– emergency care – prudent layperson standard adopted; HMOs may
not require providers to obtain prior authorization/approval in
order to obtain reimbursement for services rendered to meet EMTALA
requirements.
Prohibition on Incentives
Md Code Ann., Ins. § 15-113, Health-Gen. § 19-706 – incentive
prohibition – a carrier may not reimburse a health care practitioner
in an amount less that the sum or rate negotiated in the provider
contract; section does not prohibit bonuses or other incentive-based
compensation if these do not violate § 19-705.1 of Health-Gen.
or deter the delivery of medically appropriate care.
Consumer Participation
Md. Regs. Code tit. 10, § 10.07.11.08 (1998) – policy formulation
– HMOs must have written policies governing the provision of services
according to stated objectives, and must develop the policies in
consultation with specified persons, including one or more enrollee
representative(s); at a minimum, the policies must cover admission
and discharge, physician services (e.g., medical staff organization),
arrangements for services not directly provided by the HMO, and
continuity and availability of care through an established referral
mechanism and provider contracts.
Provider Protections
Md Code Ann., Ins. § 15-112(e) – nondiscrimination – carriers
may not deny an application for participation or terminate participation
on the basis of the number of grievances or complaints the provider
files on behalf of a patient.
Md Code Ann., Ins. § 15-112(g) – nonretaliation – carriers
may not penalize providers for advocating the interests of a patient
through complaint, grievance, review or appeal processes.
Selected Benefit Mandates
Md Code Ann., Ins. § 15-827 – clinical trials – does not apply
to Medicaid; policies or contacts that must provide coverage for
patient cost in a clinical trial as a result of treatment for a
life-threatening condition or cancer; must be approved Phase I-III
clinical trials for cancer and Phase II-IV for other conditions
plus Phase I on a case-by-case basis, facility and personnel must
have appropriate expertise, there cannot be a clearly superior noninvestigational
alternative and available data must provide a reasonable expectation
that the treatment will be at least as effective as the noninvestigational
alternative.
Md Code Ann., Ins. § 15-804, Health-Gen. § 19-706 – off-label
uses of drugs – policies or contracts that provide coverage for
drugs may not exclude off-label uses (if recognized for treatment
in any standard reference compendium or the medical literature).
Md Code Ann., Ins. § 15-815 – breast reconstruction – coverage
mandate; applies to insurers, nonprofit health service plans, and
HMOs.
Md Code Ann., Ins. § 15-822, Health-Gen. § 19-706 – diabetes
– insurers, health service plans and HMOs must cover equipment and
self-management and educational services certified as necessary
by a qualified provider.
Miscellaneous
Md Code Ann., Health-Gen. § 19-729 – marketing – an HMO may
not, e.g., advertise or merchandise its services in a way that misrepresents
it services or capacity for service or engage in a deceptive, misleading,
unfair or unauthorized practice in the area of advertising or merchandising.
Md. Code Ann., Ins. § 27-303 – unfair claim settlement – a
failure to meet the requirements of Title 15, subtitle 10A or 10B
is defined as an unfair claim settlement practice.
+Note that in Maryland, all of the following are involved in regulation:
Insurance Commissioner, Health Education and Advocacy Unit in the
Division of Consumer Protection of the Office of Attorney General,
Secretary of Health and Mental Hygiene.
Return to Top of Page
Massachusetts
Consumer/Patient Protections
Access
Mass. Gen. Laws Ann. ch. 176B, § 7 – continuity of care – medical
service corporations must continue to provide compensation to terminated
physicians at the contract rate until the physicians’ patients have
established a relationship with another participating physician.
Emergency Care
Mass. Gen. Laws Ann. ch. 176I, § 3 – emergency care – if a
covered person receives emergency care and cannot reasonably reach
a preferred provider, payment for care related to the emergency
shall be made at the same level and in the same manner as if the
covered person had been treated by a preferred provider; applies
to plans that offer incentives for covered persons to use the services
of preferred providers (including plans offered by HMOs).
Provider Protections
Mass. Gen. Laws Ann. ch. 175, § 110(M), ch. 176B, § 7,
ch. 176G, § 6, ch. 176I, § 2 – nonretaliation – insurers,
HMOs, PPOs, etc. may not refuse to contract with or compensate a
provider solely because the provider has in good faith communicated
with a patient regarding the insurer’s products as they relate to
the needs of the provider’s patients.
Selected Benefit Mandates
Mass. Gen. Laws Ann. ch. 175, § 110(K) – home care services
– broad definition of services to be provided; mandate applies to
group medical benefits contracts.
Mass. Gen. Laws Ann. ch. 175, § 47B, ch. 176G, § 4 – mental
health services – insurers and HMOs must cover 60 days/year of inpatient
treatment at a mental hospital (under some circumstances, 2 days
of outpatient treatment can be substituted for 1 day of inpatient
treatment); lifetime maximums for treatment for mental conditions
must be at least equal to maximums for treatment of other conditions;
benefits for inpatient treatment at a general hospital must be the
same for mental and other illnesses; and outpatient benefits must
be provided up to $500/year.
Mass. Gen. Laws Ann. ch. 176G, § 4 – early intervention – dependent
coverage under HMO policies must include early intervention services.
Mass. Gen. Laws Ann. ch. 176A, § 8L, ch. 176B, § 4K, ch.
176G, § 4D – nonprescription enteral formulas for home use
– HMOs must cover where ordered by a physician and medically necessary;
coverage must include low protein food products, but may be capped
at $2500 annually.
Mass. Gen. Laws Ann. ch. 175, § 47K, ch. 176A, § 8N, ch.
176B, § 4N, ch. 176G, § 4E – off-label drug use/cancer
– applies to traditional insurers, HMOs, hospital service corporations,
etc.; includes provision immunizing attending physicians and HMOs
from liability for damages in connection with compliance (references
ch. 175, § 47K, L).
Mass. Gen. Laws Ann. ch. 175, § 47O, ch. 176A, § 8Q, ch.
176B, § 4P, ch. 176G, § 4E – off-label drug use/HIV –
applies to traditional insurers, HMOs, hospital service corporations,
etc., that cover prescription drugs.
Mass. Gen. Laws Ann. ch. 175, § 47R, ch. 176A, § 8O, ch.
176B, § 4O, ch. 176G, § 4F – BMTs – group HMO contracts
must cover transplants for metastatic breast cancer if criteria
established by the DPH are met.
Mass. Gen. Laws Ann. ch. 175, § 47T, ch. 176A, § 8T, ch.
176B, § 4R, ch. 176G, § 4J – scalp hair prostheses – polices
must cover if hair occurs in connection with cancer treatment, up
to $350/year; parallel provisions for various types of entities.
Miscellaneous
Mass. Gen. Laws Ann. ch. 176G, § 4B – confidentiality – special
confidentiality provision for communications to a psychotherapist,
but with some major exceptions.
Return to Top of Page
Michigan
Consumer/Patient Protections
Access
*Mich. Comp. Laws Ann. § 333.21052(1) – continuity of care
– HMOs must provide enrollees with a form that includes a description
of how the HMO provides for continuity of care in the event a provider’s
participation terminates during the course of treatment.
Mich. Admin. Code r. 325.6635 – access – HMOs must assure the maintenance
of professional staff sufficient to meet the needs of the membership;
the specialty mix of physicians must be consistent with the projected
health needs of the population enrolled or to be enrolled, the experienced
need of like organizations within and without the state, and accepted
standards consistent with the practice of quality medicine.
Complaints/UR
Mich. Comp. Laws Ann. § 333.21035 – grievances – applies to
HMOs’ prospective coverage determinations; in routine cases, final
determination must be made not later than 90 calendar days after
submission; an expedited procedure must offer an initial determination
not later than 72 hours after receipt, and an enrollee or representative
has 3 days to request further HMO review or appeal to the department;
further HMO review must conclude within 30 days, at which time the
enrollee or representative has 10 days to appeal; expedited grievance
procedure applies if a physician substantiates that the time frame
for a routine grievance “would acutely jeopardize the life of the
enrollee.”
Mich. Comp. Laws Ann. §§ 333.20121-333.21088 – independent
review – governor appoints advisory commission (half consumers and
half representatives of various types of licensees); the chair appoints
a task force (commission members plus nonmember experts if necessary)
to assist in matters pertaining to licensure and certification of
HMOs; an enrollee may file a grievance with the task force after
exhausting internal procedures, and the advisory commission renders
a determination as to the validity of the grievance and directs
measures it considers appropriate under the circumstances.
Disclosure
Mich. Comp. Laws Ann. § 333.21052a – gag clauses – HMOs may
not prohibit or discourage health professionals from advocating
on behalf of an enrollee for appropriate medical treatment options
through the grievance procedure or from discussing with an enrollee
or provider health treatments and services, legally required quality
assurance plans, or financial relationships.
Mich. Comp. Laws Ann. § 333.21052(2) – incentive disclosure
– HMOs must provide upon request to enrollees an indication of the
financial relationships between the HMO and any closed provider
panel.
Emergency Care
Mich. Comp. Laws Ann. §§ 333.21004, 550.1418, 500.3406k
– emergency care – adopts prudent layperson standard in definition
of emergency health services for HMOs, nonprofit health care corporations,
and expense-incurred policies; covered entities may not deny payment
for emergency health services up to the point of stabilization because
of the final diagnosis or a failure to get prior authorization.
Provider Protections
See provision concerning gag clauses above.
Consumer Participation
Mich. Comp. Laws Ann. § 333.21051 – governing body – HMO governing
body must have a minimum of 1/3 of its membership consisting of
adult enrollees who are not responsible for the conduct of, or financially
interested in, the HMO’s affairs; each subscriber has 1 vote, and
enrollee board members are elected by a simple plurality of the
voting subscribers.
Selected Benefit Mandates
Mich. Comp. Laws Ann. § 333.21054b – cancer drugs – HMOs must
cover FDA-approved drugs used in antineoplastic therapy plus reasonable
costs of administration (includes off-label uses, with standard
caveats).
Miscellaneous
Mich. Comp. Laws Ann. § 333.21034 – rate-setting – insurance
commissioner may approve a rate differential based on disability
if it is supported by sound actuarial principles…and it related
to actual and credible loss statistics or reasonably anticipated
experience in case of new coverages.
Return to Top of Page
Minnesota
Consumer/Patient Protections
Access
*Minn. Stat. Ann. § 62Q.56 – continuity of care – health plan
companies (inclusive definition) must have a written plan that explains,
among other things, the procedures by which enrollees will be transferred
to other participating providers, when special medical needs, special
risks, or other special circumstances require them to have a longer
transition period or be transferred to nonparticipating providers,
who will identify these enrollees and by what criteria, and how
continuity of care will be provided for these enrollees; provider
termination: if the contract termination was not for cause, enrollees
can request a referral to the terminating provider for up to 120
days if they have special medical needs or have other special circumstances
(the HPC may require supporting documentation), and each request
must be considered on a case-by-case basis; change in health plan:
for group/continuation and conversion coverage only, where the employer
changes plans, HPCs must have a process to handle requests from
new enrollees with special needs, risks or other special circumstances
for up to 120 days continuation with a former provider.
*Minn. Stat. Ann. § 62Q.07 – access – HPCs must have action
plan that includes, among other things, a detailed description of
the HPC’s policies and procedures for enrolling and serving high
risk and special needs populations (defined to include recipients
of medical assistance and persons with chronic conditions and disabilities),
including the barriers present for these populations and how the
HPC is addressing them in order to provide greater access; escape
clause for MCOs with 50,000 or fewer in-state managed care enrollees—can
satisfy requirement simply by reporting that they have no policies
and procedures and have undertaken no activities (if true).
*Minn. Stat. Ann. § 62Q.58 – standing referrals – HPCs must
establish a procedure by which an enrollee may apply for a standing
referral to a specialist if referrals are required for coverage,
including criteria and conditions; the PCP remains responsible for
coordination of care and specialist may not make secondary referrals
related to primary care without prior PCP approval, but an enrollee
may request primary care services from that specialist and the specialist,
in agreement with the PCP, may elect to provide those services following
HPC procedures.
Minn. Stat. Ann. § 62Q.52 – OB/GYNs – HPCs must allow female
enrollees direct access (IN) for annual exams, maternity care, and
evaluation and treatment of acute gynecological conditions or emergencies.
*Minn. R. 4685.1010 – timely access – HMOs, either directly or through
provider contracts, must arrange for covered health care services
including referrals to participating and nonparticipating specialty
physicians to be accessible to enrollees on a timely basis in accordance
with medically appropriate guidelines consistent with generally
accepted practice parameters.
Complaints/UR
Minn. Stat. Ann. § 62D.12 – anti-“gotcha” provision – HMOs
may not deny or limit coverage of a service which the enrollee has
already received solely on the basis of lack of prior authorization
or second opinion, to the extent that the service would otherwise
have been covered under the contract had prior authorization or
a second opinion been obtained.
Minn. Stat. Ann. §§ 62J.78, 62J.79 – ombudsman – establishes
office of health care consumer assistance, advocacy, and information
within the department of health; director must appoint at least
nine consumer advocates; empowered to assist enrollees in understanding
and asserting their contractual and legal rights, including advocating
for them in administrative proceedings, in obtaining referrals,
and in accessing other services, and to monitor complaints for patterns
and make recommendations to plans.
Minn. Stat. Ann. §§ 62D.11, 62Q.105 – complaints – eff.
7/1/99, HPCs must inform complainants of their decision within 30
days of complaint receipt, and must make “reasonable efforts” to
resolve medically urgent enrollee complaints within 72 hours; HPCs
must have an “impartial” appeals process (which may be ADR process
if HPC pays) and must advise complainants who receive adverse decisions
of their right to appeal through this internal process or to the
commissioner; MCOs must submit all QOC-related complaints to its
review board/org; records must be maintained for five years.
Minn. Stat. Ann. §§ 62Q.106, 62Q.30 – independent review
– a complainant may at any time submit a complaint to the appropriate
commissioner to investigate; eff, 7/1/99, the commissioner must
establish an expedited fact finding and dispute resolution process
to assist enrollees with contested treatment, coverage, and service
issues and take action against any HPC that is the subject of repeated
orders suggesting a patter of inappropriate underutilization.
Minn R. 4685.1700 – standards for urgent complaints – if a complaint
involves a dispute about an immediately and urgently needed service
that the health maintenance organization claims is experimental,
not medically necessary, or otherwise not generally accepted by
the medical profession, the HMO must use an expedited dispute resolution
process appropriate to the particular situation; the HMO must notify
the commissioner of the complaint by the end of the next business
day after it is registered and its decision at the time or by the
end of the next business day following the decision; the complaint
need not be in writing. (update?) (Penalties for failure to comply
include fines of up to $25,000 per violation and suspension or revocation
of license)
Minn. Stat. Ann. § 62Q.107 – standard of review – no health
plan may specify a standard of review upon which a court may review
a denial of a claim or any other HPC decision with respect to an
enrollee; any standard less favorable to the enrollee than preponderance
of the evidence specifically prohibited, e.g., arbitrary and capricious
or abuse of discretion.
Disclosure
Minn. Stat. Ann. § 62J.72 – incentive disclosure - during open
enrollment, upon enrollment, and annually thereafter, HPCs must
provide a description of the general nature of the reimbursement
methodologies used to pay providers, with an explanation of any
aspect that creates an incentive to limit care; upon request, HPCs
and providers must provide an enrollee with more specific information,
including a written description of any compensation arrangement
that is dependent on the amount of health coverage or health care
services provided to the enrollee or the number of referrals to
or utilization of specialists and any risk sharing incentive plan
(although specific amounts paid to a provider and other “proprietary
information” need not be disclosed).
Minn. Stat. Ann. § 62J.71 – gag clauses – agreements/directives
are prohibited if they prohibit a health care provider from communicating
with an enrollee about the enrollee’s health status, health care
or treatment options, in good faith and within the provider’s scope
of practice; making a recommendation about the suitability or desirability
of company/insurer/plan, unless the provider has a financial conflict
of interest in the enrollee’s choice; providing testimony or making
any other contact with governmental personnel; disclosing accurate
information about payment/coverage; and informing an enrollee about
the reimbursement methodology in use; does not prohibit provisions/directives
against disclosure of specific amounts paid and other proprietary
information. (§ 62J.701 explicitly makes §§ 62J.695
to 62J.80 applicable to governmental programs.)
Minn. Stat. Ann. § 62Q.64 – executive compensation disclosure
- HPCs must file a list that includes top executive compensation
with the consumer advisory board, and the filing is public data.
Emergency Care
Minn. Stat. Ann. § 62Q.55 – emergency care – emergency services
must be covered without regard to network or service area restrictions;
in reviewing a coverage denial, HPCs must consider beliefs of reasonable
layperson, etc.; HPCs may require notice as soon as possible, but
not later than 48 hrs, after provision, but may not deny payment
for otherwise covered services due to failure to give timely notice.
*Minn. R. 46 85.0700 – emergency care – HMOs must cover provision
by OON providers required for reasons of medical necessity and not
convenience.
Nondiscrimination
*Minn. Stat. Ann. § 72A.20(32) – unfair health risk avoidance
– no insurer or HPC may design a network of providers, policies
on access to providers, or marketing strategy in such a way as to
discourage enrollment by individuals or groups whose health care
needs are perceived as likely to be more expensive than the average
(does not prohibit underwriting and rating practices that comply
with state law).
Minn. Stat. Ann. §§ 62D.10, 62D.12 – nondiscrimination
– HMO plans and other prepaid plans must accept all otherwise eligible
individuals in the order in which they apply for enrollment in a
manner which does not discriminate on the basis of age, sex, race,
health, or economic status; the rates charged by HMOs shall not
discriminate except in accordance with accepted actuarial principles.
Prohibition of Incentives
Minn. Stat. Ann. § 72A.20(33) – incentive prohibition – no
insurer or HPC may give any financial incentive to a health care
provider based solely on the number of services denied or referrals
not authorized by the provider (does not prohibit capitation or
other compensation methods that serve to hold health care providers
financially accountable for the cost of caring for a patient population).
Consumer Participation
Minn. Stat. Ann. § 62D.06 – governing body – at least 40 percent
of governing bodies of HMOs that have been authorized for at least
one year must be enrollees or members (through self-insured contract)
elected by enrollees/members; present or former health care administrators
or providers and those with a direct substantial or managerial interest
in the rendering of health services are not eligible for these posts;
members may not outnumber enrollees; the body must establish a mechanism
to give enrollees opportunities to express their opinions on policy
and operation.
Minn. Stat. Ann. § 62J.75 – advisory body to regulators – creates
consumer advisory board to state regulatory agencies.
Provider Protections
Minn. Stat. Ann. §§ 62D.12, 62J.71, 62J.80 – nonretaliation
– providers are protected from retaliation for refusal to enter
into a prohibited agreement or for taking any action described in
the gag clauses or for discussing options not covered by the plan,
for criticizing the company/insurer/plan, or for expressing personal
disagreement with decision regarding treatment or coverage; does
not protect providers if there is evidence that actions are illegal,
constitute malpractice, or contrary to accepted medical practices.
Selected Benefit Mandates
*Minn. Stat. Ann. § 62Q.66 – DME – no HPC that covers DME may
utilize medical coverage criteria that limits coverage solely to
equipment used in the home; HPCs that cover DME must disclose to
enrollees, and prospective enrollees upon request, general descriptions
of coverage and criteria and procedures for any required prior authorizations
and the address and telephone number of a representative to contact
for further information.
Minn. Stat. Ann. § 62Q.525 – off-label uses of drugs – HPCs
that cover drugs may not exclude drugs for cancer treatment on the
ground that the drug is not FDA-approved for the use (with the usual
qualifications about recognition in reference compendia or the medical
literature).
Miscellaneous
Minn. Stat. Ann. § 62Q.03 – risk adjustment – establishes public
programs risk adjustment work group, which is to be “representative
of the persons served by publicly paid health programs and providers
and health plans that meet their needs.”
Minn. Stat. Ann. § 62D.09 – marketing – no marketing materials
may lead consumers to believe that all health care needs will be
covered; in HMO chapter.
Minn. Stat. Ann. § 62Q.60 – mental health – definitions of
medical necessity relating to mental health services may not be
more restrictive than the statutory definition (“’Medically necessary
care’ means health care services appropriate, in terms of type,
frequency, level, setting, and duration, to the enrollee’s diagnosis
or condition, and diagnostic testing and preventive services.
Medically necessary care must be consistent with generally accepted
practice parameters as determined by health care providers in the
same or similar general specialty as typically manages the condition,
procedure, or treatment at issue and must (1) health restore or
maintain the enrollee’s health; or (2) prevent deterioration of
the enrollee’s condition.”)
Minn. Stat. Ann. § 62Q.095 – mandatory offer – HPCs (with some
exceptions) must offer expanded provider network option.
Return to Top of Page
Mississippi
Consumer/Patient Protections
Access
Miss. Code Ann. § 83-41-409 – access – in order to certified
and recertified, a managed care plan must, among other things, demonstrate
that its provider network has providers of sufficient number throughout
the service area to assure reasonable access to care with minimum
inconvenience by plan enrollees.
Miss. Code Ann. § 83-41-217 – OB/GYNs – participating OB/GYNs
must be allowed to serve as PCPs and women must be allowed direct
access to IN OB/GYNs.
Complaints/UR
Miss. Code Ann. § 41-83-31 – UR – no adverse determination
may be made relating to the necessity/justification of health care
services without prior evaluation and concurrence by a physician,
who is available to discuss the reasons with the affected provider
upon request; any determination which may result in denial of third-party
reimbursement or precertification of a health care service must
include the evaluation, findings and concurrence of a physician
trained in the relevant specialty or subspecialty, if requested
by the patient’s physician.
+Miss. Code Ann. § 83-41-415 – Medicaid exception – Articles
7 (governing HMOs and other prepaid plans) and 9 (Patient Protection
Act) do not apply to the Division of Medicaid in the Office of the
Governor.
Financial incentives
Miscellaneous
Miss. Reg. LA&H 74-3 – marketing – advertisements must be truthful
and not misleading in fact or in implication; words or phrases whose
meaning is clear only by implication or familiarity with insurance
terminology shall not be used; no advertisement shall omit information
or use words, etc. it the effect is to mislead or deceive as to
the nature or extent of any benefit or premium; no advertisement
shall use words or phrases such as “all” or “full” or “comprehensive”
in a manner which exaggerates any benefits, etc.
Return to Top of Page
Missouri
Consumer/Patient Protections
Access
*Mo. Ann. Stat. §§ 354.552, 354.603(1), 354.615(1) – OON
providers – if a community-based HMO (criteria include provider
ownership and fewer than 50,000 covered lives) does not employ or
contract with a physician with the expertise necessary to provide
medically necessary care covered by the health plan, it must arrange
for a referral to a physician with the necessary expertise, at no
additional cost to the enrollee beyond what the enrollee would otherwise
pay for IN services; if an HMO has an insufficient number or type
of participating providers to provide a covered benefit, it shall
ensure that the enrollee obtains the covered benefit at no greater
cost than if the benefit was obtained from a participating provider,
or make other arrangements acceptable to the director; if an HMO
determines that it does not have a health care provider with appropriate
training and experience in its panel or network to meet the particular
health care needs of an enrollee, it must make a referral to an
appropriate provider pursuant to a treatment plan approved by the
HMO in consultation with the PCP and the enrollee/designee, at no
additional cost to the enrollee beyond what the enrollee would otherwise
pay for IN services.
Mo. Ann. Stat. § 354.603 – geographic access – HMOs must establish
and maintain adequate arrangements to ensure reasonable proximity
of participating providers to enrollees’ residences/businesses.
(Mo. Code Regs. tit. 20, § 400-7.095 establishes specific distance
standards for various types of specialists/services, with some variation
based upon county categorization as urban, basic or rural.)
*Mo. Ann. Stat. § 354.615(3), (4) – specialists as PCPs – an
HMO must have a procedure by which a new enrollee, or an enrollee
upon diagnosis, with a life-threatening condition or disease or
a degenerative and disabling condition or disease, either of which
requires specialized medical care over a prolonged period of time,
may receive a referral to a specialist/specialty care center with
expertise in treating the disease or condition (IN, unless OON criteria
are met) who will be responsible for and capable of providing and
coordinating the enrollee’s primary and specialty care pursuant
to a treatment plan approved by the HMO in consultation with the
PCP if appropriate, specialist, and enrollee/designee.
*Mo. Ann. Stat. §§ 354.554, 354.615(2) – standing referrals
– community-based HMOs must allow enrollees who suffer from life-threatening
or degenerative, disabling conditions requiring a regimen of specialized
treatment lasting for six months or more to receive a standing referral
for specialty care case management by a physician or specialty care
center with expertise in treating the condition, which will coordinate
primary and specialty care under treatment plans approved by the
HMO in consultation with the PCP and the specialist/specialty care
center; an HMO must have a procedure by which an enrollee who needs
ongoing care from a specialist may receive a standing referral to
such specialist (IN, unless OON criteria are met) pursuant to a
treatment plan approved by the HMO in consultation with the PCP,
specialist, and enrollee/designee.
*Mo. Ann. Stat. § 354.612 – continuity of care – contracts
between health plans and providers must include a provision for
continuation of care up to 90 days by a terminating provider where
continuation is medically necessary and in accordance with the dictates
of medical prudence, including circumstances such disability, pregnancy,
or life-threatening illness.
Mo. Ann. Stat. § 354.618 – OB/GYNs – HMOs must allow direct
access to an IN provider at least once a year.
Complaints/UR
Mo. Ann. Stat. § 354.562 – grievances – the department of insurance
is to promulgate rules governing grievance procedures for community-based
HMOs that are not less or more stringent than the HCFA rules for
Medicare managed care plans. (Mo. Code Reg. tit. 20, §
400-7.110 establishes specific timeframes, including acknowlegment
within 10 working days, 20 working days to complete an investigation
“unless the investigation cannot be completed within this time”
and resolution by someone not involved in the circumstances giving
rise to the grievance within 5 working days after completion; the
notice of resolution must explain the resolution “in terms which
are clear and specific” and any right to appeal; HMOs must respond
to inquiries from the department of insurance within 15 working
days; the director may take disciplinary action for any violation.)
Mo. Ann. Stat. § 354.546 – (non)independent review – HMOs must
allow enrollees to seek a second medical opinion or consultation
relating to major surgery, or other treatment necessitating general
anesthesia or other serious illness involving loss of bodily part
or function or other debilitating disease, from the HMO’s choice
of other PCPs and specialty physicians at no additional cost to
the enrollee beyond what the enrollee would pay for initial opinion/consultation;
if the HMO does not employ/contract with another physician with
the expertise necessary to provide a second opinion, then it must
arrange for OON referral at no greater cost than for an IN benefit.
Mo. Ann. Stat. § 376.1361 – UR – a UR program must use documented
clinical review criteria that are based on sound clinical evidence
and evaluated periodically to assure ongoing efficacy; a licensed
clinical peer must evaluate the clinical appropriateness of adverse
determinations; compensation to persons providing UR may not contain
incentives to make medically inappropriate review decisions or be
based on the quantity or type of adverse determinations rendered.
(§§ 376.1350 – 376.1390 are not applicable to indemnity
plans without a managed care component, e.g., no requirement to
use or incentives to use participating providers.)
Mo. Ann. Stat. § 376.1361(10) – UR/drugs and DME – a carrier
must permit enrollees/providers for enrollees to appeal for the
coverage of medically necessary pharmaceutical prescriptions and
DME as part of the UR process.
Mo. Ann. Stat. § 376.1363 – UR/procedure – UREs must make initial
determinations within 2 b.d. of obtaining all necessary information
(1 b.d. for concurrent reviews) and give notice by telephone within
24 hours of decision (with no liability until notice in case of
concurrent review); requirements for notices include statement of
clinical rationale, including clinical review criteria.
Mo. Ann. Stat. § 376.1381 et seq. – grievance review – a health
carrier that offers managed care plans must describe its grievance
procedure in member materials, to include the toll-free number and
address of the department of insurance and a statement about the
right to contact the department for assistance at any time; two
levels of review; grievance may be submitted by representative;
carrier must conduct investigation within 20 b.d. (with possibility
of 30 b.d. extension, requiring notice with specific reasons for
delay), with notice within 15 b.d. of completion; second level review
is conducted by advisory panel that includes enrollees and carrier
representatives not previously involved in the case (where grievance
involves AD, a majority must be clinical peers with no prior involvement);
same time frames as first level review.
Mo. Ann. Stat. § 376.1387 – independent review – if the director
does not resolve any grievance regarding an adverse determination,
it is resolved by referral to an IRO; the IRO renders a decision
based upon a review of the written record; the resolution is binding
upon the enrollee and carrier, and subject to judicial review if
action is filed within 30 days; however, grievances related to a
Medicaid program are resolved according to rules and procedures
established for the Medicaid program.
Mo. Ann. Stat. § 376.1389 – expedited review – a request for
expedited review may be submitted orally or in writing, and the
carrier must notify an enrollee of its determination orally within
72 hours of receipt of request.
Disclosure
Mo. Ann. Stat. §§ 354.441, 354.559, 354.606(10) – gag
clauses – no HMO or other entity shall prohibit or restrict any
provider from disclosing to any enrollee any information that such
provider deems appropriate regarding the nature of treatment, risks
or alternatives, a decision to authorize or deny services, or the
process that the plan or its contractor uses or proposes to use
to authorize or deny services or benefits (standards to determine
violations by community-based HMOs are those adopted by HCFA for
Medicare managed care plans); an HMO shall not prohibit a participating
provider from advocating in good faith on behalf of enrollees within
UR or grievance processes.
Mo. Ann. Stat. § 354.442 – disclosure – HMOs (=most if not
all prepaid plans) must provide enrollees and upon request prospective
enrollees with, e.g., notice that disputes involving clinical decisions
must be made by qualified clinical personnel, in notices of determination
information about the basis of the decision and further appeal rights,
if any, description of emergency services that includes prudent
layperson definition and notice that these services are not subject
to prior approval, notice concerning availability of OON referrals,
and description of mechanisms for consumer participation; and upon
request, consumer complaint data, procedures for protecting the
confidentiality of medical records and other enrollee information,
the process for seeking to have an excluded drug included as a benefit,
procedures relating to experimental drugs, devices or treatments,
and upon written request, written clinical review criteria relating
to conditions or diseases which the organization may consider in
the UR process.
Emergency Care
Mo. Ann. Stat. §§ 354.400, 354.600, 376.1350 (UR), 376.1367
(UR) – emergency care – adopt prudent layperson standard; carrier
must cover services necessary to screen and stabilize and may not
require prior authorization of such services; when an enrollee receives
an emergency service that requires immediate post evaluation or
post stabilization services, a carrier must provide an authorization
decision within 60 minutes of receiving a request (if decision is
not made within 30 minutes, services deemed approved).
Mo. Code Regs. tit. 20, § 400-7.130 – emergency care – an HMO
shall not base its denial of payment for emergency medical services
solely on the enrollee’s failure to receive authorization prior
to receiving the service. (See § 354.410.1(2) and 354.470.1(3))
Formularies
*Mo. Ann. Stat. § 354.535 – maintenance drugs – HMOs may not
insist or mandate any provider to change an enrollee’s maintenance
drug (=a drug prescribed by a licensed practitioner to treat a medical
condition for a period greater than 30 days) unless the provider
and enrollee agree to the change; notwithstanding other provisions
of law to the contrary (see § 354.125), HMOs that change an
enrollee’s maintenance drug without provider consent are liable
for resulting damages.
Prohibition of Incentives
Mo. Stat. Ann. § 354.606(9), 354.443 – incentive prohibition
– an HMO shall not offer an inducement under the managed care plan
to a provider to provide less than medically necessary services
to an enrollee; the director shall review required filings with
the department to determine if an HMO’s financial arrangements offer
an inducement to a provider to provide less than medically necessary
services. (For “community-based” HMOs, the director is to
adopt rules that mirror the Medicare rules. § 354.560)
Consumer Participation
Mo. Code Regs. tit. 20, § 400-7.120 – opportunity for suggestions
– every HMO must establish a mechanism that affords enrollees an
opportunity to participate in matters of the HMO’s policy and operation,
at a minimum, ensuring an opportunity to offer appropriate suggestions
to the HMO’s policymaking body and due consideration by that body.
Provider Protections
*Mo. Ann. Stat. § 354.606(6) – selection criteria – HMO provider
selection criteria must not be established in a manner that will
exclude a provider because the provider treats or specializes in
treating a population presenting a risk of higher than average claims,
losses or health services utilization.
Mo. Ann. Stat. §354.606(10), (15) – nonretaliation – an HMO
shall not prohibit a participating provider from advocating in good
faith on behalf of enrollees within UR or grievance processes; an
HMO shall not penalize a provider because the provider in good faith
reports to governmental authorities any act or practice by the health
carrier that may jeopardize patient health or welfare.
Selected Benefit Mandates
Mo. Ann. Stat. § 376.1361(11) – off-label uses of drugs – a
health benefit plan (broad definition) that provides coverage for
drugs must cover any drug prescribed to treat an indication if drug
is recognized for treatment of that indication and deemed medically
appropriate; does not require payment for non-formulary drugs, except
that state may exclude or restrict coverage of covered outpatient
drug from Medicaid programs as specified under SSA.
Mo. Ann. Stat. § 376.385 – diabetes – all types of insurers
(HMOs, indemnity, etc.) must offer coverage for all physician-prescribed
medically appropriate and necessary equipment, supplies and self-management
training used in the management and treatment of gestational, type
I or type II diabetes at no greater deductible or copayment than
any other covered service, and no insurer may reduce or eliminate
coverage due to these requirements.
Mo. Ann. Stat. § 376.1200 – BMTs – all insurers must offer,
in writing, coverage for the treatment of breast cancer by dose-intensive
chemotherapy/ABMT or SCT when performed pursuant to nationally accepted
peer review protocols utilized by centers experienced in such transplants;
no greater deductible or copayment, except that may impose separate
lifetime benefit maximum of $100,000.
Mo. Ann. Stat. § 376.1209 – reconstructive surgery – if insurer
covers mastectomy, must cover reconstructive surgery and prostheses,
with same deductible and coinsurance conditions as apply to other
benefits
Mo. Ann. Stat. § 376.1219 – PKU formula – all insurers must
cover formula recommended by physician for the treatment of PKU
or any inherited disease of amino and organic acids at no greater
deductible or copy, etc.
HMO Protections
Mo. Ann. Stat. § 354.125 – immunity from vicarious liability
– a “health services corporations” shall not be liable for injuries
resulting from neglect, misfeasance, malfeasance or malpractice
on the part of any person, organization, agency or corporation rendering
health services to the health service corporation’s members and
beneficiaries. (repealed by H335?)
Miscellaneous
Mo. Code Reg. tit. 20, § 400-7.080 – risk of nonpayment – providers
have no recourse against enrollees for amounts an HMO is obligated
to pay; “in order to ensure compliance with this provision, no contract
between an HMO and provider will be valid or enforceable by the
provider unless the contract specifically establishes an independent
contractor relationship between the HMO and the provider and further
provides that under no circumstances…shall the provider bill, charge
or in any way seek to hold an enrollee legally liable for the payment
of any fees which are the legal obligation of the HMO…” (many states
have similar provisions in their HMO acts)
Mo. Code Reg. tit. 20, § 400-7.010 – form review – department
of insurance must approve specified forms, including contracts and
evidence of coverage, prior to use by HMO.
Mo. Code Reg. tit. 20, § 400-5.700 – advertising – extensive
provisions concerning advertising by accident and sickness insurers.
Return to Top of Page
Montana
Consumer/Patient Protections
Access
*Mont. Code Ann. § 33-36-201 – access – a health carrier offering
a managed care plan must maintain a network that is sufficient in
numbers and types of providers to ensure that all services to covered
persons are accessible without unreasonable delay; the carrier must
ensure reasonable proximity; after 10/1/1999, carriers must file
access plans with the department, to include the health carrier’s
efforts to address the needs of covered persons with limited English
proficiency and illiteracy, with diverse cultural and ethnic backgrounds,
and with physical and mental disabilities.
*Mont. Code Ann. § 3-36-201(2) – OON providers – a health carrier
offering a managed care plan must maintain a network that is sufficient
in numbers and types of providers to ensure that all services to
covered persons are accessible without unreasonable delay; whenever
a health carrier has an insufficient number or type of participating
providers to provide a covered benefit, the health carrier shall
ensure that the covered person obtains the covered benefit at no
greater cost to the covered person than if the covered benefit were
obtained from participating providers or shall make other arrangement
acceptable to the department.
*Mont. Code Ann. § 33-31-301(3)(i) – mental illness, alcoholism
and drug addiction – after the PCP refers an enrollee for treatment
of and ancillary services for any of these, the HMO may not limit
the enrollee to a HMO provider for such treatment/services.
Mont. Code Ann. §§ 33-22-1903, 33-22-1904 – OB/GYNs –
OB/GYNs must be allowed to serve as PCPs at their option; health
benefit plans must permit self-referral to any participating OB/GYN
for an OB/GYN exam or service, and may not require pre-authorization
although may require prior notice.
Complaints/UR
Mont. Code Ann. § 33-31-303 – complaint system – system must
be approved by commissioner; acknowledgment within 10 days of receipt
(not many specifics).
Mont. Code Ann. § 33-32-201 – UR – adverse determinations on
appeal or reconsideration relating to medical necessity or appropriateness
must be supported by prior written findings, evaluation, and concurrence
by a health care professional trained in the relevant area, with
copies provided to the patient on request; must also be preceded
by reasonable attempt to consult with the patient’s attending health
care provider.
Mont. Code Ann. § 33-32-201(5)(b) – UR/independent review –
the patient may at her/his own expense request an independent review
of the patient’s/provider’s records by a provider licensed in the
field of the provider that rendered the service [=retrospective]
and may require its consideration by the insurer in reaching its
decision; if the initial adverse determination is reversed, the
insurer bears the expense [a real incentive not to reverse!].
Mont. Code Ann. § 33-32-203 – UR/appeals – affected patients/providers
have at least 30 days to appeal or seek reconsideration; a final
decision on appeal or reconsideration must be made within 60 days
of receipt of all relevant medical records by reviewer.
Disclosure
Mont. Code Ann. §§ 33-1-802, 33-36-204(3) – gag clauses
– a health carrier (inclusive definition) or MCO may not by contract,
direction, requirement, or by financial inducement or penalty, prohibit
a provider from making or interfere with a provider making a medical
communication to an enrollee; does not prevent an entity from prohibiting
disclosure of a trade secret (defined at § 30-14-402); a health
carrier may not prohibit a participating provider from advocating
on behalf of a covered person within the UR or grievance processes.
Emergency Care
Mont. Code Ann. §§ 33-36-103, 33-36-205 – emergency care
– reasonable expectation standard adopted in definition; a health
carrier offering a managed care plan must provide or pay for emergency
services screening and emergency services and may not require prior
authorization therefor; a health carrier shall pay for services
from nonnetwork providers and may not require prior authorization
if use of a participating provider would result in a delay that
would worsen the medical condition of the covered person or if the
law requires the use of a specific provider; may not subsequently
retract an authorization unless based on material misrepresentation,
etc.; for postevaluation or poststabilization services, must provide
access to an authorized representative 24 hour a day, 7 days a week
(typical).
Nondiscrimination
Mont. Code Ann. § 33-22-526 – discrimination – a group health
plan or health insurance issuer offering group health insurance
coverage may not establish rules for eligibility of any individual
to enroll based on health status, medical condition, claims experience,
receipt of health care, medical history, genetic information, disability,
etc.; does not require particular benefits or prevent limitations/restrictions
on the amount, level, extent or nature of benefits for similarly
situated individuals; same entities may not require an individual
to pay a premium or contribution that is greater than the premium
or contribution for a similarly situated individual enrolled in
the plan; does not restrict charges to employers for coverage or
prevent discounts, etc. for adherence to health promotion and disease
prevention programs. (typical of statutes in many states)
Prohibition of Incentives
Mont. Code Ann. § 33-36-204 – incentive prohibition – a health
carrier may not offer an inducement under a managed care plan to
a participating provider to provide less than medically necessary
services to a covered person.
Consumer Participation
Mont. Code Ann. § 33-31-222 – governing body – the HMO governing
body must establish a mechanism to give enrollees an opportunity
to participate in matters of policy and operation through the establishment
of advisory panels, by the use of advisory referenda on major policy
decisions, or through the use of other mechanisms.
Provider Protections
*Mont. Code Ann. § 33-36-203 – discrimination – a health carrier
may not adopt selection criteria that exclude a provider because
the provider treats or specializes in treating populations presenting
a risk of higher than average claims, losses, or use of health care
services.
Mont. Code Ann. §§ 33-1-802, 33-36-204(8) – nonretaliation
– a health carrier or MCO may not take any action against a provider
in retaliation for a medical communication to an enrollee/representative
(§ 33-1-804 authorizes the commissioner to impose a civil penalty
for violations and to bring a civil action to collect the penalty);
a health carrier may not penalize a participating provider because
he/she in good faith reports to state or federal authorities an
act or practice by the carrier that may adversely affect patient
health or welfare.
Selected Benefit Mandates
Mont. Code Ann. §§ 33-22-134, 33-22-135 – postmastectomy
care/reconstructive surgery – insurers must cover.
Mont. Code Ann. §§ 33-22-703, 33-22-703 – mental illness,
alcoholism and drug addiction – sets minimum standards applicable
to group plans, including terms not less favorable than for physical
illness on durational and dollar limits, deductibles, and coinsurance
for basic inpatient benefits, except that inpatient treatment for
mental illness, alcoholism, and drug addiction may be subject to
a maximum yearly benefit of 21 days (inpatient treatment may be
traded on a 2-for-1 basis for partial hospitalization), and a 24-month
maximum of $4000 and a lifetime maximum of $8000; parity mandate
for aggregate dollar limits is subject to various carveouts and
this mandate terminates 9/30/2001.
Return to Top of Page
Nebraska
Consumer/Patient Protections
Access
*1998 Neb. Laws L.B. 1162, sec. 43 (Neb. Rev. Stat. §?) (Managed
Care Plan Network Adequacy Act) – access – applies to all health
carriers that offer managed care plans; network must be sufficient
in numbers and types of providers to assure that all health care
services to covered persons will be accessible without unreasonable
delay; health carriers must maintain an access plan that includes
the carrier’s efforts to address the needs of covered persons with
limited English proficiency and illiteracy, with diverse cultural
and ethnic backgrounds, and with physical and mental disabilities,
and the carrier’s system for ensuring the coordination and continuity
of care for covered persons referred to specialty physicians, using
ancillary services including social services and other community
resources, and for ensuring appropriate discharge planning, and
the carrier’s proposed plan for providing continuity of care in
the event of contract termination.
*Neb. Admin. R. & Regs. tit. 182, § 1-002 – access – HMOs
must demonstrate, among other things, that the location of facilities,
and proximity to and availability of transportation will enhance
accessibility of service to the reasonably anticipated enrollees,
including aged and handicapped persons, that facilities will not
present architectural barriers to aged and handicapped persons;
and that continuity of service to enrollees will be enhanced by
provision of a means for ensuring that enrollees receive the proper
level and type of care and that the provision of services is coordinated,
but within and outside the HMO.
1998 Neb. Laws sec. 43(1)(a) (Managed Care Plan Network Adequacy
Act) – OON referrals – in any case in which the health carrier has
an insufficient number or type of participating provider to provide
a covered benefit, the health carrier must ensure that the covered
person obtains the covered benefit and the health carrier must reimburse
the nonparticipating provider at the carrier’s usual and customary
rate or at an agreed upon rate.
Neb. Rev. Stat. § 44-786 – OB/GYNs – health carriers must allow
participating OB/GYNs to serve as PCPs.
Complaints/UR
1998 Neb. Laws sec. 68, 73 (Health Carrier Grievance Procedure Act)
– grievances – applies to all health carriers that offer managed
care plans; if a covered person’s request for services is denied,
the health carrier must provide an explanation of the reasons and
how to submit a grievance and the telephone number to call for information
and assistance; a carrier shall ensure that a majority of persons
reviewing a grievance involving an adverse determination have appropriate
expertise; 15 working days (with the possibility of a 15 working
day extension for circumstances beyond the carrier’s control) allowed
for decision, and the reviewer may not be the same person who made
the initial determination; at the first level no right to attend,
but may submit written material; content of written decision specified;
second-level grievance review must be conducted by a panel, majority
must be not previously uninvolved, majority must be health care
professionals with appropriate expertise, and its decision is binding
on the carrier; covered person has right to attend, ask questions,
be represented, etc.; written decision must be issued within 5 working
days after meeting.
1998 Neb. Laws sec. 68, 75 (Health Carrier Grievance Procedure Act)
– adverse determinations – comprehensive definition of adverse determination,
i.e., a determination by a health carrier or its designee UR agent
that an admission, availability of care, continued stay, or other
health care service has been reviewed and, based upon the information
provided, does not meet the health carrier’s requirements for medical
necessity, appropriateness, health care setting, level of care,
or effectiveness, and the requested health care service is therefor
denied, reduced, or terminated; a health carrier shall establish
written procedures for a standard review of an adverse determination;
when reasonably necessary or requested by the covered person’s provider,
standard reviews shall be evaluated by an appropriate clinical peer(s)
in the same or similar specialty as would typically managed the
case, not involved in the initial adverse determination; notice
of decision within 15 working days; carriers must have an expedited
review procedure for situations in which the standard timeframe
would seriously jeopardize life or health or ability to regain maximum
function; requests may be submitted orally or in writing; same rules
about qualifications of reviewers; timeframe for decision is “as
expeditiously as the covered person’s medical condition requires”
but in no event more than 72 hours after commencement; for concurrent
review, service must be continued without liability to covered persons
under notice of determination; must provide access to clinical peer
within one business day.
Neb. Rev. Stat. §§ 44-5402, 44-5412 – UR/appeals – comprehensive
definition of adverse determination; in an appeal, the covered person/physician
must be given timely access to the clinical basis a decision not
to approve/certify for clinical reasons; during a final appeal,
a physician must be reasonably available to review the case (unless
services were provided or authorized by a nonphysician provider).
Neb. Rev. Stat. § 44-5414(11) – UR/standards – a UR program
must use documented clinical review criteria that are based on sound
clinical evidence and evaluated periodically to assure ongoing efficacy.
Neb. Rev. Stat. § 44-5412 – UR/financial incentives – UR agents
prohibited from compensating employees/agents based directly on
the number of adverse determinations.
Neb. Rev. Stat. §§ 44-5402, 44-5412 – UR/emergency care
– adopts prudent layperson definition of emergency medical condition;
UR agent must allow a minimum of 24 hours for a covered person/representative
to provide notice of emergency treatment and request certification
or continuing treatment.
Disclosure
1998 Neb. Laws sec. 44(i) (Managed Care Plan Network Adequacy Act)
– gag clauses – a health carrier shall not prohibit a participating
provider from discussing treatment options with covered persons
irrespective of the carrier’s position on the treatment options
or from advocating on behalf of covered persons within the utilization
review or grievance processes established by the health carrier
or a contractor.
Emergency Care
Neb. Rev. Stat. §§ 44-6802, 44-6823 (Managed Care Emergency
Services Act) – emergency care – applies to all health carriers
that offer managed care plans; adopts prudent layperson definition
of emergency medical condition; imposes responsibility for charges
for medically necessary emergency services including OON services;
if the treating physician/ER staffer determines that additional
medically necessary services are promptly needed and has requested
approval, approval is deemed given if health carrier has not provided
access to individual authorized to approve request or such individual
has not denied authorization within 30 minutes.
Prohibition of Incentives
1998 Neb. Laws sec. 44(h) (Managed Care Plan Network Adequacy Act)
– incentive prohibition – a health carrier shall not offer an inducement
under the managed care plan to a provider to provide less than medically
necessary health care services to a covered person.
Provider Protections
1998 Neb. Laws sec. 44(o) (Managed Care Plan Network Adequacy Act)
– nonretaliation – a health carrier shall not penalize a provider
because the provider, in good faith, reports to state or federal
authorities any act or practice by the carrier that jeopardizes
patient health or welfare.
Selected Benefit Mandates
1998 Neb. Laws sec. 81 – off-label uses of drugs – applies to plans
that cover prescription drugs; limited to treatment of cancer and
HIV/AIDS.
Miscellaneous
1998 Neb. Laws sec. 60 (Quality Assessment and Improvement Act)
– confidentiality – data or information pertaining to the diagnosis,
treatment, or health of a covered person obtained from the person
or a provider by a health carrier is confidential and shall not
be disclosed to any person except to the extent that it may be necessary
to carry out the purposes of the Quality Assessment and Improvement
Act and as allowed by state law; or upon the express consent of
the covered person; or pursuant to statute or court order for the
production of evidence or the discovery thereof; or in the event
of a claim or litigation between the covered person and the health
carrier in which the data or information is pertinent.
1998 Neb. Laws sec. 44(e) (Managed Care Plan Network Adequacy Act)
– no recourse – in no event shall a participating provider collect
or attempt to collect from a covered person any money owed to the
provider by the health carrier, etc.
1998 Neb. Laws sec. 45(2)(b) (Managed Care Plan Network Adequacy
Act) – nondelegation – a health carrier’s statutory responsibility
to monitor the offering of covered benefits to covered persons shall
not be delegated or assigned to an intermediary.
Neb. Rev. Stat. §§ 44-5414(14) (UR Act), sec. 23 (Managed
Care Emergency Services Act), sec. 48 (Managed Care Plan Network
Adequacy Act), sec. 63 (Quality Assessment and Improvement Act),
sec. 81 (Health Carrier Grievance Procedure Act) – enforcement –
language suggests director may have obligation to issue cease and
desist order if violation is found after hearing; discretion to
impose fines up to $1000 per violation ($15,000 if flagrant), plus
suspend/revoke license.
Return to Top of Page
Nevada
Consumer/Patient Protections
Complaints/UR
Nev. Rev. Stat. §§ 695G.150, 695G.160 – adverse determinations
– decisions not to authorize a service recommended by a provider
and covered by the health plan can only be made by Nevada-licensed
physicians with the necessary expertise who have reviewed the available
medical documentation; health plans must have written criteria for
coverage decisions, available to affected insureds upon request.
Nev. Rev. Stat. § 695G.200 – complaints – system for resolving
complaints must be approved by the commissioner ; upon request,
MCOs must assign an employee to assist persons in filing complaints
or appealing a decision of the review board.
Nev. Rev. Stat. §§ 695G.210, 695G.230 – review board –
system for resolving complaints must include initial investigation
and review by a review board and an appeal procedure; the majority
of the members of the review board must be insureds of the MCO;
the board has 30 days to notify the insured of a determination (expedited
review in cases of imminent and serious threat to health must result
in notice within 72 hours); notices must contain an explanation
of any further rights; notice of coverage denials must include reasons
and criteria used.
Nev. Rev. Stat. §§ 679B.550, 679B.560 – ombudsman – the
insurance division is to establish a toll-free number for receiving
inquiries and complaints from consumers, providing answers and referrals
and counseling and assistance; insurers are to provide the number
and hours of operation to insureds.
Disclosure
Nev. Rev. Stat. § 695G.240 – gag clauses – MCOs may not restrict
or interfere with any communication between a provider and patient
regarding any information that the provider determines is relevant
to the patient’s health care.
Emergency Care
Nev. Rev. Stat. §§ 695G.170 – emergency services – prudent
person standard adopted; MCOs must cover and may not require prior
authorization.
Prohibition on Incentives
Nev. Rev. Stat. § 695G.260 – incentive prohibition – MCOs are
prohibited from offering or paying any type of material inducement,
bonus or other financial incentive to a provider of health care
to deny, reduce, withhold, limit or delay specific medically necessary
health care services to an insured; use of capitation or other financial
incentives is not prohibited if the arrangement is designed to provide
an incentive to the provider to use health care services effectively
and consistently in the best interest of the health care of the
insured
Selected Benefit Mandates
Nev. Rev. Stat. § 695C.1723 – inherited metabolic diseases
– HMOs must cover enteral formulas for home use and at least $2500
for special food products, if prescribed by a physician as medically
necessary for certain metabolic diseases.
Nev. Rev. Stat. § 695C.1727 – diabetes – all insurance covering
hospital, medical or surgical expenses must cover management and
treatment of diabetes, including coverage for self-management.
Nev. Rev. Stat. § 695C.174 – alcohol/drug abuse – HMOs must
cover a minimum of $1500 for treatment of withdrawal, $9000 for
inpatient treatment and $2500 for counseling, per calendar year.
Nev. Rev. Stat. § 695C.1755 – TMJ – no exclusions for TMJ permitted,
but may exclude dental procedures and HMOs may limit liability to
no more than 50% of usual and customary charges, etc.
Nev. Rev. Stat. § 695C.176 – hospice – each health care plan
must provide benefits for hospice care.
Miscellaneous
Nev. Rev. Stat. §§ 695G.130, 695G.220 – reports – MCOs
are required to file an annual report relating to quality, e.g.,
criteria used, financial reports, description of complaints evenuating
in legal proceedings; and a report on complaints including statistics
on total number, current status, average time to resolution.
Nev. Rev. Stat. § 695G.100 – public record – any document required
to be filed with the commissioner, other than medical records and
other information relating to a specific insured, must be treated
as a public record.
Return to Top of Page
New Hampshire
Consumer/Patient Protections
Note: FFS forms of health care expense coverage, and health insurers
which do not significantly limit covered persons’ choices of providers,
are not subject to regulation under managed care chapter.
N.H. Rev. Stat. Ann. § 420-J:1. UR is covered under a
separate chapter, which directs the commissioner to establish rules
for timeframes, confidentiality, reviewer qualifications, etc.
N.H. Rev. Stat. Ann. § 420-E:7. See N.H. Code Admin.
R. Ann. Ins. 2001.11 (decisions on most matters required within
2 business days after receipt of necessary information; URE must
notify beneficiary/provider within 24 hours after determination
that information is lacking); N.H. Code Admin. R. Ann. Ins. 2001.14
(URE must have written procedures for assuring that patient-specific
information is dept confidential, used only for UR, QM, discharge
planning, and CM, shared only with claims administrator and others
with authority to receive it, etc.).
Access
*N.H. Rev. Stat. Ann. § 420-J:7 – network adequacy – the commissioner
is to adopt rules addressing, among other things, wait times for
appointments and choice of and access to providers for specialty
care, specifically addressing the needs of the chronically ill,
mentally ill, developmentally disabled or those with a life threatening
illness.
Disclosure
N.H. Rev. Stat. Ann. § 420-J:8 – gag clauses – no contract
between a health carrier and a health care provider shall limit
what information the provider may disclose to patients or prospective
patients regarding the provisions, terms, or requirements of the
health carrier’s products as they relate to the needs of the provider’s
patients except for trade secrets of significant competitive value.
Complaints/UR
N.H. Rev. Stat. Ann. § 420-J:5 – grievances – written decision
within 20 business days after receipt of grievance and all information
necessary for review, with possibility of 10 business day extension
for circumstances beyond the carrier’s control; reviewers must not
have made initial determination; contents for notice specified;
same definition of adverse determination as for Nebraska; standard
review of adverse determination must be made by clinical peer(s)
not involved in initial determination; second level grievance review
are to be conducted by panel, with majority not previously involved
and at least one clinical peer involved in review, and written decision
within 5 business days of completion of review meeting; provisions
for expedited review procedure similar to Nebraska.
Selected Benefit Mandates
N.H. Rev. Stat. Ann. §§415:18-c, 420-B:8-f – ABMT – group
or blanket accident or health insurance and HMOs must cover expenses
arising from the treatment of breast cancer by ABMT according to
protocols reviewed and approved by NCI.
N.H. Rev. Stat. Ann. §§ 415:18-d, 420-B:8-f – scalp hair
prostheses - group or blanket accident or health insurance and HMOs
that cover prostheses must also cover scalp hair prostheses recommended
by a physician as medically necessary.
N.H. Rev. Stat. Ann. §§ 415:18-e, 420-B:8 -ff – nonprescription
enteral formulas - group or blanket accident or health insurance
and HMOs must cover formulas for certain disorders of the GI tract
if a physician has issued a written order stating that the formula
is needed to sustain life, medically necessary, and the least restrictive
and most cost effective means for meeting the needs of the patient.
N.H. Rev. Stat. Ann. §§ 415:18-f, 420-B:8-k – diabetes
- group or blanket accident or health insurance and HMOs must cover
medically appropriate and necessary outpatient self-management training
and educational services, including insulin, etc.
N.H. Rev. Stat. Ann. § 415:18-a – mental or nervous conditions
– group policies must cover expenses arising from treatment of illnesses
or disorders which, in professional judgment, are subject to significant
improvement through short-term therapy, and benefits for expenses
arising from diagnosis and evaluation of all other mental illnesses
and disorders; terms of major medical policies respecting inpatient
treatment must be at least as favorable as for other illnesses,
etc.; for major medical policies, deductibles and copayments must
be at least as favorable, except that may impose 12-month maximum
of $3000 and lifetime maximum of $10,000 per covered individual.
Miscellaneous
N.H. Rev. Stat. Ann. § 420-J:10 – confidentiality – same as
Nebraska provision.
N.H. Rev. Stat. Ann. § 420-J:14 – enforcement – commissioner
may impose administrative fines not to exceed $2500 per violation
or suspend or revoke a certificate of authority or license for failure
to comply.
New Jersey
Consumer/Patient Protections
Access
*N.J. Admin. Code tit. 8, §§ 38-6.2(a), 38-6.3 – access
– HMOs must have a sufficient number of specialists available to
members to provide medically necessary specialty care (within lesser
of 45 miles or 1 hr. driving time of 90% of members within county/approved
sub-county service area); HMOs must assure access (lesser of 45
miles or 1 hr. driving time of 90% of members within county/approved
sub-county service area) to specialized services) including inpatient
psychiatric services, residential substance abuse treatment center,
specialty outpatient centers for HIV/AIDS, sickle cell disease,
hemophilia, and cranio facial and congenital anomalies, and comprehensive
rehab services; licensed long term care facility, MRI, emergency
mental health service, outpatient therapy providers for mental health
and substance abuse conditions, and licensed renal dialysis provider
and several other services must be within lesser of 20 miles or
30 min. driving time of 90% of members within county/approved sub-county
area (where 20% of projected/actual membership rely on public transportation,
driving time must be based on average transit time using public
transportation).
*N.J. Admin. Code tit. 8, § 38-6.2(b) – specialists as PCPs
– HMOs may allow specialists to be designated as PCPs for specified
individual members or patient groups who, due to health status or
chronic illness, would benefit from medical care management by a
specialist.
N.J. Admin. Code tit. 8, § 38-9.1 – referral rights – statement
of members’ rights must include the right to obtain assistance and
referral to providers with experience in treatment of patients with
chronic disabilities (and the right to receive from the provider,
in terms the member understands, an explanation of his/her complete
medical condition, recommended treatment, its risk(s), expected
results and reasonable medical alternatives, whether or not covered).
N.J. Admin. Code tit. 8, § 38-3.5 – continuity of care – HMOs
must have a policy that assures continued coverage of services at
the contract price by a terminated provider for up to 120 calendar
days in cases where it is medically necessary for the member to
continue treatment with the terminated provider.
Complaints/UR
N.J. Admin. Code tit. 8, § 38-3.6 – complaints and appeals
– HMOs must establish a system that includes these features: a member
services representative to assist members with complaints upon request,
specified response time not to exceed 30 days from receipt, procedures
for follow-up, and a mechanism for notifying members that they may
contact the department (Div. of Medical Assistance for Medicaid
enrollees) if dissatisfied with the internal system.
N.J. Stat. Ann. § 26:2S-6; N.J. Admin. Code tit. 8, §§
38-8.2 to 38-8.6 – UR/general – 24x7 phone availability of RN/MD
to providers, to members if PCP or backup is not accessible by phone
24x7; all determinations to deny or limit an admission, service,
procedure or extension of stay must be rendered by a physician,
and must be made on a timely basis as required by the exigencies
of the situation; no retroactive denial of previously approved covered
services absent material misrepresentation or fraud; the appeal
process is to consist of an informal internal review (must include
opportunity to discuss determination with medical director or physician
designee rendering determination; timeframes are max. 72 hours in
urgent or emergency cases, 5 business days for others), a formal
internal review (panel of health care professionals not previously
involved, plus appropriately trained consultants; timeframes are
max. 72 hours in urgent or emergency cases, 20 b.d. for others with
20 b.d. extensions possible with proper documentation of reasonable
cause for delay beyond HMO control), and a formal external review
by an independent URO.
N.J. Stat. Ann. § 26:2S-6 – medical necessity – carriers’ treatment
policies, protocols, quality assurance programs and UR decisions
must be based on generally accepted standards of health care practice.
N.J. Stat. Ann. § 26:2S-11; N.J. Admin. Code tit. 8, §§
38-8.6 to 38-8.7 – independent review – review is available for
decisions to deny, reduce or terminate a benefit upon exhaustion
of internal appeals (but if an HMO fails to comply with any deadlines
for internal appeals, the member and/or provider is relieved of
this obligation and may proceed directly to the external process);
within 30 days of receipt of the written determination from a stage
2 internal appeal, the member/provider must file a written request
with the department and pay a $25 filing fee ($2 upon determination
of financial hardship, e.g., Medicaid, SSI), but carrier bears cost
of review; the IURO full review is initially conducted by a RN or
MD, with referral to a specialist consultant as necessary; timeframe
for decision is standard “as soon as possible in accordance with
the medical exigencies of the case” but in no event more than 30
days (unless delay is due to circumstances beyond IURO control);
HMO must accept or reject recommendation within 10 b.d.
N.J. Stat. Ann. § 26:2S-12 – independent review/standards –
reviewer is to determine the appropriate, medically necessary services
the person should receive, based on applicable, generally accepted
practice guidelines and any applicable clinical protocols or practice
guidelines developed by the carrier (but cannot extend scope of
coverage); if commissioner detects pattern of noncompliance with
recommendations, must review UR program.
Disclosure
N.J. Stat. Ann. § 26:2S-5; N.J. Admin. Code tit. 8, §
38-13.4 – incentive disclosure – carriers that offer managed care
plans must disclose to subscribers at enrollment and annually thereafter
(and to potential subscribers upon request), among other things,
general information about financial incentives (plus availability
of satisfaction and quality information through the department of
insurance); a generic disclosure statement must be included in enrollment
applications and member handbooks; upon request, HMOs must disclose
the method by which a specific provider is compensated, but need
not state dollar amount or other details.
N.J. Stat. Ann. § 26:2S-4 – formularies – carriers must disclose
to subscribers at enrollment and upon request thereafter, among
other things, restrictions or limitation on prescription drug benefits.
N.J. Stat. Ann. § 26:2S-9 – gag clauses/nonretaliation – contracts
between a provider and a carrier that offers a managed care plan
must state that the provider shall not be penalized or terminated
for acting as a patient advocate in seeking appropriate, medically
necessary health care services and must protect the ability of a
provider to communicate openly with a patient about all appropriate
diagnostic testing and treatment options.
Emergency Care
N.J. Admin. Code tit. 8, § 38-5.3 – emergency care – HMOs must
cover trauma services, at least to the point where the attending
physician judges the member medically stable, no longer critical,
and safe to transfer; OON care must be covered where the member
cannot reasonably access in-network services.
Nondiscrimination
*N.J. Admin. Code tit. 8, § 38-3.2 – nondiscrimination – HMOs
may not refuse to renew coverage or alter the terms of an existing
contract solely on the basis of, among other things, the health
of the member, the frequency of the member’s use of health care
services, the filing of a complaint or appeal by the member, or
other reasons prohibited by the Trade Practices Act, N.J.S.A. 17B-30-1
et seq., or the New Jersey Law Against Discrimination, N.J.S.A.
10:5-1.1 et seq.
*N.J. Admin. Code tit. 8, § 38-15.2 – nondiscrimination/providers
– all provider contracts must specify that the providers shall not
discriminate in their treatment of HMO patients.
Prohibition of Incentives
N.J. Stat. Ann. § 26:2S-9 – incentives – carriers that offer
managed care plans are prohibited from providing financial incentives
to providers for withholding medically necessary services (but does
not limit use of capitated payment arrangements).
N.J. Admin. Code tit. 8, §§ 38-15.1, 38-15.2 – risk sharing
– no person shall assume financial risk for the cost or provision
of health services to others unless the person is an entity licensed
under the state insurance laws, a provider actually performing the
health services, or an employer with respect to its own employees
and their dependents; capitation may not be used as the sole reimbursement
method to providers who primarily provide supplies (e.g., prescription
drugs, DME) rather than services.
Provider Protections
N.J. Admin. Code tit. 8, § 38-15.2 – nonretaliation – all provider
contracts must specify that no provider may be terminated or penalized
solely because of filing a complaint or appeal permitted by the
rules; no contract may impose obligations upon a provider which
conflict with statutes or rules governing licensure of the provider.
Selected Benefit Mandates
*N.J. Admin. Code tit. 8, § 38-5.2 – basic services – HMOs
are required to provide/arrange for a set of basic comprehensive
health services as medically necessary; list includes rehab services,
equipment and supplies for the treatment of diabetes (also see §
8:38-5.4), inpatient substance abuse care (min. 30 days/contract
year), skilled nursing care (min. 30 days/contract year), home health
services (min. 60 visits/contract year), and hospice services.
N.J. Admin. Code tit. 8, § 38-5.6 – Wilm’s tumor – HMOs must
cover treatment, including ABMT when standard chemotherapy is unsuccessful,
notwithstanding that it may be deemed experimental or investigational.
N.J. Stat. Ann. § 26:2J-4.5, N.J. Admin. Code tit. 8, §
38-5.7 – off-label uses of drugs – HMOs that provide pharmacy services
must cover.
Miscellaneous
N.J. Admin. Code tit. 8, § 38-15.2 – no recourse – all provider
contracts must contain a provision whereby the provider shall hold
the member harmless for the cost of any service or supply covered
by the HMO (does not reach required copayments, deductibles or coinsurance
but does prohibit balance billing for services/supplies obtained
through the HMO network).
N.J. Admin. Code tit. 8, § 38-15.2 – confidentiality – all
provider contracts must specify that patient information shall be
kept confidential, but that the HMO and provider have mutual right
to medical records/patient information.
Return to Top of Page
New Mexico
Consumer/Patient Protections
Access
*N.M. Stat. Ann. § 59A-57-4 – specialists as PCPs – managed
health care plans must ensure that health care providers that are
specialists may act as primary care providers for patients with
chronic medical conditions.
*N.M. Stat. Ann. § 59A-57-4, N.M. Admin. Code tit. 13, §
10.13.11 – OON referrals/continuity of care – MHCPs must ensure
that reasonable access is provided to OON providers if medically
necessary covered services are not reasonably available through
participating health care providers or if necessary to provide continuity
of care during brief transition periods; the MHCP must fully reimburse
the OON provider at the usual and customary rate or an agreed upon
rate; before a MHCP may deny such a referral the request must be
reviewed by a specialist similar to the type of specialist to whom
a referral is requested.
*N.M. Admin. Code tit. 13, § 10.13.28 – continuity of care
– the transitional period for terminating providers/new enrollees
shall continue for a time that is sufficient to permit coordinated
transition planning consistent with the patient’s condition and
needs relating to continuity of care, and, in any event, not less
than 30 days.
*N.M. Admin. Code tit. 13, § 10.13.11 – standing referrals
– if, in the best medical judgment of the enrollee’s PCP, the enrollee’s
health condition requires ongoing specialty care, such as for chronic
illnesses requiring medical supervision beyond the PCP’s capability
or training, the PCP may, after consultation with the specialist
and MHCP, refer the enrollee for ongoing care as the severity of
the condition warrants; the ultimate determination remains with
the PCP; in such cases, neither PCP nor enrollee will be required
to obtain prior authorization from the MHCP for subsequent specialist
visits; the MHCP may review such referrals on an annual basis; the
MHCP may require referral to an IN specialist unless there are no
IN specialists of the type required.
N.M. Admin. Code tit. 13, § 10.13.11 – access – specific standards
relating to geographical proximity of specialists/specialty services
and appointment wait times.
N.M. Admin. Code tit. 13, § 10.13.9 – OB/GYNs – MHCPs must
allow qualified women’s health care providers including OB/GYNs
to serve as PCPs and allow enrollee direct access to IN providers
for certain services.
Disclosure
N.M. Stat. Ann. § 59A-57-6 – gag clauses – no MHCP may adopt
a gag rule or practice that prohibits a provider from discussing
a treatment option with an enrollee, even if not plan-approved (see
also N.M. Admin. Code tit. 13, § 10.13.25, also prohibiting
prohibitions of disparaging comments).
N.M. Admin. Code tit. 13, § 10.13.8 – incentive disclosure
– enrollees have the right to know upon request of any financial
arrangements or provisions between the insurer and its providers
which may restrict referral or treatment options or limit the services
offered.
N.M. Admin. Code tit. 13, § 10.13.14 – incentive disclosure
– each MHCP evidence of coverage/disclosure form must include a
statement regarding whether or not participating providers must
comply with any specified numbers, targeted averages, or maximum
durations of patient visits (if yes, the specific requirements must
be stated).
Complaints/UR
N.M. Admin. Code tit. 13, § 10.13.7 – definitions/medical necessity
– medical necessity or medically necessary means appropriate or
necessary services as determined by a participating provider affiliated
with the managed health care plan, in consultation with the MHCP,
which are rendered to an enrollee for any covered condition requiring,
according to generally accepted principles of good medical practice,
the diagnosis or direct care and treatment of an illness, injury,
or medical condition, and are not services provided only as a convenience.
N.M. Stat. Ann. § 59A-57-4 – grievances – procedure must be
prompt and fair, with expedited review in emergent cases; final
decision must be made by a qualified health care professional; UR
program must ensure that enrollees have proper access to services
including referrals to necessary specialists.
N.M. Admin. Code tit. 13, § 10.13.14, N.M. Admin. Code tit.
13, § 10.13.15 – grievances – each MHCP evidence of coverage/disclosure
form must include a description of the appeals process and a statement
identifying the Superintendent as an external source with whom grievances
may be filed with the toll-free number; the MHCP must initially
assume that every complaint constitutes a grievance; two levels
of internal review, with determination at first level binding unless
grievant appeals within 30 days; 30-day timeframe for notice of
decision runs from date enrollee submits all information (with possibility
of extension where MHCP experiences delay in obtaining documents
and can demonstrate delay will not result in increased medical risk
to enrollee); timeframe is 5 days from receipt of complaint for
urgent care, OON services, medically necessary care; second-level
review is conducted by a committee with no more than half having
any previous involvement with case; decision is binding unless grievant
appeals within 30 days of receipt of decision; grievant may appear
in person; hearing must be held within 30 days (15 days advance
notice to grievant); written decision within 10 days of hearing.
N.M. Admin. Code tit. 13, § 10.13.15 – independent review –
enrollees may submit their grievances to the superintendent at any
time, but superintendent has discretion to require exhaustion of
internal procedures.
N.M. Admin. Code tit. 13, § 10.13.15 – nonretaliation – an
enrollee who exercises the right to file a grievance may not be
subjected to any retaliatory action.
N.M. Admin. Code tit. 13, § 10.13.15 – UR – the appeal process
is to consist of an informal internal review (timeframes are max.
48 hours in urgent or emergency cases, 7 days for others; binding
unless appealed within 30 days), a formal internal review (panel
of health care professionals not previously involved, plus appropriately
trained consultants; grievant may designate a specialist to participate
in review at his/her own expense; timeframes are max. 48 hours in
urgent or emergency cases, 30 days for others with additional 20
day extension possible; hearing within 24 hours urgent/emergency,
10 days other; grievant may attend, etc.), and a formal external
review by an independent URO.
N.M. Admin. Code tit. 13, § 10.13.19 – UR standards – all determinations
to authorize an admission, service, procedure or extension of stay
must be rendered by a physician, RN, or other qualified health professional;
all determinations to deny or limit an admission, service, procedure
or extension of stay must be rendered by a physician; all determinations
must be made on a timely basis as required by the exigencies of
the situation and in accordance with sound medical principles, in
any even not to exceed 24 hours for emergency care and 7 days for
other determination; no retroactive denials of previously approved
services; notices must contain reasons, etc.
N.M. Admin. Code tit. 13, § 10.13.14 – UR report – annually
each MHCP must disclose to the Superintendent and its contracting
providers the process by which it authorizes or denies services
rendered by its providers pursuant to the benefits covered by the
plan; any MHCP claiming that such information is proprietary has
the burden of proof before the Superintendent.
N.M. Admin. Code tit. 13, § 10.13.19 – UR standards – UR determinations
must be based on written clinical criteria and protocols developed
with involvement from practicing physicians and other health professionals
and providers within the MHCP’s network; these criteria and protocols
must be periodically reviewed and updated and must, with the exception
of internal or proprietary quantitative thresholds for utilization
management, be readily available, upon request, to affected providers
and enrollees; the MHCP has the burden of showing that information
is proprietary.
N.M. Admin. Code tit. 13, § 10.13.15 – independent review –
if MHCP fails to comply with any deadlines for internal appeals,
the member and/or provider is relieved of the obligation to complete
the internal process and may proceed directly to the external process;
within 30 days of receipt of the written determination from a stage
2 internal appeal, the member/provider must file a written request
with the department; the superintendent reviews submissions and
accepts meritorious ones; timeframe for decision is 48 hours for
urgent or emergent cases, 21 days for others; both the grievant
and a MHCP rep. may appear in person, etc.; within 7 days after
the superintendent receives the IURB recommendation, he/she informs
the parties whether he/she accepts/rejects it, and the MHCP then
has 10 days to accept/reject (or request a formal hearing); if the
MHCP refuses to comply with a recommendation adopted by the superintendent,
the superintendent may institute proceedings; requirements for IURBs
include composition (two physicians and one attorney with relevant
expertise licensed to practice in N.M.).
N.M. Stat. Ann. § 59A-57-5, N.M. Admin. Code tit. 13, §
10.13.15 – internal ombudsman – each MHCP must establish and adequately
staff a consumer assistance office; where an enrollee initially
makes an oral complaint and expresses interest in pursuing a grievance,
the MHCP must assist the enrollee in make a written complaint/initiating
a grievance.
Prohibition on Incentives
N.M. Stat. Ann. § 59A-57-6 – incentive prohibition – no MHCP
may include in any of its contracts with providers any provisions
that offer an inducement, financial or otherwise, to provide less
than medically necessary services to an enrollee.
Emergency Care
N.M. Stat. Ann. §§ 59A-57-1, 59A-57-4 – emergency care
– adopts prudent layperson standard; MHCPs must ensure that emergency
care is immediately available without prior authorization requirements
and appropriate OON emergency care is not subject to additional
costs (elaborated at N.M. Admin. Code tit. 13, § 10.13.9).
Formularies
*N.M. Admin. Code tit. 13, § 10.13.12 – non-formulary drugs
– MHCPs must allow enrollees to obtain drugs not on the formulary,
without penalty and in a timely fashion, when the treatment for
which the drug is prescribed is a covered benefit and the participating
provider in consultation with the MHCP determines that the formulary’s
equivalent has been or is reasonably expected to be less effective
for the enrollee; or the formulary drug has caused or is reasonably
expected to cause adverse reactions in the enrollee.
Nondiscrimination
*N.M. Admin. Code tit. 13, §§ 10.13.14, 10.13.17, 10.13.18,
10.13.22 – discrimination – no health care insurer or contracting
health care facility or provider may discriminate against an enrollee
by refusing to enter any health benefits contract, canceling or
declining to renew or reinstate a contract, or altering its terms
and the quality of services (to be) rendered because of (among other
things) the enrollee’s health status, disability, or frequency of
use of health care services or filing of a permitted grievance or
appeal (however premium, price or charge differentials because of
age or age based on objective, valid, and up-to-date statistical
and actuarial data are not prohibited); each MHCP evidence of coverage/disclosure
form must describe, among other things, conditions of cancellation,
including a statement that if an enrollee believes coverage was
canceled due to health status or health care requirements, he/she
may appeal termination to the Superintendent; a MHCP may not cancel
coverage for non-payment of copays if cancellation would constitute
abandonment of a patient who is hospitalized for a life-threatening
condition; a MHCP may not cancel coverage due to refusal to follow
a prescribed course of treatment; if the Superintendent determines
that an enrollee has been wrongfully terminated, may request immediate
retroactive reinstatement.
*N.M. Admin. Code tit. 13, § 10.13.25 – discrimination – each
provider contracts must require the provider/facility to provide
health care services without discrimination on the basis of a patient’s
health status or disability, among other things.
Consumer Participation
N.M. Stat. Ann. § 59A-57-5 – each managed health care plan
shall establish a consumer advisory board.
Provider Protections
N.M. Stat. Ann. § 59A-57-6 – no conflict – no managed health
care plan may require a provider to violate any recognized fiduciary
duty of his profession or place his license in jeopardy.
N.M. Admin. Code tit. 13, § 10.13.25 – nonretaliation – an
insurer or MHCP is prohibited from employing contract provisions
that penalize a provider or facility that assists an enrollee in
seeking reconsideration of a decision to deny or limit benefits.
Selected Benefit Mandates
N.M. Stat. Ann. §§ 59A-46-43, 59A-22-41 – diabetes – HMOs
and health insurers must cover as a basic service, entitling enrollees
to the medically accepted standard of medical care for diabetes
(treatment and supplies, self-management training and medical nutrition
therapy); when new or improved equipment, appliances, prescription
drugs, insulin, or supplies are approved by the FDA, the HMO must
maintain an adequate formulary to provide these resources and guarantee
reimbursement/coverage within the limits of the plan/policy.
N.M. Admin. Code tit. 13, § 10.13.9 – basic services – insurers
offering comprehensive services through a MHCP must provide/arrange
for physician services reasonably required to maintain good health,
medically necessary outpatient and inpatient services, emergency
services, short-term rehabilitation services and physical therapy
where treating physician determines that it can be expected to result
in significant improvement of an enrollee’s physical condition within
two months, etc.; also general dental services determined to be
medically necessary in connection with certain disorders and cosmetic
surgery from which an improvement in physiologic function could
reasonably be expected.
N.M. Admin. Code tit. 13, § 10.13.12 – off-label uses of drugs
– MHCPs that cover prescription drugs must also cover, subject to
usual caveats.
Miscellaneous
*N.M. Stat. Ann. § 59A-57-10 – applicability to Medicaid –
with a few caveats, the Patient Protection Act applies to the state
Medicaid program; recipients/applicants who file an appeal with
HS are precluded from filing with on the same issue with the superintendent,
unless HS refuses to hear the appeal.
N.M. Stat. Ann. §§ 59A-57-5, 59A-57-11 – enforcement –
a person adversely affected may file a complaint with the superintendent
regarding a violation; the superintendent may issue any order he
deems necessary or appropriate; penalties include a fine of up to
$10,000 per violation.
*N.M. Stat. Ann. § 59A-57-9 – private ROA – a person who suffers
a loss as a result of a violation of a right protected pursuant
to the provisions of the Patient Protection Act [59A-57-1 to 59A-57-11],
its regulations or a managed health care plan may bring an action
to recover actual damages or $100, whichever is greater; a person
likely to be damaged by a denial of a right may be granted an injunction
(proof of monetary damages or intent not required); an individual
enrollee is a third-party beneficiary of the managed health care
plan contract and may sue to enforce it (but the contract may be
amended without the enrollee’s consent); the Act does not make a
plan vicariously liable for the actions of independent contractor
health care providers.
N.M. Admin. Code tit. 13, § 10.13.14 – quality – upon request
of enrollees, prospective enrollees, or subscribers, the MHCP shall
provide copies of its quality assurance plan and patterns of utilization
of services that it routinely tracks.
N.M. Admin. Code tit. 13, § 10.13.21 – confidentiality – any
data or information pertaining to the diagnosis, treatment or health
of any enrollee shall be held in confidence and shall not be disclosed
to any person except: as necessary to carry out the rule, upon express
consent of the enrollee, pursuant to state or court order, in litigation
between enrollee and insurer if pertinent, or where otherwise required
by law.
N.M. Admin. Code tit. 13, § 10.13.26 – marketing – typical
provisions.
Return to Top of Page
New York
Consumer/Patient Protections
Access
*N.Y. Ins. Law § 4804(a) (health insurers, hospital or health
service corporations), N.Y. Pub. Health Law § 4403(6)(a) (HMOs)
(McKinney) – OON referrals – if an insurer offering a managed care
product/HMO determines that it does not have an IN provider with
appropriate training and experience to meet the particular health
care needs of an enrollee, the insurer must make a referral to an
appropriate provider, pursuant to a treatment plan approved by the
insurer in consultation with the PCP, the OON provider and the enrollee/designee,
at no additional cost to the enrollee beyond what would otherwise
be due for IN services.
*N.Y. Ins. Law § 4804(b), N.Y. Pub. Health Law § 4403(6)(b)
(McKinney) – standing referrals – an insurer offering a managed
care product/HMO must have a procedure by which an enrollee who
needs ongoing care from a specialist may receive a standing referral
to the specialist; need is determined by the insurer/PCP in consultation
with the insurer, in consultation with the specialist; OON referral
is only required if conditions of (a) are met; referral must be
pursuant to an approved treatment plan, which may limit the number
of visits or period during which visits are authorized and require
updates to the PCP.
*N.Y. Ins. Law § 4804(c), (d), N.Y. Pub. Health Law §
4403(c), (d) (McKinney) – specialists as PCPs – an insurer/HMO must
have a procedure by which a new/newly diagnosed enrollee with a
life-threatening condition or disease or a degenerative and disabling
disease or condition, requiring specialized medical care over a
prolonged period of time, may receive a referral to a specialist
with expertise in treating the disease/condition responsible for
and capable of providing and coordinating the enrollee’s primary
and specialty care; referral must be pursuant to an insurer-approved
treatment plan; OON is required only if conditions of (a) are met,
but in such a case charges must be no greater than for IN services;
similar provision concerning referral to specialty care center.
*N.Y. Pub. Health Law § 4403(5) – access/network adequacy –
at the time of initial licensure and at least every 3 years thereafter
(plus application to expand service area), the commissioner is to
ensure that an HMO maintains a network adequate meet enrollees’
comprehensive health needs and provide appropriate choice of providers
by determining that, e.g., there are sufficient providers in each
area of specialty practice to meet the needs of the enrollment population;
criteria to be considered include the availability of appropriate
and timely care that is provided in compliance with the standards
of the ADA to assure access to health care for the enrollee population.
*N.Y. Ins. Law § 4804(e), (f), N.Y. Pub. Health Law §
4403(e), (f) (McKinney) – continuity of care – in case of provider
leaving network, insured must be permitted to continue ongoing course
of treatment for up to 90 days from the date of notice to the insured
of the disaffiliation, but only if the provider agrees to certain
conditions; a new insured must be permitted to continue ongoing
course of treatment for up to 60 days from the effective date of
enrollment if the insured has a life-threatening or degenerative
and disabling disease or condition (or has entered second trimester
of pregnancy), subject to same qualifier.
N.Y. Pub. Health Law § 4406-b – OB/GYNs – applies to HMOs;
direct access to qualified provider for two exams annually or any
care related to pregnancy (plus needed follow-up care).
Complaints/UR
N.Y. Ins. Law § 4802, N.Y. Pub. Health Law § 4408-a (McKinney)
– grievances and internal appeals – the procedure must be reasonably
accessible to those who do not speak English; grievances respecting
referral and coverage may be submitted orally; the procedure must
be reasonably accessible to those who do not speak English; insurer
must have toll-free number; all grievances must be resolved in an
expeditious manner, and in any event no more than: 48 hours after
receipt of all necessary information when delay would significantly
increase the risk to an enrollee’s health; 30 days after receipt...for
requests for referrals or determinations concerning coverage; 45
days...in all other cases; insurer/HMO must designate qualified
personnel to review (licensed, certified or registered health care
professionals where grievance concerns clinical matters); content
of notice is specified; enrollee/designee has 60 b.d. to file written
appeal; determination of appeal on clinical matter must be made
by qualified personnel (meaning a licensed...who did not make the
initial determination), and at least one must be a clinical peer
reviewer (defined term); insurer/HMO shall seek to resolve all appeals
in the most expeditious manner and make a determination and provide
notice no more than: 2 b.d. after receipt of all necessary information
when a delay would significantly increase the risk to the enrollee’s
health; 30 b.d....in all other instances; content of notice specified;
insurers/HMOs are prohibited from retaliating or taking any discriminatory
action against an enrollee because the enrollee has filed a grievance
or appeal; rights and remedies conferred are cumulative, not in
lieu of others.
N.Y. Ins. Law §§ 4900 to 4916 (insurers and hospital or
health service corporations), N.Y. Pub. Health Law §§
4900 to 4916 (HMOs, IPAs and medical groups) (McKinney) (new provisions
eff. 7/1/99) – UR/definitions (§4900) – adverse determination
means a determination by a UR agent that an admission, extension
of stay, or other health care services (includes pharmaceuticals
and DME), upon review based on the information provided, is not
medically necessary; clinical peer reviewer means a physician or
other licensed health care professional who typically manages the
medical condition or disease or treatment under review and, for
external review, such a person who is board certified/eligible or
credentialed in the appropriate specialty, has been practicing the
specialty for at least 5 years, and is knowledgeable about the service
or treatment under appeal; disabling condition or disease means
a condition or disease which, according to the current diagnosis
of the enrollee’s attending physician, is consistent with the definition
of “disabled person” pursuant to §208(5) of the social services
law; life-threatening condition or disease means a condition or
disease which, according to the current diagnosis of the enrollee’s
attending physician, has a high probability of causing the enrollee’s
death.
N.Y. Ins. Law § 4902, N.Y. Pub. Health Law § 4902 (McKinney)
– UR/standards – UR agents must have, among other things, an expedited
appeals process for denials of continued inpatient care or where
there is imminent or serious threat to the health of the enrollee,
appropriate policies and procedures to ensure that all applicable
laws to protect the confidentiality of individual medical records
are followed, emergency services not subject to prior authorization.
N.Y. Ins. Law § 4903, N.Y. Pub. Health Law § 4903 (McKinney)
– UR/initial review – where a review involves an adverse determination,
must be conducted by a clinical peer reviewer; routine prospective
review determination must be made and noticed within 3 b.d. of receipt
of necessary information (1 b.d. in case of determination involving
continued or extended health care services or additional services
within a course of treatment, and notice to provider suffices);
content of notice specified; if UR agent fails to consult with recommending
provider, provider must have the opportunity to request reconsideration;
failure by the UR agent to make a determination within the prescribed
time periods is deemed an adverse determination subject to appeal.
N.Y. Ins. Law § 4904, N.Y. Pub. Health Law § 4904 (McKinney)
– UR/appeal – in the expedited appeal process, the UR agent must
provide reasonable access to it clinical peer reviewer within 1
b.d. of receiving a request, and a determination must be made within
2 b.d. of receipt of necessary information to conduct the appeal;
if the appealing party is not satisfied, may further appeal through
the standard or the external appeal process; timeframe for determination
in standard appeal process is 45 days, with right to external appeal
of adverse determination, and appeals may be filed in writing or
by telephone; content of notices specified; both expedited and standard
appeals shall only be conducted by clinical peer reviewers other
than those who rendered the adverse determination; failure by the
UR agent to make a determination within the prescribed time periods
is deemed an adverse determination subject to appeal.
N.Y. Ins. Law § 4905, N.Y. Pub. Health Law § 4905 (McKinney)
– UR/confidentiality, incentives, etc. – each UR agent must have
written procedures for assuring that patient-specific information
obtained during the UR process will be kept confidential accordance
with applicable laws; summary data is not to be considered confidential
if it does not provide information to allow identification of individual
patients; UR agents may not permit or provide compensation to employees/agents/contractors
based on either a percentage of the amount by which a claim is reduced
for payment or the number of claims or cost of services for which
the person has denied authorization or payment, or any other method
that encourages the rendering of an adverse determination; a UR
agent may not base an adverse determination on a refusal to consent
to observing any service; neither UR agents nor their commissioning
entities may penalize enrollees/designees or their providers for,
or discourage them from, undertaking an appeal, ADR, or judicial
review of an adverse determination. (§ 4906 – rights not waivable)
External appeals
N.Y. Ins. Law § 4910, N.Y. Pub. Health Law § 4910 (McKinney)
– external appeals/applicability – eff. 7/1/99; an enrollee/designee
(or provider, in retrospective cases) has the right to request an
external appeal when coverage has been denied on the grounds that
the health care service is (a) not medically necessary or (b) (i)
experimental or investigational and (ii) the enrollee has a life-threatening
or disabling condition or disease (a) for which standard health
services or procedures have been ineffective or would be medically
inappropriate, or (b) for which there does not exist a more beneficial
standard health service or procedure covered by the plan, or (c)
for which there exists a clinical trial (defined term), and (iii)
the attending physician recommended (a) a health service or procedure/drug
that, based on two documents from the available medical and scientific
evidence, is likely to be more beneficial to the enrollee than any
covered standard health service or procedure; or (b) a clinical
trial for which the enrollee is eligible and (iv) the service or
procedure would otherwise be covered under the policy except for
the plan’s determination that it is experimental or investigational;
internal appeals must be exhausted unless waived by agreement of
the parties; the plan may charge a fee of up to $50 (refundable
if the enrollee prevails, and waivable in Medicaid and other hardshop
cases); any external appeal process established under existing federal
and state law relating to Medicare/Medicaid appeals (and subsequently
enacted federal law) supersedes determinations under this process;
payment for the appeal is the responsibility of the health plan
(§ 4914); enrollees may not be required to exhaust external
appeals prior to seeking judicial relief (s 42 of act).
N.Y. Ins. Law §§ 4911 to 4913, N.Y. Pub. Health Law §§
4911 to 4913 (McKinney) – external appeals/standards – external
review agents must be certified by the state; standards for certification
include development of procedures to ensure the selection of qualified
and impartial clinical peer reviewers and procedures to ensure confidentiality;
a separate provision disqualifies reviewers from conducting an appeal
where there is a conflict of interest (with the commissioner to
issue regulations to minimize conflicts where they may be unavoidable);
subject to incentive prohibitions similar to those for UR (§
4915).
N.Y. Ins. Law § 4914, N.Y. Pub. Health Law § 4914 (McKinney)
– external appeals/procedure – an enrollee has 45 days after receipt
of a notice of a final adverse determination or denial in which
to initiate an appeal; the external appeal agent has 30 days from
receipt of request to make a determination and 2 b.d. to notify
the enrollee and plan of the determination; where the attending
physician states that a delay in providing the service would pose
an imminent or serious threat to the enrollee’s health, the appeal
must be completed within 3 days with immediate notice by telephone
or fax; for external appeals concerning medical necessity, the standard
is whether the plan acted reasonably and with sound medical judgment
and in the best interest of the patient, taking into consideration
the clinical standards of the plan, the information provided concerning
the patient, the attending physician’s recommendation, and applicable
generally accepted practice guidelines developed by the federal
government, national or professional medical societies, boards and
associations; the determination must be conducted by one or a greater
odd number of clinical peer reviewers, and is subject to the terms
and conditions generally applicable to benefits under the plan’s
evidence of coverage, and it is binding on the parties and admissable
in court.
N.Y. Ins. Law § 4914, N.Y. Pub. Health Law § 4914 (McKinney)
– external appeals/procedure (experimental treatment) – the determination
of whether patient costs will be covered must be conducted by a
panel of three or a greater odd number of clinical peer reviewers;
the standard is either a determination of the majority that, upon
review of the applicable medical and scientific evidence (or confirmation
that the recommended treatment is a clinical trial), the enrollee’s
medical record, and any other pertinent information, the proposed
service/treatment is likely to be more beneficial than any standard
treatment(s) for the condition or disease (or, in the case of a
clinical trial, is likely to benefit the enrollee in the treatment
of the condition or disease); the determination is subject to the
terms and conditions generally applicable to benefits under the
plan’s evidence of coverage, and it is binding on the parties and
admissable in court.
N.Y. Ins. Law §§ 3216(i)(22), 3221(k)(12), 4303(z), 4321(f)
(McKinney) – experimental treatments – parallel provisions applicable
to individual accident and health insurance policies, group or blanket
health insurance policies, hospital or health service corporations,
and HMOs; no policy/contract issued after 7/1/99 may exclude coverage
of a health care service on the basis that the service is experimental/investigational,
is rendered as part of a clinical trial, or a pharmaceutical product
prescribed for an off-label use provided that coverage of the patient
care costs of the service has been recommended by an external appeal
agent following the approved appeal process.
Disclosure
N.Y. Pub. Health Law § 4408(1)(d) (HMOs), N.Y. Ins. Law §§
3217-a(a)(4), 4324(a)(4) (health insurers, hospital and health service
corporations) (McKinney) – incentive disclosure – each HMO/insurer
must provide each subscriber, and upon request each prospective
subscriber prior to enrollment, with a written description prepared
annually of the types of methodologies used to reimburse particular
types of providers or reimburse for the provision of particular
types of services (with the caveat that disclosure of individual
contracts or specific details is not required).
N.Y. Ins. Law §§ 3217-a, 4324, N.Y. Pub. Health Law §
4408 (McKinney) – other disclosure – written disclosure to each
insured, and prospective enrollees upon request, must include the
definition of medical necessity in use, UR policies and procedures,
grievance procedures, and descriptions of various rights under state
law, among other things; available to enrollees and prospective
enrollees upon request: information relating to consumer complaints,
procedures for protecting confidentiality, a description of procedures
for making decisions about experimental status, and (if requested
in writing), specific written clinical review criteria relating
to a particular condition or disease.
N.Y. Ins. Law §§ 3217-b, 4325, N.Y. Pub. Health Law 4406-c
(McKinney) – gag clauses – insurers, health and hospital service
corporations, and health care plans (HMOs, IPAs and medical groups)
are prohibited from prohibiting or restricting, by contract or written
policy or procedure, any provider from (i) disclosing to any insured/designated
representative/prospective insured any information the provider
deems appropriate regarding treatments and alternatives or the terms
of the insurer’s product as they relate to the insured or (ii) filing
a complaint, making a report or commenting to an appropriate governmental
body regarding policies/practices that may negatively impact quality
or access or (iii) advocating on behalf of the insured.
Emergency Care
N.Y. Ins. Law §§ 3216(i)(9), 3221(k)(4), 4303(a)(2), 4900(c),
4902(a)(8), 4905(m), N.Y. Pub. Health Law §§ 4900(3),
4902(1)(h), 4905(13) (McKinney) – emergency care – parallel provisions
applicable to individual accident and health insurance policies,
group or blanket health insurance policies, hospital or health service
corporations, and HMOs; adopts prudent layperson standard; not subject
to prior approval/in no event shall any one be required to inform
or contact a UR agent prior to the provision of emergency care.
Nondiscrimination
N.Y. Ins. Law § 3221(q)(1) (McKinney) – nondiscrimination –
insurers issuing/delivering a group or blanket policy are prohibited
from establishing rules for eligibility based on a list of health
status-related factors, including health status, medical condition
(including both physical and mental illnesses), claims experience,
and receipt of health care, disability; no insurer may, on the basis
of any health-status-related factor, require any insured to pay
a premium or contribution which is greater than the premium for
a similarly situated insured enrolled in the plan.
Prohibition on Incentives
N.Y. Pub. Health Law §§ 4403(a)(5), 4406-c(5-b) (HMOs),
N.Y. Ins. Law §§ 3217-b(f), 4325(f) (health insurers,
hospital and health service corporations) (eff. date 7-1-99) – incentive
prohibition – the statutory language suggests that financial risk
may not be transferred to providers without some assessment of capacity
to absorb risk; also, contracts may not penalize providers for unfavorable
case mix so as to jeopardize the quality of or enrollees’ appropriate
access to medically necessary services (with the caveat that discounted
FFS and capitation are not presumed prima facie to jeopardize quality
or access); regulatory review of contracts is mandated at licensure
and at least every 3 years thereafter. (separate sections
deal with financial incentives to UR agents)
Consumer Participation
N.Y. Comp. Codes R. & Regs. tit. 10, § 98.11(f) (1998)
– governance – within one year of the HMO receiving a certificate
of authority, no less than 20 percent of the members of the governing
authority must be enrollees of the HMO; employees or providers of
health services may not serve as enrollee representatives.
Provider Protections
*N.Y. Ins. Law § 4803(d), N.Y Pub. Health Law § 4406-d(4)
(McKinney) – profiling – applies to insurers, health and hospital
service corporations, and health care plans (HMOs, IPAs and medical
groups); any profiling data used to evaluate the performance or
practice of a health care professional must be measured against
stated criteria and an appropriate group of health care professionals
using similar treatment modalities serving a comparable patient
population.
* N.Y. Ins. Law §§ 3217-b(f), 4325(f), N.Y. Pub. Health
Law § 4406-c(5-b) (McKinney) – case mix – no contract entered
into with health care providers will be enforceable is it includes
terms which penalize providers for unfavorable case mix so as to
jeopardize the quality of or enrollees’ appropriate access to medically
necessary services; provided, however, that payment at less than
prevailing fee for service rates or capitation will not be deemed
or presumed prima facie to jeopardize quality or access.
N.Y. Ins. Law § 4803(d), N.Y. Pub. Health Law § 4406-d(5)
– nonretaliation – insurers/plans are prohibited from terminating
or refusing to renew the participation of health care professional
solely because the professional has advocated on behalf of an insured,
filed a complaint against the insurer, appeal a decision of the
insurer, provided information to any enrollee or governmental body
as permitted under the gag clauses, or requested a hearing or review
under provisions that protect providers.
HMO Protections
N.Y. Pub. Health Law § 4410 (McKinney) – practice of medicine
– the provision of comprehensive health care services directly or
indirectly by an HMO through a plan shall not be considered the
practice of the profession of medicine by such organization or plan;
however, each member, employee or agent shall be fully and personally
liable and accountable for any negligent or wrongful act or misconduct
committed by him or any person under his direct supervision and
control while rendering professional services on behalf of the organization/plan.
(fairly standard, although verbiage about personal liability seems
to be beyond many state statutes; contrast Missouri)
Selected Benefit Mandates
N.Y. Ins. Law §§ 3216(i)(12), 3221(l)(12), 4303(q)(1),
4406 (makes art. 43 Selected Benefit Mandates applicable to HMOs)
(McKinney) – off-label uses of drugs – parallel provisions applicable
to individual accident and health insurance policies, group or blanket
health insurance policies, hospital or health service corporations
and HMOs that cover prescription drugs; limited to cancer treatment.
N.Y. Ins. Law §§ 3216(i)(16), 3221(k)(7), 4303(u)(1),
4406 (McKinney) – diabetes – parallel provisions applicable to individual
accident and health insurance policies, group or blanket health
insurance policies, hospital or health service corporations HMOs;
includes diabetes self-management education.
N.Y. Ins. Law §§ 3216(i)(19), 3221(k)(9), 4303(w)(1),
4406 (McKinney) – second opinion (cancer) – parallel provisions
applicable to individual accident and health insurance policies,
group or blanket health insurance policies, hospital or health service
corporations and HMOs; every policy which provides comprehensive
coverage must cover a second medical opinion by an appropriate specialist
in the event of a positive or negative diagnosis of cancer, recurrence,
or recommendation of a course of treatment, including a non-participating
specialist (when the attending physician makes the referral) at
no additional cost to the insured.
N.Y. Ins. Law §§ 3216(i)(20), 3221(k)(10), 4303(x)(1),
4406 (McKinney) – reconstructive surgery – standard.
N.Y. Ins. Law § 3216(i)(21), 4303(y), 4406 (McKinney) – enteral
formulas for home use – standard provision.
N.Y. Ins. Law § 3221(l)(4), (5), (6) (McKinney) – mental illness/substance
abuse – applies to group policies.
Special Needs Plans
HIV
N.Y. Pub. Health Law § 4403-c (McKinney) – HIV/certification
– provisions include specification of application content (among
other things, applicant must describe any experience in providing
HIV services funded or approved by the department, demonstrate its
ability to provide or continue to provider quality HIV services,
and describe its current and proposed capacity to provide or arrange
for services for a defined area and population) and matters that
must be demonstrated prior to certification (among other things,
willingness to enroll any persons who is eligible and the existence
of a mechanism by which the enrolled population may participate
in determining the policies of the organization, definition of a
specific network of providers and facilities capable of providing
comprehensive HIV special needs services, financial responsibility
and soundness, willingness and ability to assure that necessary
services will be provided in a timely manner, to assure continuity
of care, and to implement procedures for referrals, as requested,
to appropriate care for affected family members, acceptable procedures
for outreach, acceptable procedures for linguistically and culturally-competent
communication, acceptable procedures for monitoring the quality
of care per clinical standards maintained by the state’s AIDS Institute,
and approved mechanisms for resolving complaints and grievances—but
commissioner is empowered to impose alternative requirements).
*N.Y. Pub. Health Law § 4403-c (McKinney) – HIV/plan responsibilities
– certified plans are responsible for providing or arranging for
all medical assistance services and for assisting enrollees in the
prudent selection of such services; nondiscrimination is addressed
(plans are prohibited from requesting disenrollment of an enrollee
based on any diagnosis, condition, or perceived diagnosis or condition,
or an enrollee’s efforts to exercise his or her rights under the
grievance process); plans must permit standing referrals and allow
for continuity of care (timeframes match general provisions); confidentiality
is addressed; UR requirements apply; § 4408 disclosure requirements
apply; § 4406-c prohibitions apply; special needs plans are
to function distinctly from other health plans.
*N.Y. Pub. Health Law § 4403-c (McKinney) – HIV/commissioner
responsibilities – risk adjustment is addressed (in developing capitation
rates the commissioner is authorized to consider, at a minimum,
age, eligibility category, historic cost and utilization of covered
enrollees and services, anticipated costs of emerging treatment
modalities, and the expected impact of a managed care environment);
the department is to establish a stop-loss reinsurance program to
provide reasonable protection for catastrophic cases and adverse
selection; quality assurance is addressed (the department is to
monitor the performance, quality, and utilization of the plans on
at least an annual basis, items to be addressed including access
to OON specialty services; provision is made for grants to plans.
Mental Health
*N.Y. Pub. Health Law § 4403-d (McKinney) – mental health/certification
– provisions include specification of application content (among
other things, applicant must describe any experience in providing
mental health or related services funded or approved by the department,
demonstrate its ability to provide or continue to provide quality
services, describe its current and proposed capacity to provide
or arrange for services for a defined area and population, and provide
assurances that it will use involuntary treatment and safety interventions
only when to the extent clinically necessary and appropriate, implement
procedures to communicate appropriately NESPs, and make every effort
to expand access to and coordination of services) and matters that
must be demonstrated prior to certification (among other things,
willingness to enroll any persons who is eligible and the existence
of a mechanism by which the enrolled population and their families
may participate in determining the policies of the organization,
definition of a specific network of providers and facilities capable
of providing mental health and related support services, financial
responsibility and soundness, willingness and ability to assure
that necessary services will be provided in a timely manner, to
enhance continuity of care, and to implement procedures for referrals,
as requested, to appropriate care for affected family members, acceptable
procedures for outreach, and acceptable procedures to facilitate
hospital discharges to appropriate settings—but commissioners are
empowered to impose alternative requirements)
*N.Y. Pub. Health Law § 4403-d (McKinney) – plan responsibilities
– plans must allow for continuity of care (timeframes match general
provisions); a general benefit package is specified and plans are
required to arrange for the development and implementation of an
individualized service plan for each enrollee under the supervision
of a physician (with enrollee participation); confidentiality is
addressed; UR requirements apply; § 4408 disclosure requirements
apply; § 4406-c prohibitions apply; special needs plans are
to function distinctly from other health plans.
*N.Y. Pub. Health Law § 4403-d (McKinney) – commissioner responsibilities
– program is to be jointly administered by the commissioners of
health and mental health; the RFP is to prepared in cooperation
with county agencies; quality assurance is addressed (the department
is to monitor the performance, quality, and utilization of the plans
on at least an annual basis, items to be addressed including access
to OON specialty services); risk adjustment is addressed (in developing
capitation rates the commissioner is authorized to consider, at
a minimum, age, eligibility category, historic cost and utilization
of covered enrollees and services, anticipated costs of emerging
treatment modalities, and the expected impact of a managed care
environment); the department is to establish a stop-loss reinsurance
program to provide reasonable protection for catastrophic cases
and adverse selection; provision is made for grants to plans.
Note: there is also a transitional partial capitation certification
for rural areas (§ 4403-e) and authorization for demonstration
projects in the area of managed long-term care (§ 4403-f).
Miscellaneous
N.Y. Pub. Health Law § 4410 – confidentiality – HMO/plan not
allowed to disclose information acquired in the course of rendering
care, unless the patient waives the right of confidentiality, or
as otherwise required by law; the commissioner may only obtain enrollee
information subject to the establishment of protocols to ensure
that patient-specific information is not disclosed to third parties
other than to entities serving as agents of the state for purposes
of quality assurance and oversight; in addition to any other sanction
provided by law, any employee of the department who willfully violates
this regulation or any other rule/procedure pertaining to disclosure
of material collected pursuant to this subdivision will be deemed
to have committed an act of misconduct and will be disciplined in
accordance with the provisions of the civil service law. (Also,
UR standards mandate policies and procedures to ensure compliance
with laws protecting confidentiality.)
N.Y. Pub. Health Law § 4406-a – arbitration – applies to HMOs;
regulates arbitration election notices/agreements (enrollees and
covered family members must have option to decline).
Return to Top of Page
North Carolina
Consumer/Patient Protections
Access
*N.C. Gen. Stat. § 58-3-200(c) – OON providers – does not apply
to DHHS-administered plans; if contracting providers able to meet
the health care needs of an insured are not reasonably available
to an insured without unreasonable delay, the insured cannot be
penalized or subjected to OON benefit levels for seeking services
outside the network.
N.C. Gen. Stat. § 58-51-38 – OB/GYNs – managed care plans (HMOs,
PPOs) must allow female beneficiaries direct access to a participating
OB/GYN for OB-GYN services.
Complaints/UR
*N.C. Gen. Stat. § 58-3-200(b) – definition of medical necessity
– an insurer (broad definition) that limits its health benefit plan
(exclude plans administered through DHHS) coverage to medically
necessary services and supplies must define “medically necessary
services or supplies” as those covered services or supplies that
are: (1) provided for the diagnosis, treatment, cure, or relief
of a health condition, illness, or disease; and not for experimental,
investigational, or cosmetic purposes; (2) necessary for and appropriate
to the diagnosis, treatment, cure, or relief of a health condition,
illness, injury, disease, or its symptoms; (3) within generally
accepted standards of medical care in the community; (4) not solely
for the convenience of the insured, the insured’s family, or the
provider; the insurer is not precluded from comparing the cost-effectiveness
of alternative services or supplies when determining which of the
services or supplies will be covered; no retraction of determinations
in favor of coverage unless the determination was based on a material
misrepresentation (same definition and requirements for UR under
§ 58-50-61 et seq.).
N.C. Gen. Stat. § 58-50-61 – UR/operations – health benefit
plan does not include plans administered by DHHS; insurer or URO
must use documented clinical review criteria based on sound clinical
evidence and periodically evaluated to assure ongoing efficacy;
medical doctor must evaluate clinical appropriateness of noncertifications
(=determination that service does not meet requirements for medical
necessity, appropriateness, setting, level or care and is denied,
reduced or termination, and does not address situation where specific
service requested is clearly stated); compensation to reviewers
containing any incentives to make particular review decision or
based on the number or type of noncertifications rendered are prohibited.
N.C. Gen. Stat. §§ 58-50-61, 58-50-62 – UR/procedure –
appeal plus two tiers of grievance review; in concurrent reviews,
insurer must pay pending notice of noncertification; clinical review
criteria must be provided upon request; in standard appeals, decisions
must be rendered within 30 days of request, with content of notice
specified; insurers may require documentation of medical justification
for expedited appeals, with decision within 4 days of receipt of
information justifying expedited review; for first level grievance
review, decision within 30 days of receipt; reviewers must be new
to matter and if clinical, must include a medical doctor with appropriate
expertise; content of decision specified; in second level grievance
review, covered person must be given notice within 10 days of rights
to request and receive information, attend, present, ask questions,
and be assisted or represented; panel must be comprised of person
new to the matter (with possible exception of clinical peer) who
are not employees of the insurer or URO and do not have a financial
interest in the outcome, and must have appropriate expertise, including
at least one clinical peer; review meeting must take place within
45 days of receipt of request, with decision within 7 b.d. of meeting,
and content of notice specified including availability of commissioner’s
office for assistance (telephone number and address); expedited
procedure must be available at second level; nondiscrimination.
Disclosure
N.C. Gen. Stat. § 58-3-191(b) – disclosure (includes formularies)
– information that plans (HMO, PPO) must provide to plan participants
and bona fide prospective participants upon request includes, for
denials, written reasons and an explanation of the UR criteria relied
on, the plan's restrictive formularies or prior approval requirements
for obtaining prescription drugs, whether a particular drug or therapeutic
class of drugs is excluded from its formulary, and the circumstances
under which a nonformulary drug may be covered, and the plan’s procedures
for determining whether a specified procedure, test, or treatment
is experimental; insurers must make the reports filed with the commissioner
available on their premises and provided any insured access to them
upon request.
N.C. Gen. Stat. § 58-3-191(a) – disclosure (to commissioner)
re access/incentives – plan’s annual report to the commissioner
must include, among other things, (i) the health plan’s method for
arranging or providing health care services from OON providers,
both within and outside of its service area, when IN providers are
not available to provider covered services, and (ii) aggregate financial
compensation data, including the percentage of providers paid under
capitation, discounted FFS or salary, the services included in the
capitation payment, and the range of compensation paid by withhold
or incentive payments.
N.C. Gen. Stat. § 58-3-176 – gag clauses – insurers (broad
definition) are prohibited from limiting participating providers’
ability to discuss clinical treatment options with enrollees or
their professional obligations to patients as specified under their
licenses.
Emergency Care
N.C. Gen. Stat. § 58-3-190 – emergency care – adopts prudent
layperson standard; insurers may not require prior authorization
if standard is met; OON services must be covered if a prudent layperson
would have believed that delay would worsen the emergency or services
were not sought IN owing to circumstances beyond the covered person’s
control; standard no reneging provision (“an insurer that has given
prior authorization for emergency services shall cover the services...unless...”);
both the ER and the insurer must make a good faith effort to communicate
to expedite postevaluation and poststabilization services (prudent
layperson standard also incorporated in UR provisions, § 58-50-61).
Nondiscrimination
*N.C. Admin. Code tit. 11, r. 20.0202 – discrimination – all contracts
between network plan carriers and health care providers must require
providers to, among other things, maintain confidentiality of health
records and personal information as required by law, cooperate with
members in member grievance procedures, and contain a provision
that the provider shall not discriminate against members on the
basis of health status, etc.
Provider Protections
*N.C. Gen. Stat. § 58-3-200(e) – nondiscrimination – insurers
are prohibited from establishing provider selection or contract
renewal standards or procedures that are designed to avoid or otherwise
of the effect of avoiding enrolling high-risk populations by excluding
providers because they are located in geographic areas that contain
high-risk populations or because they treat or specialize in treating
populations that present a risk of higher-than-average claims or
health care services utilization.
N.C. Gen. Stat. § 58-50-62 – UR/nonretaliation – insurers may
not discriminate against providers based on any action taken in
an UR review, appeal or grievance proceeding.
Selected Benefit Mandates
N.C. Gen. Stat. §§ 58-51-61 (insurers/PPOs), 58-65-91
(hospital or medical service plans), 58-67-74 (HMOs) – diabetes
– policies/plans must provide coverage for medically appropriate
and necessary services, including diabetes outpatient self-management
training and educational services, and equipment, supplies, medications,
and laboratory procedures used to treat diabetes.
N.C. Gen. Stat. §§ 58-51-59 (insurers/PPOs), 58-65-94
(hospital or medical service plans/PPOs), 58-67-78 (HMOs, but article
67 does not apply to Medicaid HMOs) – off-label uses of drugs –
policies/plans that cover FDA-approved prescribed drugs for the
treatment of certain types of cancer may not exclude coverage of
any drug on the basis that the drug has been prescribed for the
treatment of a type of cancer for which the drug has not been approved
by the FDA; standard caveat that the drug must be FDA-approved and
must have been proven effective and accepted for the treatment of
the specific type of cancer for which the drug has been prescribed;
in addition, coverage is not required for any experimental or investigational
drugs or any drug that the federal Food and Drug Administration
has determined to be contraindicated for treatment of the specific
type of cancer.
Miscellaneous
N.C. Gen. Stat. § 58-51-55 – mental health – a policy that
covers both physical illness and mental illness may not impose a
lesser lifetime or annual dollar limit on the mental health benefits,
subject to certain qualifications; applies to group health insurance
contracts covering more than 50 employees; expires 10-1-2001.
N.C. Admin. Code tit. 11, r. 20.0509 – confidentiality – Each HMO
shall develop written policies and procedures to protect the confidentiality
of medical record information and personal information relating
to covered individuals.
Return to Top of Page
North Dakota
Consumer/Patient Protections
Access
N.D. Admin. Code §§ 45-06-07-04(12), (14), 45-06-07-06
– continuity of care – a group contract issued by an HMO must contain
a provision that any enrollee who is an inpatient in a hospital
or SNF on the date of discontinuance of the contract will have continuing
coverage (at the contract premium) until discharge; a group contract
issued by an HMO must offer an extension to enrollees who are totally
disabled at the date of discontinuance until the earlier of 12 months
after contract termination or recovery from total disability; HMOs
are to have written procedures governing the availability of services
utilized by enrollees, including treatment of chronic illness.
Complaints/UR
N.D. Admin. Code § 45-06-07-03(15) – medical necessity – defined
as appropriate and necessary services as determined by a provider
affiliated with the HMO which are rendered to an enrollee for any
condition requiring, according to generally accepted principles
of good medical practice, the diagnosis or direct care and treatment
of an illness or injury and are not provided only as a convenience;
does not preclude HMO for establishing standards or penalizing providers
for failure to meet them; in the case of emergency services, the
HMO has the right to make the final determination of whether services
should be covered.
N.D. Admin. Code §§ 45-06-07-07, 45-06-10-02 – grievances
– very limited grievance and appeal provisions, but does require
involvement of a practitioner trained in the relevant specialty
on appeal, and does prohibit any form of compensation to a practitioner
giving an opinion that is dependent on the result.
N.D. Century Code §§ 26.1-26.4-01 to 26.1-26.4-05 – UR/standards
– notification of determination to provider of record or enrollee
or other appropriate individual within 2 b.d. of receipt of request
and all information necessary to complete the review; determinations
must be reviewed by physician (or licensed psychologist, if appropriate)
or made in accordance with standards or guidelines approved by a
physician or licensed psychologist; any notice must include the
principal reason for the determination and procedures to initiate
an appeal; on appeal, determination must be made by physician or
psychologist, and decision must be made no later than 30 days from
date of filing and receipt of all necessary information, reduced
to 48 hours in emergency or life-threatening situations; staff must
be available toll-free at least 40 hrs. per week during normal business
hours; UR agents must allow a minimum of 24 hrs. following emergency
treatment to give notice and request certification; a second-level
appeal must involved a physician trained in the relevant specialty;
commissioner may accept accreditation in lieu of compliance with
these standards; UR agent has 30 days to respond to notice of alleged
violation; after hearing commissioner may issue a cease and desist
order or order payment of up to $10,000 per type of violation (if
frequency indicates a business practice) or suspend or revoke a
license; law does not apply to agent providing services to the federal
government or to the department of human services.
Disclosure
N.D. Century Code § 26.1-04-03(14) – gag clauses/nonretaliation
– applies to any public or private plan; an entity offering a health
plan may not restrict or interfere with any medical communication
and may not, solely on the basis of a medical communication, refuse
to contract with or terminate a provider or refuse to refer patients
or pay for covered services; medical communication means any communication,
other than a knowing or willful misrepresentation, made by a provider
to a patient regarding health care needs or treatment options and
the applicability of the plan to the patient’s needs or treatment,
and includes communications concerning incentives.
Emergency Care
N.D. Admin. Code §§ 45-06-07-03(5), 45-06-07-04 – emergency
care – HMOs must cover emergency care services within the service
area from nonaffiliated providers only where delay in receiving
care from the HMO could reasonably be expected to cause severe jeopardy
to the enrollee’s condition; an HMO may not limit coverage within
the service area to affiliated providers only.
Nondiscrimination
*N.D. Admin. Code §§ 45-06-07-04(8), 45-06-07-05 – nondiscrimination
– coverage may not be canceled or terminated on the basis of an
enrollee’s health or because the enrollee has exercise the enrollee’s
rights under the HMO’s grievance procedure; an HMO may not unfairly
discriminate against any enrollee or applicant for enrollment on
the basis of, among other things, frequency of utilization of services,
but does not prohibit setting rates or establishing a schedule of
charges in accordance with relevant actuarial data; an HMO may not
establish rules for eligibility including continued eligibility
of any individual under the terms of a group contract based on a
health-status related factor, but does not mandate particular benefits
or prevent limitations or restrictions on the amount, level, extent,
or nature of benefits for similarly situated enrolled individuals;
an HMO offering group contracts may not require a premium or contribution
greater than that for a similarly situated enrolled individual based
on any health status-related factor (linked to definition in N.D.
Century Code § 26.1-36.3-01, which relates to nondiscrimination
provisions in the state’s small employer insurance program).
Selected Benefit Mandates
N.D. Century Code § 26.1-36-06.1 – off-label uses of drugs
– an insurer, health service corporation, or HMO that provides coverage
for drugs may not exclude a drug for a particular indication on
the grounds that it has not been approved by the FDA for that use
if it is recognized for the treatment of that indication in the
standard reference compendia or medical literature.
N.D. Century Code § 26.1-36-08 – substance abuse – applies
to group policies or contracts; specifies minimum days of service
that must be covered for inpatient treatment, partial hospitalization,
and outpatient treatment.
N.D. Century Code § 26.1-36-09 – mental health – applies to
group policies or contracts; specifies minimum days of service that
must be covered for inpatient treatment, partial hospitalization,
and outpatient treatment; includes restrictions on copayments.
N.D. Century Code § 26.1-36-09.7 – metabolic disorders – an
insurer, health service corporation, or HMO that provides prescription
coverage must cover medical foods and low protein modified food
products determined by a physician to be medically necessary for
treatment of an inherited metabolic disease up to $3000/year; limited
to individuals born after 12/31/62;expires 7/31/99.
Miscellaneous
N.D. Century Code § 26.1-18.1-23 – confidentiality – a combination
consumer protection/privilege statute.
Return to Top of Page
Ohio
Consumer Protection
Access
*Ohio Rev. Code Ann. § 1753.14(A) – standing referrals – applies
to health insuring corporations (a HIC is a corporation that, pursuant
to a policy, contract, certificate, or agreement, pays for, reimburses,
or provides, delivers, arranges for, or otherwise makes available,
basic health care services, supplemental health care services, or
specialty health care services, or a combination of basic health
care services and either supplemental health care services or specialty
health care services, through either an open panel plan or a closed
panel plan, excluding certain limited liability companies and public
entities and insurers that offer only open panel plans and compensate
providers directly); HICs that do not allow direct access to all
specialists must implement a procedure by which an enrollee may
receive a standing referral to a specialist if a PCP determines
in consultation with a specialist that an enrollee needs continuing
care from a specialist; the treatment plan may limit the number
of visits, the period of time for which visits are authorized, or
require reports to the PCP.
*Ohio Rev. Code Ann. § 1753.14(B) – specialists as PCPs – HICs
must implement a procedure by which an enrollee with a condition
or disease that requires specialized medical care over a prolonged
period of time and is life-threatening, degenerative, or disabling
may receive a referral to a specialist who has expertise in treating
the condition or disease for the purpose of having the specialist
coordinate the enrollee’s health care, if a PCP determines in consultation
with a specialist that the enrollee needs the specialist’s expertise;
for both (A) and (B), a determination must be made within 3 b.d.
after PCP request and provision of all necessary information;, and
a referral must be made within 4 b.d. following a favorable determination
(except in cases of rare or unusual conditions for which specialists
are difficult to identify); these provisions do not permit OON referral.
*Ohio Rev. Code Ann. § 1751.13(A)(2) – OON providers – when
a HIC is unable to provide a covered health care service from contracted
provider (includes facilities), it must provide the service from
a noncontracted provider at no greater cost to the enrollee than
an IN service.
Ohio Rev. Code Ann. §§ 1751.11(D)(3), 1751.13(C)(3), 1751.13(I)(1)
– continuity of care – if an enrollee's coverage under a group policy,
contract, etc. terminates while the enrollee is receiving inpatient
care, coverage must be continued until the earliest of (a) the enrollee's
discharge, (b) the determination by the enrollee's attending physician
that inpatient care is no longer medically indicated (does not preclude
UR), (c) the enrollee's reaching the limit for contractual benefits,
or (d) the effective date of any new coverage (subject to certain
caveats, e.g., in the case of Medicare plans); all provider contracts
must contain provisions requiring providers to continue to provide
covered health care services to enrollees in the event of a HIC’s
insolvency or discontinuance of operations as needed to complete
any medically necessary procedures in process at the time of insolvency
or discontinuance (completion of a medically necessary procedure
includes the rendering of all covered health care services that
constitute medically necessary follow-up care for that procedure)
(if an enrollee is receiving inpatient care, in addition to the
limits described above, the provisions may limit such required provision
of services to the period ending 30 days after insolvency or discontinuance)**;
HICs must notify affected enrollees of the termination of a PCP
or hospital contract by mail within 30 days and must pay for all
covered services rendered to an enrollee by the provider between
the date of termination and 5 days after notice is mailed.
Complaints/UR
*Ohio Rev. Code Ann. § 1753.23 – internal technology assessment
process – HICs must have an internal technology assessment process
that meets all of the following criteria: (A) decisions are made
by medical professionals, including physicians; (B) relevant medical
evidence is reviewed, including, if available, peer-reviewed medical
and scientific literature on the subject, published opinions, action,
and other relevant documents of independent research organizations
such as NIH, FDA, HCFA, and AHCPR, and published opinions of experts
or affected specialty societies; (C) general coverage decisions
that exclude drugs, devices, protocols, procedures, or other therapies
on the basis that they are not safe or efficacious and remain experimental
or investigational are reviewed and updated as new scientific evidence
becomes available; (D) a description of the process is made available
to participating providers and enrollees upon request; coverage
protocols and procedures must include a description of the evidence
upon which they are based and the date of adoptionl.
*Ohio Rev. Code Ann. § 1753.24 – independent review – limited
to enrollees with terminal conditions; process must meet criteria
including: notice to eligible enrollees within 5 b.d. after issuance
of denial; review by an independent entity retained by the HIC (either
an AMC or an entity that has expert review as its primary function
and major source of revenue); selection by the entity of a review
panel of at least 3 physicians or other providers expert in the
treatment of the enrollee’s condition and knowledgeable about the
requested therapy (2 if the enrollee consents), except that a single
expert may be substituted if only 1 expert is available; neither
the entity nor the experts may have any affiliation with the HIC
or the enrollee (except that AMC-affiliated experts are not disqualified
because they treat other HIC enrollees); the HIC bears the costs
of review; opinions must be rendered within 30 days of the enrollee’s
request for review, or 7 days if the enrollee’s physician determines
that a therapy would be significantly less effective if not promptly
initiated; the standard for opinion is whether there is sufficient
evidence to demonstrate that the recommended or requested therapy
is likely to be more beneficial to the enrollee than standard therapies;
the decision of the majority of experts is binding on the HIC with
respect to that enrollee; if the panel is evenly divided the decision
must be in favor of coverage.
Ohio Rev. Code Ann. §§ 1751.77-1751.86 – UR standards
– UR programs must use documented clinical review criteria that
are based on sound clinical evidence and are evaluated periodically
to assure ongoing efficiency; a clinical peer (meaning a physician
where the services being evaluated are provided by a physician)
in the same or similar specialty as typically manages the medical
condition or treatment under review must evaluate the clinical appropriateness
of adverse determinations subject to appeal; determinations must
be issued in a timely manner and a process must be established to
ensure that criteria are applied consistently; for prospective or
concurrent review only the information necessary for certification
may be collected; compensation that contains direct or indirect
incentives to make inappropriate review decisions is prohibited.
Ohio Rev. Code Ann. §§ 1751.77-1751.86 – UR procedures
– initial determinations must be made within 2 b.d. after obtaining
all necessary information, with notices to the provider within 3
b.d. of the determination; the deadlines are reduced to 1 b.d. in
the case of concurrent review, and services must be continued until
the enrollee has been notified of the determination; HICs must maintain
written procedures for expedited review procedures; content of notices
is specified, including statement of reasons and instructions for
further action; HICs must also have written procedures to address
provider failure or inability to provide all necessary information
for review; the provider may request reconsideration of an adverse
determination; the superintendent may accept accreditation as compliance
with standards and procedures.
Ohio Rev. Code Ann. § 1751.86 – UR violations – a violator
is deemed to have engaged in an unfair and deceptive act or practice
in the business of insurance (penalties are civil fines, suspension
or revocation of license).
Disclosure
Ohio Rev. Code Ann. § 1751.13(D) – gag clauses – no HIC contract
with a provider may contain a provision that restricts the provider’s
ethical and legal responsibility to fully advise enrollees about
their medical condition and about medically appropriate treatment
options.
Emergency Care
Ohio Rev. Code Ann. § 1753.28 – emergency care – adopts prudent
layperson definition; a HIC that provides coverage of basic health
care services must cover emergency services without regard to day
or time or prior authorization; OON services must be covered if
due to circumstances beyond the enrollee’s control the enrollee
was unable to utilize a IN ER without serious threat to life or
health, a prudent layperson would have reasonably believed that
the time required to travel to an IN ER could result in adverse
health consequences of the type specified in the definition of emergency
medical condition, a HIC representative refers the enrollee to an
ER without specifying an IN ER, an ambulance takes the enrollee
to an OON ER other than at the direction of the enrollee, the enrollee
is unconscious, a natural disaster precludes use of an IN ER, or
the network status of a hospital changed and no good faith effort
was made to inform enrollees.
Formularies
*Ohio Rev. Code Ann. § 1753.21 – formularies – if an HIC uses
a restricted formulary, it must (1) develop such formulary in consultation
with and with the approval of a pharmacy and therapeutics committee
with a majority of its members being physicians and pharmacists
and (2) have a procedure by which an enrollee may obtain, without
penalty or additional cost sharing, coverage of a nonformulary drug
when the prescriber documents that the formulary alternative has
been ineffective in the treatment of the enrollee or has caused
or is reasonably expected to cause a harmful or adverse reaction.
Nondiscrimination
*Ohio Rev. Code Ann. § 1751.13(C) – discrimination – a HIC
must annually certify to the superintendent that all provider contracts
contain a provision requiring the provider to provide health care
services without discrimination on the basis of, among other things,
a patient’s health status or disability**; does not apply to circumstances
where a provider appropriately does not render services due to limitations
arising from the provider’s lack of training, experience, or skill,
or due to licensing restrictions.
Prohibition on Incentives
Ohio Rev. Code Ann. § 1751.13(D) – financial incentives – no
HIC contract with a provider may contain a provision that directly
or indirectly offers an inducement to the provider to reduce or
limit medically necessary health care services to an enrollee.
Provider Protections
Ohio Rev. Code Ann. § 1751.13(D) – nonretaliation – no HIC
contract with a provider may contain a provision that penalizes
a provider that assists an enrollee seeking reconsideration of benefit
denial or limitation decision, or for principally advocating for
medically necessary health services or for providing information
or testimony to a legislative or regulatory body.
Ohio Rev. Code Ann. § 1753.05 – economic profiling – a HIC
may use economic profiling as a factor in credentialing a provider,
however, such profiling must take into consideration the case mix,
severity of illness, and age of patients.
Selected Benefit Mandates
Ohio Rev. Code Ann. § 1751.66 – off-label uses of drugs – no
HIC that covers prescription drugs may limit or exclude coverage
of an approved drug for off-label use if standard conditions are
met.
Miscellaneous
Ohio Rev. Code Ann. §§ 1751.13(C), 1751.521 – confidentiality
– a HIC must annually certify to the superintendent that all provider
contracts contain a provision concerning the confidentiality of
health records**; if a HIC requests a release of medical information,
the release must clearly explain what information may be disclosed
under the terms of the release.
Ohio Rev. Code Ann. § 1701.03 – clinical freedom – corporations
formed for the purpose of providing a combination of the professional
services are prohibited from controlling the professional clinical
judgment exercised within accepted and prevailing standards of practice
in rendering care, treatment, or professional advice to an individual
patient; utilization review, quality assurance, peer review, or
other performance or quality standards are not to be construed as
controlling the professional clinical judgment of an individual
practitioner.
OH LEGIS 216 (1998):
Ohio Rev. Code Ann. § 1751.12(D)(1) – copayments – copayments
must be reasonable and must not be a barrier to the necessary utilization
of services by enrollees; HICs may not impose copayment charges
on basic health care services that exceed 30% of the total cost
of providing any single covered health care service, except for
physician office visits, emergency health services, and urgent care
services (total cost = HIC cost - any applicable provider discount);
an open panel plan may not impose copayments on OON benefits that
exceed 50% of the total cost of providing any single covered health
care service; HICs may not impose, in any contract year, on any
enrollee, copayments that exceed 200% of the total annual premium
rate to the enrollees (does not include any reasonable copayments
that are not a barrier to the necessary utilization of health care
services and are imposed on physician office visits, emergency health
services, urgent care services, supplemental health care services,
or specialty health care services).
Ohio Rev. Code Ann. § 1751.12(E) – lifetime maximum – HICs
may not impose lifetime maximums on basic health care services (defined),
but may establish a benefit limit for inpatient hospital services
provided pursuant to a policy, contract, etc. for supplemental health
care services.
**§ 1751.13(C) does not apply to Medicare managed care contracts,
Medicaid, other federal programs, or the coverage of state employees.
Return to Top of Page
Oklahoma
Consumer/Patient Protections
Access
Okla. Stat. Ann. tit. 63 § 2525.5 – access – MCOs (= a plan
that contracts with selected providers and offers financial incentives
for enrollees to use participating providers, etc.) must demonstrate
that they have adequate access to providers, so that all covered
health care services will be provided in a timely fashion.
Complaints/UR
Okla. Admin. Code 310:655-15-7 (HMO licensure rules) – grievances
– grievance system must include written acknowledgement within 7
days and final determination within 120 days (subject to extension
for delay in obtaining information from non-contracting provider);
notice of final determination to advise enrollee of right to file
request for assistance with state health agency.
*Okla. Stat. Ann. tit. 36 § 2525.5 – UR – applies to MCOs;
state board of health is to issues rules, including rules that requests
for nonemergency services must be answered within 5 b.d. of request,
and qualified personnel must be available for same b.d. telephone
responses to inquiries about medical necessity including continued
LOS; contested denials of service by the attending physician in
cases where there are not medically agreed upon guidelines shall
be evaluated in consultation with physicians of the same or similar
specialty or training as the attending physician who is contesting
the denial.
Okla. Stat. Ann. § 6558 – UR – applies to all UR; private review
agents must submit information to commissioner in connection with
application for certification which includes: UR plan describing
review standards, mechanisms for provider input, and appeals procedures,
assurance of accessibility of representatives during normal business
hours, policies and procedures to ensure compliance with laws respecting
confidentiality of medical records (also mentioned in § 6562),
and procedures to ensure, in connection with rejection of request
for evaluation, treatment or procedure, upon request, mailing of
a copy of report within 15 days after receipt of request for report.
Disclosure
Okla. Stat. Ann. § 2525.5 – gag clauses – no MCO may engage
in the practice of medicine or any other profession except as provided
by law or include any provision in a provider contract that precludes
or discourages a plan’s providers from informing a patient of the
care the patient requires, including noncovered services or advocating
on behalf of a patient.
Okla. Admin. Code Code 310:655-17-10 (HMO licensure rules) – gag
clauses– UR and QA programs “shall not be construed” to interfere
with a physician’s obligation under professional licensure and certification
standards to exercise independent judgment; an HMO’s procedures
for UR and QA programs may not include the following: (1) any requirement
that a physician receive permission from the HMO prior to discussing
with a patient the possible need for emergency or urgent care; or
(2) any limitation on a physician advising a patient about service
or treatment options not provided, arranged or reimbursed by the
HMO.
Emergency Care
Okla. Stat. Ann. § 2525.5 – emergency care – MCOs may not require
prior authorization for emergency care (definition refers reasonable
appearance); out-of-area urgent follow-up care must be covered as
long as it is necessitated to stabilize the urgent situation, and
complies with plan provisions and federal guidelines.
Nondiscrimination
Okla. Admin. Code 310:655-15-4 (HMO licensure rules) – membership/discrimination
– an HMO may not discriminate on the basis of health status, health
care needs, or age
Prohibition on Incentives
Okla. Admin. Code 310:655-25-6 (HMO licensure rules) – financial
incentives – providers shall not be subject directly or indirectly
to any payment for withholding medically necessary health care services.
Provider Protections
*Okla. Stat. Ann. § 2525.5 – physician credentialing – applies
to MCOs; when economic considerations are part of the credentialing
decision, objective criteria must be used, and plans may not discriminate
against enrollees with expensive medical conditions by excluding
practitioners with practices containing a substantial number of
such patients.
Okla. Admin. Code 310:655-25-6 (HMO licensure rules) – nonretaliation
– providers shall not be subject directly or indirectly to any penalty
for requesting reconsideration or assisting an enrollee in seeking
reconsideration of an HMO decision to deny or limit coverage, advocating
before the HMO on behalf of the enrollee, or advising an enrollee
about medical care or medically appropriate treatment options, or
any prohibition against making factual nonproprietary statements
regarding the HMO.
Selected Benefit Mandates
Okla. Stat. Ann. §§ 1-2604, 1-2605 – off-label uses of
drugs – individual and group policies and HMO contracts that cover
prescription drugs may not exclude coverage of off-label use of
FDA-approved drugs in connection with cancer treatment.
Okla. Stat. Ann. § 6060.2 – diabetes – broad application; lists
equipment and supplies, and provider services, to be provided, plus
provision for state health agency, in consultation with state chapter
of national diabetes organization and at least 3 medical directors
of health plans, to update annually to include other FDA-approved
items; coverage for services of podiatrists and diabetes self-management
training also mandated; does not apply to plans designed only for
subscribers eligible under Title XVIII of the SSA or similar public
plans.
Okla. Stat. Ann. § 6060.5 – reconstructive surgery – must be
covered following mastectomy.
*Okla. Stat. Ann. § 6060.6 – dental procedures for certain
minor and severely disabled persons – any health benefit plan that
provides hospitalization benefits must also cover anesthesia, hospital
and ambulatory surgical center, and physician expenses associated
with a medically necessary dental procedure provided to a covered
person who has a medical emotional condition which requires hospitalization
or general anesthesia for dental care and is either severely disabled
or age 8 and under.
Okla. Admin. Code 310:655-5-1, 655-15-2 (HMO licensure rules) –
comprehensive services – an HMO or prepaid plan must provide or
arrange for comprehensive services; definition includes: (4) outpatient
services and inpatient hospital services including “short-term rehabilitation
services and physical therapy which the HMO expects can result in
the significant improvement of an enrollee’s condition within two
months”; (6) 20 outpatient visits per enrollee per year as may be
necessary and appropriate for short-term evaluative or crisis intervention
mental health services, or both; (7) diagnosis, medical treatment
and referral services for alcohol or drug abuse or addiction, including
detox on an in or outpatient basis and referral for medical or nonmedical
ancillary services (but nonmedical services such as voc rehab and
employment counseling and prolonged rehab “need not be a part of
comprehensive health services”); and (9) home health services.
Miscellaneous
*Okla. Stat. Ann. § 2525.5(B)(4) – confidentiality – MCOs are
prohibited from disclosing to employers any medical information
about an enrollee without such person’s specific prior authorization.
Return to Top of Page
Oregon
Consumer/Patient Protections
Access
Or. Rev. Stat. Ann. § 743.845 – OB/GYN – insurers must permit
female enrollee to designate a women’s health care provider as PCP
or have direct access to a women’s health care provider for an annual
exam and pregnancy care.
*Or. Rev. Stat. Ann. § 743.808 – choice of PCP – all insurers
that require an enrollee to designate a PCP must permit the enrollee
to change PCPs at least 2 times in any 12-month period.
Complaints/UR
Or. Rev. Stat. Ann. § 743.804(3) – grievances – insurers must
have a “timely and organized” system that includes an appeal process
with 2 levels of review, the second of which is by persons not previously
involved in the dispute, and written decisions in plain language
justifying appeal determinations; also, § 743.804(8) requires
an insurer to give enrollees who have filed grievances detailed
information on procedures and information on how to access the complaint
line of the Department of Consumer and Business Services.
Or. Rev. Stat. Ann. § 743.807 – UR – process and methodology
should be made available to providers upon request; a state-licensed
doctor of medicine or osteopathy shall be responsible for all final
recommendations regarding the necessity, appropriateness, and site
of service; patient or provider with request denied as not medically
necessary or experimental shall be provided opportunity for timely
appeal before appropriate medical consultant or peer review committee;
a provider request for prior authorization of nonemergency services
must be answered within 2 b.d. and qualified personnel must be available
for same-day telephone responses to inquiries re certifying continued
LOS.
Or. Rev. Stat. Ann. § 743.837 – prior authorizations – prior
authorization determinations are binding on the insurer if obtained
no more than 30 days prior to date of service (if relate to enrollee
eligibility, binding if obtained no more that 5 b.d. prior to date
of service).
*Or. Rev. Stat. Ann. § 743.829 – clinical decision-making/nonretaliation
– all clinical decisions regarding LOS in a health care facility,
transfer between levels of care and follow-up care shall be the
decision of the treating provider in consultation with the patient,
as appropriate; an insurer may not terminate or restrict the practice
privileges of a provider solely on the basis of one or more of these
clinical decisions.
Disclosure
Or. Rev. Stat. Ann. § 743.804(5) – disclosure (financial incentives,
etc.) – insurers must furnish to enrollees (or policyholders for
distribution to enrollees) written general information including:
disclosure of any risk-sharing arrangements with providers; a summary
of procedures for protecting the confidentiality of medical records
and other enrollee information; notice of information that is available
upon request of an enrollee or prospective enrollee, including rules
related to the insurer’s drug formulary, and a description of risk-sharing
arrangement with providers consistent with HCFA requirements; upon
request of an enrollee, an insurer must provide a written summary
of information that may be considered in UR of a particular condition
or disease to the extent the insurer maintains such criteria (but
doesn’t require an insurer to “advise an enrollee how the insurer
would cover or treat that particular enrollee’s disease or condition,”
and proprietary review criteria are subject to verbal disclosure
only).
Or. Rev. Stat. Ann. § 743.829 – gag clauses/nonretaliation
– no insurer may terminate or otherwise financially penalize a provider
for (1) communicating with a patient in a manner that is not slanderous,
defamatory or intentionally inaccurate concerning the patient’s
medical condition, options for treatment, or the provider’s general
financial arrangements with the insurer or (2) referring a patient
to another provider (does not include allocation of costs for referral
services to provider).
Emergency Care
Or. Rev. Stat. Ann. § 743.699 – emergency care – all insurers
offering a health benefit plan must provide coverage without prior
authorization for emergency screening and stabilization, and emergency
services provided by a nonparticipating provider if justified using
a prudent layperson standard (also see definition in § 743.801(1),
incorporated in disclosure section at § 743.804).
Formularies
Or. Rev. Stat. Ann. § 743.804(4) – non-formulary drugs – insurers
that use formularies must have a written procedure for coverage
of prescriptions of non-formulary drugs and a written procedure
to provide full disclosure to enrollees of any cost sharing or other
requirements to obtain drugs and medications no included in the
formulary.
Consumer Participation
Or. Rev. Stat. Ann. § 743.817 – all insurers offering managed
health insurance must establish a means to provide enrollees, purchasers
and providers a meaningful opportunity to participate in the development
and implementation of insurer policy and operation through the establishment
of advisory panels and consultation with such panels on major policy
decisions or other means including meetings with the governing board.
Or. Rev. Stat. Ann. § 743.827 – director of state regulatory
agency is to appoint a Health Care Consumer Protection Advisory
Committee with fair representation of consumers, providers and insurers
to advise the director on implementation and related issues.
Provider Protections
Or. Rev. Stat. Ann. § 743.803 – nonretaliation – no medical
services contract may require the provider to agree to deny care
to a patient because of a determination that the care is not covered,
or to deny referral to another provider for the care, if the patient
is informed that the patient will be responsible for payment and
the patient nonetheless desires the care or referral; all medical
services contracts must provide that a physician may advocate a
decision, policy or practice without being subject to termination
or penalty “for the sole reason of” such advocacy.
Selected Benefit Mandates
Or. Rev. Stat. Ann. § 743.697 – off-label uses of drugs – policies
or contracts that cover prescription drugs must cover off-label
uses if the Health Resources Commission determines that the drug
is effective for treatment of that indication, with standard qualification
about FDA approval.
Or. Rev. Stat. Ann. § 743.726 – metabolic disorders – broad
application; includes medical foods.
Miscellaneous
Or. Rev. Stat. Ann. § 743.804(10) – confidentiality – insurers
must ensure confidentiality by adopting and implementing written
confidentiality policies and procedures, stating expectations in
medical services contracts, and affording enrollees the opportunity
to approve or deny release of identifiable information, except as
required by law.
Or. Rev. Stat. Ann. § 743.821 – enrollee liability – provider
contracts must include provision that prohibits provider from billing
or otherwise attempting to collect from enrollees amounts owed by
insurers (typical of most if not all states).
Return to Top of Page
Pennsylvania
Consumer/Patient Protections
Access
*Penn. Stat. 40 § 991.2111 – standing referral/specialist as
PCP – a managed care plan (= plan that uses a gatekeeper to manage
utilization of health care services, integrates financing and delivery
of health care services by selective contracting with providers,
and provides financial incentives for enrollees to use participating
providers) must, among other things, adopt and maintain procedures
by which an enrollee with a life-threatening, degenerative or disabling
disease or condition may, upon request, receive an evaluation and,
plan’s established standards are met, be permitted to receive: (i)
a standing referral to a specialist with clinical expertise in treating
the disease or condition; or (ii) the designation of a specialist
to provider and coordinate the enrollee’s primary and specialty
care.
*Penn. Stat. 40 § 991.2117 – continuity of care – if a managed
care plan initiates termination of a participating provider
(not for cause), an enrollee has the option of continuing an ongoing
course of treatment with that provider for up to 60 days from the
date the enrollee is notified by the plan of the termination/pending
termination, on IN terms and conditions; a new enrollee may continue
an ongoing course of treatment with a nonparticipating provider
for a transitional period of up to 60 days from the enrollment date,
on IN terms and conditions.
Penn. Stat. 40 § 991.2111 – OB/GYNs – managed care plans must
provide direct access to OB/GYN services.
ADA Compliance
*Penn. Stat. 40 § 991.2111 – ADA compliance – a managed care
plan must ensure that there are participating health care providers
that are physically accessible to people with disabilities and can
communicate with individuals with sensory disabilities in accordance
with Title III of the ADA.
Complaints/UR
Penn. Stat. 40 § 991.2141 – complaints – complaints may be
oral or written; an initial review is to be completed within 30
days of receipt, with written notice within 5 b.d. of the decision;
second level review is by a committee consisting of 3 or more individuals
who did not participate in the initial review, and 1/3 of whom are
not employed by the managed care plan, to be completed within 45
days of receipt of request for such review, with written notice
within 5 b.d. of the decision, including procedure for appeal to
the state health or insurance agency (note: a grievance refers to
a request for reconsideration of a decision concerning medical necessity
and appropriateness).
Penn. Stat. 40 § 991.2142 – independent review – enrollee has
15 days from receipt of notice of decision of second level review
in which to appeal to the health or insurance agency, as appropriate;
the appropriate department will determine whether a violation of
the law has occurred and may impose any authorized penalties; the
state agencies may communicate with the parties as appropriate to
assist in the resolution of a complaint at any time during the complaint
process.
Penn. Stat. 40 § 991.2152 – UR/incentives – UR entities must
maintain normal business hours and respond to calls that come into
an answering service or recording system within 1 business day and
communicate prospective UR decisions within 2 b.d. of receipt of
all supporting information reasonably necessary to complete the
review (1 b.d. for concurrent decisions); protect confidentiality;
notify a provider of additional facts or documents required within
48 hours of receipt of a request for review; compensation to any
person or entity performing utilization review may not contain incentives
for the person or entity to approve or deny payment for the delivery
of any health care service; UR that results in a denial of payment
must be made by a licensed physician (a licensed psychologist may
perform UR for behavioral health care services within the psychologist’s
scope of practice and expertise).
Penn. Stat. 40 § 991.2161 – grievances – initial review by
person(s) who did not previously participate in decision to deny
payment, completed within 30 days of receipt of grievance, with
notice within 5 b.d. of decision; second level review by 3 or more
persons who did not previously participate, completed within 45
days with notice within 5 b.d. of decision; initial and second level
reviews must include a licensed physician or, where appropriate,
an approved licensed psychologist; should the enrollee’s life, health,
or ability to regain maximum function be in jeopardy, an expedited
internal grievance process must be available, with notification
of decision to the enrollee and provider within 48 hours of the
filing of the expedited grievance.
Penn. Stat. 40 § 991.2162 – independent review – an enrollee
or provider with enrollee consent may appeal a denial following
completion of the internal grievance process; the state health agency
randomly assigns a UR entity (not directly affiliated with the managed
care plan); request must be filed with the plan within 15 days of
receipt of the final notice of denial; decision must be make by
one or more licensed physicians or approved psychologists in active
practice or in the same or similar specialty that typically manages
or recommends the service being reviewed; written decision within
60 days of filing; the standard of review is “whether the health
care service denied by the internal grievance process was medically
necessary and appropriate under the terms of the plan”; subject
to appeal to court within 60 days of receipt, with rebuttable presumption
in favor of decision, but plan must authorize service or pay claim
determined to be medically necessary and appropriate whether or
not appeal has been filed; all fees and costs (not including attorney
fees) are paid by the nonprevailing party if the provider filed,
by the managed care plan if the enrollee filed; contracts may provide
an ADR system to the external grievance process if the health agency
approves the contract, but an ADR system shall not be utilized for
any external grievance filed by an enrollee.
Disclosure
Penn. Stat. 40 § 991.2113 – gag clauses – no managed care plan
may penalize or restrict a provider from discussing: processes used
to deny payment for services, medically necessary and appropriate
care with or on behalf of an enrollee, or a plan’s decision to deny
payment; contract provisions that so restrict disclosure are void;
no managed care plan may terminate a provider for: advocating for
medically necessary and appropriate care consistent with a professional
standard of care, filing a grievance, or protesting a decision,
policy or practice the provider reasonably believes interferes with
the provider’s ability to provide medically necessary and appropriate
health care.
Penn. Stat. 40 § 991.2136 – disclosure – items for disclosure
to each enrollee (and prospective enrollee upon written request)
include the following, easily understandable by the layperson: summary
of complaint and grievance procedures, including toll-free number
and enrollee’s right to designate a representative, notice that
emergency services are not subject to prior approval, description
of procedures to obtain OON referrals, standing referrals, etc.,
and a list of information available upon written request (confidentiality
protection procedures, process for obtaining non-formulary drugs
or drugs for off-label uses, criteria for determinations of experimental
status, summary of reimbursement methodologies).
Emergency Care
Penn. Stat. 40 §§ 991.2102, 991.2116 – emergency care
– if an emergency provider determines that emergency services (=
service provided after sudden onset of condition warranting immediate
medical attention as judged by prudent layperson standard) are necessary,
the provider shall initiate necessary intervention to evaluate,
and stabilize if necessary, without seeking or receiving authorization,
and the managed care plan shall pay all reasonably necessary costs;
relocation is permitted when the enrollee is stabilized and can
be moved without detrimental consequences.
Prohibition on Incentives
Penn. Stat. 40 § 991.2112 – financial incentives – no managed
care plan may use any financial incentive to compensate a provider
for providing less than medically necessary and appropriate care
to an enrollee (does not prohibit a capitated payment or other risk-sharing
arrangement).
Provider Protections
*Penn. Stat. Ann. 40 § 991.2121 – provider credentialing –
no managed care plan may exclude or terminate a provider from participating
in the plan for communicating with or advocating for patients per
the gag clauses or for having a practice that includes a substantial
number of patients with expensive medical conditions.
Miscellaneous
Penn. Stat. Ann. 40 § 991.2181 – enforcement – state health
agency is to make guidelines available concerning requirements different
from NCQA standards, and health and insurance agencies are to investigate
potential violations and submit an annual report to the legislature;
possible penalties include a civil penalty up to $5,000, an injunction,
or the requirement of a plan of correction.
Penn. Stat. Ann. 40 § 991.2191 – exceptions – worker’s compensation,
peer review, FFS programs operated under Title XIX of SSA (Medicaid).
*Penn. Admin. Code § 9.404 – financial protection of HMO members
served through IDSs – health agency’s purpose in reviewing provider
reimbursement methodology is to identify methods which may lead
to inadequate or poor quality care and to ensure that the HMO and
IDS (an entity that assumes some risk) have adequate systems to
monitor quality of care and prevent undertreatment, hence reserves
the right to require submission of actual rates of payment.
Penn. Stat. 40 § 991.2131 – confidentiality – a managed care
plan and a UR entity must adopt and maintain procedures to ensure
that all identifiable information regarding enrollee health, diagnosis
and treatment is adequately protected and remains confidential in
compliance with federal and state laws and regulations and professional
ethical standards; does not deny access for internal quality review
or outcomes improvement and research, but enrollees must remain
anonymous to the greatest extent possible (and provide consent,
in the case of the latter).
Return to Top of Page
Rhode Island
Consumer/Patient Protections
Access
Gen. Laws R.I. §§ 27-18-44, 27-20-31, 27-41-45 – OB/GYNs
– for women, annual visit to in-network OB/GYN without referral.
Complaints/UR
Gen. Laws R.I. § 23-17.12-9 – decisions and internal appeals
– determinations must be made within 1 b.d. of receipt of all necessary
information; on appeals, notice must be given as soon as practical,
but no later than 15 days after receipt of required documentation;
all initial adverse determinations and first level of appeals not
to certify a service ordered by a practitioner must be made by a
practitioner with the same licensure status or a licensed physician;
the review agent must also line up a qualified professional to review
a 2nd level appeal; no physician or reviewer with prior involvement
in the case may serve as sole reviewer on appeal, unless there is
new information; no appeals physician or other reviewer may be compensated
based on upholding an adverse determination; reviewers must comply
with confidentiality laws.
RI Admin Rules, Dept. of Health, General § 5.0 – decisions
and internal appeals – the process regarding adverse determinations
must include provisions to assure that verbal requests are accepted
where a provider or patient can demonstrate that a timely response
is urgent; that no determination that care is medically inappropriate
may be made until there is evidence that a qualified practitioner
has spoken with the patient’s attending provider or a designee,
if reasonably available; that no employee or other individual rendering
an adverse determination may receive any financial incentives based
upon the number of denials or approvals made by him/her; that the
agency and its employees adhere to all applicable laws protecting
the confidentiality of medical records.
Gen. Laws R.I. § 23-27.12-10 – external appeals – when the
2nd level appeal does not reverse an adverse determination, the
review agent must provide for external appeal to an unrelated and
objective appeal agency selected by the director of the state health
department; the review and decision must be based on the medical
necessity for the care, treatment or service, and the appropriateness
of the service delivery for which authorization has been denied,
neutral physicians or dentists must be utilized to make final determinations,
payment of the fee must be split between the parties, and the decision
is binding but remains subject to judicial review.
RI Admin Rules, Dept. of Health, General § 7.0 – external appeals
– to initiate an external appeal, the patient or provider of record
must file written notification of appeal with the review agent,
with a check for ½ the fee, within 60 days of receipt of
notice that the 2nd level appeal has been denied; for expedited
appeals, the external agency must make a determination within 2
b.d. (10 b.d. in non-emergency appeals); the review must be based
on: (a) the review criteria utilized by the review agent to make
the denial; (b) the medical necessity for the care, treatment or
service denied; (c) the appropriateness of the service delivery
denied, but “in no case shall the external appeals agent be required
to authorize services in excess of those which are provided for
in any contract.”
Disclosure
Gen. Laws R.I. § 23-17.13-3 – disclosure – director is responsible
for sorting disclosure items into mandatory versus upon request
categories (items include “written disclosure of the enrollee’s
right to be free from discrimination by the health plan and the
right to refuse treatment without jeopardizing future treatment,”
and vague disclosure of financial arrangements).
R.I. Admin. Rules § 4.0 – disclosure – mandatory list includes
summary statement of plan’s confidentiality policy, statement of
right to be free of discrimination and to refuse treatment without
jeopardizing future treatment, and vague disclosure of financial
arrangements; upon request list consists of (a) a schedule of revenues
and expenses including direct service ratios and costs for specific
categories of services and (b) complaint, adverse decision, and
prior authorization statistics.
Gen. Laws R.I. §§ 23-17.13-3(c)(5), 23-17.14—16,
27-41-14.1 – gag clause/nonretaliation provision – a health plan/hospital/HMO
may not refuse to contract with or compensate an otherwise eligible
provider solely because that provider in good faith communicated
with his or her patient(s) regarding the products and/or services
of the insurer/hospital/HMO as they relate to the needs of the provider’s
patients.
Prohibitions on Incentives
Gen. Laws R.I. § 23-17.13-3 – financial incentives – health
plans may not enter into compensation agreements with any provider
of covered services or pharmaceutical manufacturer pursuant to which
specific payment is made directly or indirectly and an inducement
or incentive to reduce or limit services, reduce LOS or use of alternative
treatment settings or use of a particular medication with respect
to an individual patient (but capitation agreements and similar
risk sharing arrangements are not prohibited).
Gen. Laws R.I. § 23-17.13-3(c)(12) – risk-sharing – if a plan
places a provider or provider group at financial risk for services
not provided by the provider/group, the plan must require that such
provider/group has met all appropriate standards of the department
of business regulation.
Consumer Participation
Gen. Laws R.I. § 23-17.13-3(c)(4) – subscriber input – all
health plans must establish a mechanism under which local subscribers
provide input into the plan’s procedures and processes regarding
the delivery of health care services.
Provider Protections
*Gen. Laws R.I. § 23-17.13-3(c)(6), (8) – economic profiling
– any economic profiling of providers must be adjusted to recognize
case mix, severity of illness, age and other features of a practice
that may account for higher or lower than expected costs; health
plans may not discriminate against providers solely because they
treat a substantial number of patients who require expensive or
uncompensated care.
Gen Laws. R.I. §§ 27-18-45, 27-20-32, 27-41-46 – nonretaliation
– insurers are prohibited from retaliating against a provider for
reporting or preparing to report a violation of law or contract
by the insurer; criminal and civil penalties specified, and civil
actions by the providers for injunctive relief and damages are also
authorized.
Selected Benefit Mandates
*Gen. Laws R.I. §§ 27-18-36.2, 27-20-27.2, 27-41-41.2
– cancer clinical trials – insurers must cover new cancer therapies
provided in the context of an approved Phase III or IV clinical
trial (also patient care costs under Phase II clinical trials, until
12/31/99 (this period may be extended under S245).
Gen. Laws R.I. §§ 27-55-1 – 27-55-3 – off-label uses of
drugs – only applies to the treatment of cancer; usual qualifications.
Gen. Laws R.I. §§ 27-18-38, 27-20-30, 27-41-44 – diabetes
– insurers must cover FDA-approved equipment and supplies and self-management
education.
Miscellaneous
Gen. Laws R.I. § 23-17.13-3 – certification of plans – requires
the director of the health agency to provide standardized definitions
for terms such as “medical necessity,” with caveat that no definition
shall be construed to require a health care entity to add a benefit
or increase the scope of a benefit under any contract (and definitions
adopted are more explanatory than prescriptive, see R.I. Admin.
Rules R23-17.13-CHP, Appendix A).
Return to Top of Page
South Carolina
Consumer/Patient Protections
Access
*S.C. 1998 Sess. Laws S.B. 310 (to be codified at § 38-71-1730
– continuity of care – an employee, spouse or dependent receiving
treatment for an illness covered under a closed panel health plan
may continue to receive services from a provider who elects to discontinue
participation for up to 90 days (or until the anniversary date of
the plan, if earlier); does not apply to Medicaid plans.
S.C. 1998 Sess. Laws H.B. 3889 (to be codified at § 38-33-325)
– OB/GYN – HMOs and other MCOs must permit two annual visits to
an IN OB/GYN, plus authorization for continuing treatment resulting
from OB/GYN complications so diagnosed must come directly from the
HMO.
Disclosure
S.C. 1998 Sess. Laws S.B. 310 (to be codified at § 38-71-1740)
– gag clauses – network plans’ provider contracts may not limit
the provider’s ability to discuss treatment options and UR decisions
with patients.
Emergency Care
S.C. 1998 Sess. Laws H.B. 3985 (to be codified at §§ 38-71-1510
– 38-71-1550) – emergency care – adopts prudent layperson definition
of emergency medical condition; provides that appropriate intervention
must be initiated to stabilize any emergency medical condition before
requesting authorization for treatment from an MCO (definition linked
to selective contracting with providers); an MCO that covers emergency
medical care services must pay providers for services provided to
a patient who presents in an emergency medical condition, and may
not retrospectively deny or reduce payments except in cases of fraud
and other limited circumstances.
MCO Protections
S.C. 1998 Sess. Laws S.B. 310 (to be codified at § 38-71-1740)
– vicarious liability – each party to a managed care participating
provider agreement is responsible for the legal consequences and
costs of his own acts or omissions, or both, and is not responsible
for the acts or omissions, or both, of the other party.
Return to Top of Page
South Dakota
Consumer/Patient Protections
Access
*1999 S.D. Sess. Laws S.B. 236, West’s No. 13 – OON providers –
in any case where a health carrier (inclusive definition) has an
insufficient number or type of participating provider to provide
a covered benefit, the carrier must ensure that the covered person
obtains the benefit at no greater cost than if the benefit were
obtained IN, or make other arrangements acceptable to the director
of the Division of Insurance.
*1999 S.D. Sess. Laws S.B. 236, West’s No. 13 – continuity of care
– if a provider is terminated without cause or chooses to leave
the network, upon request the carrier must permit the covered person
to continue an ongoing course of treatment for 90 days following
the effective date of contract termination (on contract terms).
*1999 S.D. Sess. Laws S.B. 236, West’s No. 13 – access plan – carriers
must have an access plan that, among other things, describes the
carrier’s system for ensuring the coordination and continuity of
care for covered persons referred to specialty physicians or using
ancillary services and the plan for providing continuity of care
in the event of contract termination of a provider or discontinuance
of the carrier’s operations.
Complaints/UR
S.D. § 58-18-65 – grievances – applies to managed care plans;
reviews of grievances involving reviews of practitioner authorized
or provided services must be conducted by a similarly licensed peer
who scope of practice includes the services being reviewed.
S.D. Admin. R. 20:06:34:01 – 20:06:34:08 – grievances – a grievance
may be submitted within 3 years of the act giving rise to it; for
a standard review, a written decision must be provided within 30
days following the request for review; a request for expedited review
may be submitted orally or in writing, notification of the decision
must be given as expeditiously as possible but in any event within
72 hours after review is commenced, and if the expedited review
is a concurrent review, the service must be continued without liability
to the covered person until notice is given of the determination;
an appeal from an expedited review is conducted as a standard review.
1999 S.D. Sess. Laws H.B. 1012, West’s No. 74 – UR – applies to
any carrier that provides or performs UR; UR programs must use documented
clinical review criteria that are based on published sound clinical
evidence and evaluated periodically to ensure ongoing efficacy;
any adverse determination must be evaluated by appropriately licensed
and clinically qualified providers; compensation may not be based
on the quantity or type of adverse determinations rendered or include
other incentives to render inappropriate review decisions; UREs
must make initial determinations within 2 b.d. of obtaining all
necessary information (1 b.d. for concurrent reviews) and give notice
by telephone within 24 hours of decision (with no liability until
notice in case of concurrent review); requirements for notices include
statement of clinical rationale.
Disclosure
1999 S.D. Sess. Laws S.B. 235, West’s No. 137 – formularies – any
carrier offering a managed care plan must disclose to prospective
enrollees a description of any drug formulary provisions in the
plan and the process for obtaining a copy of the current formulary
upon request.
1999 S.D. Sess. Laws S.B. 235, West’s No. 137 – conflicts of interest
– any carrier offering a managed care plan must disclose to prospective
enrollees the existence of any financial arrangements or contractual
provisions with review companies or providers that limit the services
offered, restrict referral, or treatment options, among other things.
Emergency Care
1999 S.D. Sess. Laws H.B. 1013, West’s No. 88 – emergency care –
carrier must cover services necessary to screen and stabilize and
may not require prior authorization if prudent layperson acting
reasonably would have believed that emergency medical condition
existed (prudent layperson standard also applies to use of OON provider).
Formularies
1999 S.D. Sess. Laws S.B. 235, West’s No. 137 – formularies – any
carrier offering a managed care plan that uses a formulary must
have a process for requesting an exception to the formulary and
instructions on making such a request.
Consumer Participation
S.D. §§ 58-41-23, 58-41-24 – governing body – after an
HMO has been authorized for 1 year, at least 20% of the governing
body must be composed of consumers (laypeople) who are enrollees;
the governing body shall establish a mechanism to afford enrollees
an opportunity to express their opinions in matters of policy and
operation.
Provider Protections
1999 S.D. Sess. Laws S.B. 236, West’s No. 13 – nonretaliation –
carriers may not prohibit or penalize providers for discussing treatment
options with covered persons, advocating on their behalf within
the UR or grievance processes or in good faith reporting to governmental
authorities any act or practice that jeopardizes patient health
or welfare.
Miscellaneous
S.D. §§ 58-18-80, 58-38-40, 58-41-115 – mental health
parity – group insurance policies and HMO contracts must cover biologically-based
mental illnesses on the same terms as other illnesses.
S.D. §§ 58-41-33, 58-41-36, 58-41-37 – DTPA – trade practice
laws apply to HMOs; other provisions of HMO Act address unfair and
misleading evidence of coverage, deceptive advertising, etc.
Return to Top of Page
Tennessee
Consumer/Patient Protections
Note: Consumer Health Care Advocacy Act applies to “managed health
insurance issuer” (= insurer that restricts reimbursement to a defined
network or is regulated under Title 56 or an entity that accepts
financial risk for services not provided by its owners/managers
or employees). Also: “This chapter shall not be construed
to create a cause of action or remedy that would not exist in the
absence of this section, except for the purposes of enforcing the
prohibition set forth herein.”
Access
1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– access/network adequacy – issuers must maintain adequate networks,
including adequate number of specialist and sub-specialists within
a reasonable distance or travel time; procedures for making IN and
OON referrals must include a process for expediting the referral
process when indicated by a medical condition and a provision that
referrals approved by the plan cannot be retrospectively denied
except for fraud or abuse.
*1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– continuity of care – in the case of a terminating or terminated
(without cause) provider, the issuer must allow an enrollee who
is under active treatment for a particular injury or sickness to
continue to receive covered benefits from the treating provider
for a period of 120 days from the date of notice of termination,
if the provider/facility agrees to continuation of the terms of
the provider’s agreement with the issuer; related provisions allow
pregnant women to receive treatment through postpartum care and
inpatients to remain at a facility until discharge.
*1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– specialists as PCPs – issuers must develop policies that permit
approved specialists and subspecialists to serve as PCPs for enrollees
with life-threatening, chronic, disabling or degenerative conditions
or diseases which require ongoing specialty care; denials of specialists
as PCPs must be appealable. (exp. 7/1/2001)
*1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– standing referrals – issuers must develop policies for the provision
of standing referrals to enrollees with chronic and disabling conditions
which require ongoing specialty care authorized by the PCP, for
a period not to exceed 12 months. (exp. 7/1/2001)
*1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– OON providers – in any case where the issuer has no participating
providers to provide a covered benefit, the issuer must arrange
for a referral to a provider with the necessary expertise, at no
greater cost to the covered persons than for IN provider.
1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– OB/GYN – one annual preventive visit to an OB/GYN without referral.
(exp. 7/1/2001)
1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– eye care – for plans that cover eye or vision care, one annual
preventive visit to an IN ophthalmologist or optometrist, and any
necessary follow-up or emergency care, without referral. (exp. 7/1/2001)
Complaints/UR
1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– grievances/formularies – enrollees must be permitted to file a
grievance in connection with removal of a drug from a formulary
within 60 days of notice to the provider of the removal decision;
if the grievance is filed within 10 days after the enrollee knows
or should have known of the removal, the enrollee may continue to
receive the drug until completion of the grievance process; doesn’t
apply to a removal due to patient care/safety concerns; doesn’t
apply to TennCare. (exp. 7/1/2001)
Tenn. Code Ann. § 56-32-210 – grievances – applies to HMOs
(but not TennCare); procedure must include statement of right to
contact commissioner’s office for assistance at any time, with address
and phone number; review committee cannot include person who made
decision under appeal or previously handled grievance; review must
be held within 10 b.d. of receipt of grievance, with possibility
of 10 b.d. extension; covered person must be notified of right to
submit written material and have assistance of uninvolved member
of staff; decision must be made within 5 b.d. and content of notice
is specified; HMO must have expedited procedure.
Tenn. Code Ann. § 56-32-210 – independent review (commissioner)
– applies to HMOs (but not TennCare); after receiving inivital decision
by grievance committee (or decision upon reconsideration), covered
person may seek review by submitting written request to the commissioner/designee
and HMO within 30 days of final decision; the results of the review
may not be admitted as evidence in any judicial proceeding.
1998 Tenn. Sess. Laws S.B. 3279 (Tenn. Code Ann. § 56-32-?)
– independent review – every HMO must provide an independent review
process to examine coverage decisions for enrollees where, among
other criteria, coverage has been denied on grounds of medical necessity
(not because the plan considers the service experimental) for what
would otherwise be a covered benefit, internal appeals procedures
have been exhausted, and the amount at stake is at least $1000;
the enrollee must file a request with the HMO no later than 60 days
after receipt of notification of this option and must pay
$100 toward costs; the IRO must submit its determination to the
parties within 30 days of receipt of the request for review, except
that for life-threatening conditions, as determined by the enrollee’s
physician, determinations must be submitted within 7 days; deadline
may be extended up to 5 b.d. at expert’s request to consider additional
information; determinations must be based on the applicable coverage
documents and may not expand the contractually agreed upon coverage;
determinations are binding on the plan and enrollee; conflict of
interest rules established for IROs.
Disclosure
1998 Tenn. Sess. Laws H.B. 2949 (Tenn. Code Ann. § 56-32-?)
– gag clauses/nonretaliation – an issuer may not take retaliatory
action against a provider for (1) communication with an enrollee
with respect to health status, health care or treatment options
in good faith and within the provider’s scope of practice; (2) disclosure
of accurate information concerning coverage of a service or treatment;
or (3) expression of personal disagreement with an issuer’s coverage
decision, or assistance to an enrollee pursing a grievance, provided
that it is clear the provider is acting in a personal capacity.
Tenn. Code Ann. § 56-7-2349 – gag clauses – MCOs, HMOs and
PPOs may not restrict medical personnel regarding informing patients
of alternative medical care, treatments, programs or pharmaceuticals
which may be available, regardless of whether covered by the plan
(does not really live up to title of “Patients’ Right to Truth Act
of 1996”); civil penalties (fines) specified.
Tenn. Code Ann. § 56-7-122 – incentive disclosure – health
plans may not prohibit providers from disclosing to patients the
existence of financial arrangements that reward the provider for
reducing or limiting the range and amount of medically necessary
and appropriate services.
Emergency Care
Tenn. Code Ann. § 56-7-2355 – emergency care – reasonable expectations
standard for emergency medical condition; plans may not deny coverage
if symptoms indicate that an emergency medical condition could exist,
without regard to prior authorization or network status of provider;
no subsequent rescission or modification of authorization absent
fraud, etc.
Managed Benefits Include
Tenn. Code Ann. § 56-7-2352 – off-label uses of drugs – standard
terms.
Tenn. Code Ann. § 56-7-2504 – ABMT for cancer – if TennCare
covers, than other insurers must offer coverage (may be at additional
cost).
Tenn. Code Ann. § 56-7-2505 – PKU – must cover.
Tenn. Code Ann. § 56-7-2605 – diabetes – supplies, education,
etc. must be covered when prescribed by a physician as medically
necessary.
Tenn. Code Ann. § 56-7-2601 – mental illness – insurers must
offer mental health coverage (except under individual policy renewal),
and group policies provide specified benefits if the plan provides
mental health benefits.
Miscellaneous
1998 Tenn. Sess. Laws H.B. 2949 – POS option – among those states
that mandate a POS option; doesn’t apply to TennCare.
Return to Top of Page
Texas
Consumer/Patient Protections
Note: certain provisions of state law were ordered severed in Corporate
Health Ins. Inc. v. Texas Dept. of Ins (S.D. Tex. 1998), currently
on appeal.
Access
*Tex. Ins. Code Ann. art. 3.70-3C(sec. 8)(b) (insurers/PPOs), art.
20A.09(f) (HMOs) – OON providers – if services are not available
through preferred providers within the service area, non-preferred
providers must be reimbursed at the same percentage level as preferred
providers had the enrollee been treated by them; if medically necessary
covered services are not available through IN providers, the HMO,
on the request of a network provider, within a reasonable period,
must allow referral to a OON provider and reimburse the OON provider
at the usual and customary or an agreed rate, and the evidence of
coverage must provide for a review by a specialist of the same or
a similar specialty as the provider to whom referral is requested
before the HMO may deny a referral.
*Tex. Ins. Code Ann. art. 20A.09(g) – specialists as PCPs – an enrollee
with a chronic, disabling, or life-threatening (=a disease or condition
for which the likelihood of death is probable unless its course
is interrupted) illness may apply to the HMO’s medical director
to use a nonprimary care physician specialist as the enrollee’s
PCP; to be eligible the specialist must meet the HMO’s requirements
for PCP participation and be willing to accept the coordination
of all the enrollee’s health care needs (per (h), a denial of a
request is appealable).
Tex. Ins. Code Ann. art. 21.53D – OB/GYNs – health plans must permit
women to select, in addition to a PCP, a OB/GYN to provide services
within the scope of practice of the specialty; plans must permit
a woman direct access to the OB/GYN selected, e.g., no PCP referral
or preauthorization requirements.
*Tex. Ins. Code Ann. art. 3.70-3C(sec. 4)(b), art. 20A.18A(c) –
continuity of care – each contract between an insurer/HMO and provider
must provide that termination (except for incompetence or unprofessional
behavior) does not release the provider from the generally recognized
obligation to treat the enrollee nor release the insurer/HMO from
the obligation to reimburse the provider at the preferred provider/contract
rate if, at the time of termination, the insured has special circumstances
(identified by the treating physician or provider requesting permission
to continue treatment, based on a reasonable belief that discontinuing
care could cause harm to the patient) such as a disability, acute
condition, or life-threatening illness or is past the 24th week
of pregnancy and is receiving treatment in accordance with the dictates
of medical prudence; obligation imposed on insurer/HMO does not
extend beyond the 90th day from the effective termination date (9
months in the case of an enrollee who has been diagnosed with a
terminal illness; through delivery and follow-up in the case of
pregnancy).
*Tex. Ins. Code Ann. art. 20A.09(a)(4) – rehabilitation services
– if the evidence of coverage provides benefits for rehabilitation
services and therapies, the provision of those services that, in
the opinion of a physician, are medically necessary may not be denied,
limited, or terminated if they meet or exceed treatment goals for
the enrollee; for a physically disabled person, treatment goals
may include maintenance of functioning or prevention of or slowing
of further deterioration.
Complaints/UR
Tex. Ins. Code Ann. art. 3.70-3C(sec. 7), art. 20A.14(j) – nonretaliation
– insurers/HMOs are prohibited from retaliating against enrollees,
etc. because they file complaints against insurers/HMOs or appeal
decisions.
Tex. Ins. Code Ann. art. 20A.12 – complaints – complaint means (§20A.02(f))
any dissatisfaction expressed orally or in writing to the HMO with
any aspect of the HMO operation but is not a misunderstanding that
is resolved promptly by appropriate information (if the complaint
is made orally, the complainant is sent a one-page form to fill
out); the total time for acknowledgement, investigation, and resolution
of a complaint may not exceed 30 days after the HMOs receipt of
a written complaint or form; complaints concerning emergencies or
denials of continued stays for hospitalization must be concluded
in accordance with the medical immediacy of the case not to exceed
1 b.d. from receipt of the complaint; the content of response letter
is specified; records have to be maintained for 3 years and may
be reviewed by TDI during any investigation.
Tex. Ins. Code Ann. art. 20A.12 – internal appeals – the appeals
process must be completed not later than the 30th day after receipt
of a request for appeal, except that complaints concerning emergencies
or denials of continued stays for hospitalization must be concluded
in accordance with the medical immediacy of the case not to exceed
1 b.d. from receipt of the request; the appeal panel must be composed
of equal numbers of HMO staff, providers with experience in the
area of care, and enrollees who are not HMO employees (plus a specialist
in the appropriate field if specialty care is in dispute), all with
no previous involvement in the disputed decision; the content of
response letter is specified and must include the toll-free number
and address for TDI; per art. 20A.12A, independent review provisions
for UROs also apply to HMOs (severed).
Tex. Ins. Code Ann. art. 21.58A – UR/standards – personnel must
be appropriately trained and qualified, and those who obtain medical
information must be MDs, nurses, PAs, or health care providers qualified
to provide the requested service; a URO may not compensate, condition
employment, or evaluate employees or agents, or set performance
standards, based on the volume of adverse determinations, reductions
or limitations on LOS, benefits, services or charges or the number
or frequency of telephone calls or other contacts with providers
or patients, which are inconsistent with art. 21; UROs must utilize
written medically acceptable screening criteria and review procedures
which are established and periodically evaluated and updated with
appropriate involvement from physicians, including practicing physicians,
and other providers; UR decisions must be made in accordance with
currently accepted medical or health care practices, taking into
account special circumstances of each case that may require deviation
from the norm stated in the screening criteria; screening criteria
must be objective, clinically valid, compatible with established
principles of health care, and flexible enough to allow deviations
from the norms when justified on a case-by-case basis; denials must
be referred to an appropriate MD or other health care provider to
determine medical necessity; criteria must be available for commissioner
review but not subject to open records law; UROs must have a complaint
system with a procedure that includes written response within 30
days.
Tex. Ins. Code Ann. art. 21.58A – UR/procedure – notification of
a determination must be made to the enrollee, the enrollee’s representative,
or the enrollee’s provider of record not later than 2 b.d. after
the receipt of all information necessary to complete the review;
the content of a notice of an adverse determination is specified
and must be provided within 1 b.d. by telephone or fax (3 b.d. in
writing), or within the time appropriate to the circumstances relating
to the delivery of the services and the condition of the patient,
but in no case to exceed 1 hour when denying poststabilization care
subsequent to emergency treatment (notice to provider).
Tex. Ins. Code Ann. art. 21.58A – UR/appeal – appeal decisions must
be made by a physician (or a specialty provider if the requesting
provider within 10 b.d. sets forth in writing good cause); the URO
must have an expedited appeal procedure for emergency care denials
and denials of continued stays for hospitalized patients, conducted
by a provider who has not previously reviewed the case and is of
the same or similar specialty as typically manages the medical condition,
procedure or treatment under review, to be completed no later than
1 b.d. from receipt of all necessary information; written notification
of the determination must be given as soon as practical but in no
case later than 30 days after receipt of the appeal; the content
of a notice of adverse determination is specified; in a circumstance
involving an enrollee’s life-threatening condition, the enrollee
is entitled to an immediate appeal to an independent review organization
and is not required to comply with procedures for internal appeal
(severed).
Tex. Ins. Code Ann. art. 21.58A(8) – UR/confidentiality – a UR agent
must preserve the confidentiality of individual medical records
to the extent required by law and may not disclose or publish individual
medical records, personal information, or other confidential information
about a patient obtained in the performance of UR without the prior
written consent of the patient or as otherwise required by law.
Tex. Ins. Code Ann. art. 21.58A(6A), art. 21.58C – UR/independent
review – the URO pays; the commissioner is to promulgate standards
and rules for independent review organizations addressing standards,
timeliness, confidentiality, qualifications, etc. (severed)
Tex. Ins. Code Ann. art. 21.58A(9) – UR/violations – if the commissioner
determines that any person or entity conducting UR is in violation
of the UR article, the commissioner may impose sanctions, issue
a cease and desist order, or assess administrative penalties.
Tex. Ins. Code Ann. art. 21.58A(14) – UR/application – employee
welfare benefit plans as defined in ERISA are not covered; the Texas
Medicaid Program and other programs of the state medical assistance
are not generally subject to art. 21.58A, but HMOs (including those
contracting with the state Medicaid managed care program) are covered
if they perform UR, except that they need not be separately certified
as UR agents.
Tex. Ins. Code Ann. art. 20A.12A – agency review – any person may
report an alleged violation to TDI; the commissioner must investigate
within 60 days after receipt of the complaint and all information
necessary to determine compliance.
Disclosure
*Tex. Ins. Code Ann. art. 20A.11A(b) – access to information – each
certified HMO and approved nonprofit health corporation must establish
procedures to provide access to a member handbook and the complaint
and appeals process to an enrollee who has a disability affecting
the enrollee’s ability to communicate or to read (similar provision
requires translation into the language of any group comprising 10%
or more of an HMO’s enrollees).
Tex. Ins. Code Ann. art. 3.70-3C(sec. 7), arts. 20A.14(i), 20A.18A
– gag clauses – an insurer/HMO may not prohibit, attempt to prohibit,
or discourage a physician or provider from discussing with or communicating
to a current, prospective, or former patient or his/her designee,
information or opinions regarding the patient’s health care or the
provisions or services of the plan as they relate to the medical
needs of the patient.
Tex. Ins. Code Ann. art. 20A.09 – disclosure – the evidence of coverage
is to contain, among other things, notice of the right to go to
a OON provider under certain circumstances or request a specialist
as PCP.
Emergency Care
Tex. Ins. Code Ann. art. 3.70-3C(sec. 1)(1), (sec. 5) (insurers),
art 20A.02(g), 20A.04 (HMOs), art. 21.58A (UROs) – emergency care
– adopts prudent layperson definition; if the enrollee cannot reasonably
reach a preferred provider, an insurer must reimburse emergency
services that are required by law/necessary at the preferred level
until the enrollee can reasonably be expected to transfer (art.
3.70-3C(5)); an HMO’s application for a certificate of authority
must include documentation demonstrating that the HMO will pay for
emergency care services from non-network providers at the negotiated
or usual and customary rate, and that the plan will cover any evaluation
required by law and any necessary emergency care services,
and HMOs are required to approve or deny coverage of poststabilization
care as requested by a treating provider within the time appropriate
to the circumstances, but in no case later than one hour from time
of request (20A.04(a)(16)).
Prohibition on Incentives
Tex. Ins. Code Ann. art. 3.70-3C(sec. 7), art. 20A.14(l) – incentive
prohibition – insurers/HMOs are prohibited from using any financial
incentive or making any payment to a provider which acts directly
or indirectly as an inducement to limit medically necessary services;
the use of capitation as a method of payment is not prohibited.
HMO Liability
Tex. Civ. Prac. & Rem. Code Ann. §§ 88.001-88.003
– scope – applies to HMOs and other “managed care entities,” meaning
any entity that delivers, administers, or assumes risk for health
care services with systems or techniques to control or influence
the quality, accessibility, utilization, or costs and prices of
such services to a defined enrollee population, but does not include
an employer acting on behalf of its employees or a licensed pharmacy.
Tex. Civ. Prac. & Rem. Code Ann. §§ 88.001-88.003
– direct liability – a MCE has a duty to exercise ordinary care
when making health care treatment decisions and is liable for damages
for harm to an enrollee proximately caused by its failure to exercise
ordinary care.
Tex. Civ. Prac. & Rem. Code Ann. §§ 88.001-88.003
– vicarious liability – a MCE is also liable for damages for harm
to an enrollee proximately caused by health care treatment decisions
made by its (1) employees, (2) agents, (3) ostensible agents, or
(4) representatives who are acting on its behalf and over whom it
has the right to exercise influence or control or has actually exercised
influence and control which result in the failure to exercise ordinary
care; the appearance of a person’s name on a listing of approved
providers is not in itself sufficient for a finding that the person
belongs in one of these categories.
Tex. Civ. Prac. & Rem. Code Ann. §§ 88.001-88.003
– defenses – it is a defense that (1) neither the MCE nor any of
its employees, etc., controlled, influenced, or participated in
the health care treatment decision and (2) the MCE did not deny
or delay payment for any treatment prescribed or recommended by
a provider; also, the law creates no obligation to provide treatment
which is not covered by the MCE’s health care plan; laws prohibiting
corporate entities from practicing medicine may not be asserted
as a defense; in addition, as a general rule, an enrollee must exhaust
appeals and reviews instituting an action.
Tex. Civ. Prac. & Rem. Code Ann. §§ 88.001-88.003
– nonretaliation – MCEs are prohibited from removing or refusing
to renew providers for advocating for appropriate and medically
necessary (=meeting the standard for health care services as determined
by providers in accordance with prevailing practices and standards
of the medical profession and community) health care for enrollees.
(severed)
Provider Protections
*Tex. Ins. Code Ann. art. 3.70-3C(sec. 3)(h) (insurers), art. 20A.18A(h)
– profiling – an economic profile must be adjusted to recognize
the characteristics of a physician’s or health care provider’s practice
that may account for variations from expected costs.
Tex. Ins. Code Ann. art. 3.70-3C(sec. 7) (insurers), arts. 20A.14,
20A.18A – nonretaliation – insurers/HMOs are prohibited from retaliating
against providers because they (on behalf of enrollees) reasonably
file complaints against or appeal decisions of the insurers/HMOs
or communicate with patients/designees pursuant to the gag clauses.
Selected Benefit Mandates
Tex. Ins. Code Ann. arts. 21.53D, 21.53G – diabetes – health care
benefit plans (broad definition) must provide coverage consistent
with minimum standards to be adopted by the commissioner in consultation
with the Texas Diabetes Council; a plan that providers benefits
for the treatment of diabetes and associated conditions must cover
equipment, supplies, and self-management training programs, including
new treatment modalities upon approval by the FDA.
Return to Top of Page
Utah
Consumer/Patient Protections
Access
Utah Code § 31A-8-501 – OON providers – HMOs must pay for covered
services rendered by an independent provider if the enrollee lives
within 30 paved road miles and the hospital is located in a county
with a population density of less than 100 people per sq. mile (referrals
to OON providers).
Utah Code § 31A-8-105.5 – OB/GYNs – HMOs must permit at least
one exam per year from an IN OB/GYN without prior authorization
(also disability insurers, per § 31A-22-624).
Complaints/UR
*Utah Admin. Code R. 590-76 – medical necessity – defined in HMO
regulation; definition specifies that it is determined by both the
PCP and if requested by the HMO, other competent medical authority
designated by the HMO and at its expense; also, “medical necessity
shall be determined according to generally accepted principles of
good medical practice in the community.”
Utah Admin. Code R. 590-76 – grievances – HMO medical director or
physician designee must review all grievances of a medical nature;
grievances must be answered in writing within 30 days of submittal.
Disclosure
Utah Code § 31A-4-106 – gag clauses – it is unlawful for any
insurer or person to enter into a contract that limits a provider’s
ability to advise patients fully about treatment options or other
issued affecting their health care.
Emergency Care
Utah Admin. Code R. 590-76 – emergency care – no HMO contract or
certificate may limit the coverage of emergency services in the
service area to affiliated providers only.
Nondiscrimination
Utah Admin. Code R. 590-76 – pre-existing conditions/discrimination
– HMO pre-existing condition clauses limited to 1 year, and other
limits imposed; also, coverage may not be canceled or terminated
on the basis of the status of the enrollee’s health nor on the fact
the enrollee has exercised rights under the complaint system.
Utah Admin. Code R. 590-76 – nondiscrimination – HMOs are prohibited
from “unfairly” discriminating against enrollees/applicants on the
basis of, among other things, frequency of utilization of services,
but doesn’t prohibit underwriting in accordance with relevant actuarial
data.
Selected Benefit Mandates
Utah Code § 31A-22-623 – metabolic diseases – mandated coverage
of medical foods, etc. for inherited metabolic diseases.
Return to Top of Page
Vermont
Consumer/Patient Protections
Note: Rule 10.100 applies to “managed care plans”; the key criterion
is creation of incentives for members to use selected providers.
Access
*Vt. Stat. Ann., tit. 18 § 9414(b) – access/quality – MCOs
shall assure that services provided to members are consistent with
prevailing professionally recognized standards of medical practice
and have procedures to assure availability, accessibility, and continuity
of care, and identification, evaluation, and resolution of problems
in administration and delivery (administrative sanctions authorized).
*Vt. Stat. Ann., tit. 8 § 4089j – ombudsperson – creates an
office charged with assisting consumers in understanding their rights
and responsibilities, identifying, investigating and resolving complaints
on behalf of consumers and assisting them in filing and pursuing
complaints and appeals, and promoting the development of citizen
and consumer organizations; also has discretion to pursue administrative,
judicial and other remedies on behalf of consumers.
Vt. Reg. R. 10.203(J) – access – time travel and waiting time standards
specified.
*Vt. Reg. R. 10.203(J) – continuity of care – new members with life-threatening,
disabling or degenerative conditions must be allowed to continue
to see their previous OON providers who meet plan terms for 60 days
from the date of enrollment or until accepted by a IN provider,
whichever is shorter; members with life-threatening, disabling or
degenerative conditions must be allowed to continue to see their
providers who have been removed from the network without cause for
60 days from the date of termination/nonrenewal or until accepted
by an IN provider, whichever is shorter (parallel pregnancy provisions).
*Vt. Reg. R. 10.203(J) – standing referrals – a plan must establish
policies and procedures through which a member with a condition
that requires ongoing specialty care may obtain a standing referral
(=a referral that authorizes a series of visits for either a specific
time period or number of visits pursuant to a treatment plan developed
by the PCP, specialist, plan, and member) to a network specialist,
subject to UR.
*Vt. Reg. R. 10.203(J) – specialists as PCPs – a plan must establish
policies and procedures through which a member with a life-threatening
condition, disabling or degenerative condition that requires specialized
medical care over a prolonged period of time may receive a referral
to an IN specialist/specialized facility, who must be responsible
for and capable of providing and coordinating the member’s primary
and specialty care, with the authority of a PCP, subject to UR.
Vt. Reg. R. 10.203(J) – OON providers – a plan must ensure that
members may obtain referrals to OON providers when the plan does
not have a provider with appropriate training and experience to
meet particular health care needs IN, subject to UR (in which case
the plan bears any additional costs).
Complaints/UR
*Vt. Reg. R. 10.103 (definitions) – medical necessity – “medically-necessary
care” is a defined term; medically-necessary care “must be consistent
with generally accepted practice parameters as recognized by health
care providers in the same of similar general specialty as typically
treat or manage the diagnosis or condition, and (1) help restore
or maintain the member’s health; or (2) prevent deterioration of
or palliate the member’s condition; or (3) prevent the reasonably
likely onset of a health problem or detect an incipient problem.”
Vt. Stat. Ann., tit. 8 § 4089f – independent external review
– an insured who has exhausted all internal review procedures has
the right to an independent external review of a decision to deny,
reduce or terminate coverage or deny payment for a service, provided
the amount at stake is at least $100 and the decision is based on
medical necessity, a limitation on selection of a provider, a finding
that a treatment is experimental, investigational or an off-label
use of a drug, or a pre-existing condition clause; the insured must
pay a filing fee of no more than $25 (subject to reduction or waiver
in hardship cases), with the plan paying all other costs, and the
insured is protected from retaliation for filing; the decision is
binding on the plan; the Medicaid program and services to inmates
are not covered.
Vt. Reg. R. 10.203(B) – UR/structure – plans must have mechanisms:
for assessing new technology/applications based on reviews of information
from appropriate bodies, using professionals in the process; for
ensuring the consistent application of review criteria that, within
the scope of coverage limits, are compatible with the unique needs
of each individual patient and each presenting situation; for ensuring
the confidentiality of clinical and proprietary information; clinical
review criteria must be periodically reviewed and updated with the
involvement of practicing physicians and other providers within
the plan’s network; with regard to UR determinations, plans must
ensure that: (a) individual clinical case assessments, data and
practice guidelines for the relevant clinical conditions are given
equal or greater weight than UR guidelines in making decisions to
approve or deny care, with the former taking precedence over the
latter when there is a conflict between the two; (b) all determinations
to deny or limit an admission, service, procedure or extension of
stay are rendered by a physician under the direction of the medical
director, etc.; compensation to reviewers may not contain incentives
to limit access to medically-necessary care and may not be based
on the quantity or type of adverse determinations rendered.
Vt. Reg. R. 10.203(C) – UR/procedure – for initial and concurrent
review, determination and notice within 3 b.d. of obtaining all
necessary information; in the case of an adverse concurrent review
determination, the member is not liable for any services provided
before notification to the member; expedited review for urgently-needed
care (defined term) must take no more than 24 hours from request;
content of notice specified (must include Division of Health Care
Administration’s toll-free number), and plan must make actual clinical
review criteria available upon request.
Vt. Reg. R. 10.203(D) – grievances – for purposes of this section,
“member” includes a representative of the member or provider on
behalf of the member; reviewers must be independent of the issue
that is the subject of the grievance, and if it is a decision relating
to medical care, must include at least one clinical peer of the
treating provider who has consulted with the treating provider;
time periods for response: for grievances relating to emergency
or urgent care, as expeditiously as the condition requires, but
no more than 3 days after receipt of necessary information, otherwise
15 days (30 days if not related to medical care); resolution to
be documented (content specified); plan must offer second review
for members not satisfied with initial resolution, with response
in 2 days after receipt of necessary information in emergency and
urgent cases (and for concurrent review service must be continued
until member is notified of final resolution), 30 days for all others;
plans must establish procedures by which persons who are unable
to file written grievances may file orally or through an alternative
mechanism, with the plan responsible for documentation.
Disclosure
Vt. Stat. Ann., tit. 18 § 9414(a)(2) – disclosure – applies
to MCOs (= mechanisms or systems that manage health care delivery);
items to be disclosed to members include the financial inducements
offered to any provider for the reduction or limitation of health
care services.
Vt. Stat. Ann., tit. 18 § 9414(a)(3) – gag clauses – MCO contracts
may not prohibit providers from disclosing to members information
about the contract or the plan that may affect their health or any
decision regarding treatment.
Vt. Reg. R. 10.203(I) – gag clauses– a plan’s contract with a provider
may not prohibit the provider from disclosing information about
the contract or the plan to members or potential members.
(Note: this section also includes standard requirement that provider
contracts include a “hold harmless” provision.)
Vt. Reg. R. 10.207 – disclosure – plans must disclose the following
to each member upon enrollment and annually thereafter (and to prospective
members upon request): information about any formulary, the financial
inducements offered to any provider for the reduction or limitation
of services (does not require disclosure of individual contracts
or specific details of any financial arrangement), how members can
obtain standing referrals or specialists as PCPs, waiting time and
travel standards, opportunities for member participation, consumer
information and services available from the state agency, and a
list of information available upon request.
Emergency Care
Vt. Reg. R. 10.103 (definitions), 10.203(E) – emergency care – adopts
prudent layperson definition for emergency medical condition; if
exists, no prior authorization requirement; must cover services
necessary to screen and stabilize from OON provider if prudent layperson
would have reasonably believed that use of network provider would
result in delay that would worsen the emergency.
Formularies
*Vt. Reg. R. 10.207(B) – formularies – plans that cover prescription
drugs and use a formulary must include a provision for coverage
for prescription drugs not on the formulary on the same terms as
formulary drugs where the member’s provider determines that the
formulary drug (1) has not been effective in treating the patient’s
medical condition; or (2) causes or is reasonably expected to cause
adverse or harmful reactions in the member.
Prohibition on Incentives
Vt. Reg. R. 10.203(I) – financial incentives – no provider contract
shall contain a provision offering an inducement to a provider to
forego providing medically-necessary services to a member.
Provider Protections
*Vt. Reg. R. 10.203(F), (I) – credentialing and selection criteria
– plans may not refuse to credential a provider solely because the
provider treats a substantial number of patients who require expensive
or uncompensated care; selection criteria may not be established
in a manner that would exclude providers because they treat or specialize
in treating populations presenting a risk of higher-than-average
claims, losses or health services utilization or provider a higher-than-average
level of uncompensated care (but followed by several caveats).
Vt. Reg. R. 10.203(I) – nonretaliation –plans may not prohibit a
provider from, or penalize a provider for, discussing treatment
options with members or advocating on behalf of members or reporting
any act or practice of the plan that jeopardizes patient health
or welfare in good faith.
Selected Benefit Mandates
Vt. Stat. Ann., tit. 8 § 4089c – diabetes – standard equipment,
supplies, and outpatient self-management training and education
provision.
Vt. Stat. Ann., tit. 8 § 4089e – inherited metabolic diseases
– standard provision requiring coverage for medical food (and “low
protein modified food product” up to a specified dollar limit).
Miscellaneous
Vt. Reg. R. 10.203(A) – QI – plans must have an annually updated
quality improvement plan that describes how the plan intends to,
among other things: ensure that providers and members have the opportunity
to participate in developing, implementing and evaluating the QI
system, and provide members the opportunity to comment on the QI
process.
Vt. Reg. R 10.203(H) – confidentiality – plans must establish and
implement policies, standards and procedures to protect the confidentiality,
security and integrity of individually-identifiable health care
information, including periodic training for all employees, disciplinary
measures for violations, etc.
Vt. Stat. Ann., tit. 8 § 4089b – mental health coverage – fairly
strong parity law.
Return to Top of Page
Virginia
Consumer/Patient Protections
Note: Medicaid regulations reference the general regulations
as applicable to HMOs serving the Medicaid population. Va.
Admin. Code 12:30-20-60(D).
Access
*Va. Code Ann. §§ 38.2-3407.10(C), (F) – continuity of
care – a carrier that uses a provider panel must establish procedures
that give an enrollee in an active course of treatment the right,
upon request, to continue to receive health care services for up
to 90 days from notice to the PCP of termination without cause (for
the remainder of an enrollee’s life in cases of terminal illness).
*Va. Code Ann. § 38.2-3407.11:1 (1999) – specialists as PCPs
– an enrollee with an ongoing special condition may, after consultation
with the PCP, receive a referral to a specialist who will be responsible
for coordinating the enrollee’s primary and specialty care related
to the initial referral (plan or issuer required to refer if care
would most appropriately be coordinated by such a referral); special
condition means a condition that is life-threatening, degenerative
or disabling and requires specialized medical care over a prolonged
period of time; within the treatment period authorized by the referral,
the specialized needs no additional authorization and may authorize
referrals and other services related to the initial referral to
the same extent as a PCP. (Parallel provisions for state employees
in separate section)
*Va. Code Ann. § 38.2-3407.11:1 (1999) – standing referrals
– insurer, HMO, etc. must have procedure that permits enrollee with
an ongoing special condition to receive a standing referral for
treatment of the special condition (if plan or issuer or PCP in
consultation with same determines to be appropriate, plan or issuer
must make such a referral). (Separate provision requires procedures
for cancer patients to obtain standing referrals to specialists
board-certified in pain management and oncologists (§ 38.2-3407.11:1).)
Va. Code Ann. § 38.2-3407.11 – OB/GYNs – carriers (broad definition)
must cover annual exam by IN OB/GYN without authorization.
Complaints/UR
Va. Admin. Code 14:5-210-40 – medical necessity – defined as “appropriate
and necessary health care services which are rendered for any condition
which, according to generally accepted principles of good medical
practice, requires the diagnosis or direct care and treatment of
an illness, injury, or pregnancy-related condition, and are not
provided only as a convenience.”
Va. Code Ann. §§32.1-137.9, 32.1-137.12 – 32.1-137.17
– UR – standards must be objective, clinically valid, and compatible
with established principles of health care and must be sufficiently
flexible to allow deviations when justified on a case-by-case basis;
staff must be adequately trained and supported by a physician advisor;
process for reconsideration of adverse decisions must include communication
of decision within 2 b.d. of receipt of all necessary information;
for emergency health care, authorization may be requested within
48 hours or after 1 b.d.; no entity may render adverse decision
without good faith attempt to obtain information from provider,
and prior to rendering provider is entitled to review issue of medical
necessity with a physician advisor or peer with UR entity; a decision
on reconsideration must be made by a physician advisor, peer, or
panel including a physician advisor or peer and decision must be
provided in writing within 10 b.d. of receipt of request; decision
in final appeal must be rendered no later than 60 b.d. after receipt
of all required documentation (1 b.d. for expedited appeal) and
involve review by peer not previously involved and not employed
by the UR entity; due consideration should be given to the availability
or nonavailability of alternative services proposed and consideration
of any hardship imposed by the alternative on the patient and family
is not precluded; the appeals process does not apply to a decision
rendered solely on the basis that a plan does not provide benefits
for the health rendered/requested; UR entity may not penalize provider
for advocating for patient (except for pattern of filing appeals
without merit).
Va. Code Ann. § 38.2-5900 et seq. (1999) – UR/independent review
– an enrollee may file a request for review of a final adverse decision
with the Bureau of Insurance where more than $500 is at stake; must
be filed within 30 days and include a $50 filing fee (can be waived
if undue hardship); the Bureau conducts a preliminary review and
accepts cases which are appropriate for review and forwards them
to an impartial review entity; the reviewer examines the final decision
to determine whether it is objective, clinically valid, compatible
with established principles of health care, and appropriate under
the terms of the contract and renders a recommendation within 30
b.d. of the acceptance of the appeal by the Bureau; the commissioner’s
ruling carries out the recommendations unless they exceeded its
authority or are arbitrary and capricious; the ruling is binding
with respect to the issues examined; conflict of interest rules
ensure impartiality (does not take effect until earlier of promulation
of regulations by state corporation commission or 7/1/2000).
Va. Code Ann. §§ 32.1-137.6, 32.1-137.15, 38.2-5904 (1999)
– ombudsman – plan information materials, and notices of denials
of appeals, must include the mailing address, telephone number,
and electronic mail address of the Managed Care Ombudsman; ombudsman
assist covered persons in understanding their rights and responsibilities
and, upon request, assists them in using procedures and processes
available to them from their MCO, including all UR appeals; where
review of records is required, access only with express written
consent.
Va. Admin. Code 14:5-210-70 – grievances – grievances must be resolved
within reasonable period of time, not more than 180 days from date
registered (subject to extension in the event of delay in obtaining
documents or mutual agreement).
Disclosure
Va. Code Ann. § 38.2-3407.9:01 – formulary disclosure – any
insurer, HMO, etc. that includes coverage for outpatient prescription
drugs and uses a formulary must update it in consultation with a
P&T committee (majority practicing licensed health care providers)
and make available to participating providers and pharmacists a
complete list and any updates.
*Va. Code Ann. § 38.2-3407.11:1(F) (1999) – specialist care
– notice of provisions relating to specialty referrals must be included
in the policy or evidence of coverage.
Va. Code Ann. §§ 38.2-3407.10(J), (K) – gag clauses –
carrier contracts with providers may not prohibit or interfere with
the discussion of medical treatment options with patients and must
permit and require providers to discuss medical treatment options
with patients.
Emergency Care
Va. Code Ann. §§ 38.2-4300, 38.2-4312.3 – emergency care
– in chapter that covers HMOs only; adopts prudent layperson standard
in definition of emergency services, but emergency services from
OON providers in service area covered only when delay from going
to IN provider could reasonably be expected to cause the enrollee’s
condition to worsen if left unattended; HMO must reimburse for services
required under EMTALA if the HMO or PCP directed the member to the
ER or the HMO doesn’t have the required 24 hour access.
Formularies
Va. Code Ann. § 38.2-3407.9:01 – non-formulary drugs – any
insurer, HMO, etc. that includes coverage for outpatient prescription
drugs must establish a process to allow an enrollee to obtain, without
additional cost-sharing, a specific, medically necessary nonformulary
prescription drug if the formulary drug is determined by the insurer,
HMO, etc., after reasonable investigation and consultation with
the prescribing physician, to be an inappropriate therapy for the
enrollee’s medical condition; must act on request within 1 b.d.
of receipt.
Nondiscrimination
Va. Code Ann. § 38.2-5806(A) – discrimination – no managed
care health insurance plan licensee may cancel or refuse to renew
coverage for basic health care services on the basis of health status.
Selected Benefit Mandates
*Va. Code Ann. § 38.2-3418.8 (1999) – clinical trials (cancer)
– insurers, HMOs, etc. must cover patient costs association with
participation in clinical trials for treatment studies on cancer
in policies, etc. issued or renewed after 7/1/99; limited to approved
Phase II-IV trials (Phase I on a case-by-case basis) at a competent
site where there is no clearly superior noninvestigational alternative
and available evidence provides a reasonable expectation that treatment
will be at least as effective as the noninvestigational alternative,
and the member and PCP conclude that participation would be appropriate.
Va. Admin. Code 14:5-210-90 – basic services – basic health care
services that must be provided by HMOs specified, including short-term
PT and rehabilitation services that can be expected to result in
significant improvement of condition within 90 days, etc.
Va. Code Ann. § 38.2-3412.1 – mental health/substance abuse
services – includes minimum number of visits that must be covered
in various settings.
Va. Code Ann. § 38.2-3418.2 – bones and joints – applies to
broad range of insurance entities.
Va. Code Ann. § 38.2-3418.3 – hemophilia – does not apply to
Medicare or similar state or federal governmental plans.
Va. Code Ann. § 38.2-3418.5 – early intervention services –
$5000 annual cap, birth to age 3 for dependents certified as eligible
under IDEA; does not apply to Medicare or similar state or governmental
plans.
Miscellaneous
Va. Code Ann. § 38.2-3407.10(M) (1999) – notice of benefit
reduction – group policyholders are supposed to get 60 days advance
notice of benefit reductions (and they in turn are supposed to give
enrollees 30 days advance notice).
Va. Code Ann. §§ 38.2-3407.10(N), 38.2-4209(F) (PPOs),
38.2-4312(F) (1999) – prohibition on provisions in provider contracts
that require providers to deny covered services that they know to
be medically necessary and appropriate that are provided with respect
to a specific enrollee/group with similar medical conditions (eff.
7/1/99).
Return to Top of Page
Washington
Consumer/Patient Protections
Access
Wash. Rev. Code § 48.42.100 – OB/GYNs – enrollees must be permitted
direct access to participating women’s health care provider of choice.
Complaints/UR
Wash. Rev. Code § 48.43.055 – complaints – if carrier fails
to grant or reject a request for review of a complaint within 30
days, it may be treated as rejected and submitted for nonbinding
mediation.
Wash. Rev. Code §§ 48.46.020 (definition), 48.46.030 –
grievances – HMOs must afford enrollees a “meaningful grievance
procedure,” meaning “a procedure for investigation of consumer grievances
in a timely manner aimed at mutual agreement for settlement according
to procedures approved by the commissioner.”
Wash. Admin. Code 284-46-507 – experimental and investigational
exclusions – HMO certificates of coverage must define experimental
or investigational as a basis for exclusion and include an identification
of the authority or authorities that will be relied upon in making
determinations; if the HMO or an affiliate is identified as an authority,
the criteria to be used must be specified; any denial on these groups
must be given in writing within 20 b.d. of receipt of a fully documented
request, to include the name and job title of the reviewer, the
basis, procedures for appeal, etc.; the appeals procedure must provide
for review by qualified persons not involved in the initial decision.
Disclosure
Wash. Rev. Code § 48.43.095 – disclosure (incentives, formularies)
– upon the request of an enrollee or prospective enrollee, a carrier
must provide a written description of any reimbursement or payment
arrangements, and information as to whether a plan provider is restricted
to prescribing drugs from a plan formulary, what drugs are on the
formulary, and the extent to which enrollees will be reimbursed
for non-formulary drugs, among other things.
Wash. Rev. Code § 48.43.075 – gag clauses – no carrier may
(1) preclude or discourage providers from informing patients of
the care they require, including treatment options, and whether
in their view such care is consistent with medical necessity or
otherwise covered, or penalize a provider for advocating on behalf
of a patient; or (2) preclude or discourage patients or payers from
discussing the merits of different carriers with their providers
(including critical comments).
Emergency Care
Wash. Rev. Code §§ 48.43.005, 48.43.093 – emergency care
– applies to health carriers (includes disability insurer); adopts
prudent layperson definition of emergency medical condition; carrier
may not require prior authorization for such services up to the
point of stabilization; OON providers must be provided if prudent
layperson would have reasonably believed that use of IN facility
would result in a delay that would worsen the emergency (cost-sharing
differential of up to $50 permitted, but may not be applied under
certain circumstances).
Nondiscrimination
Wash. Rev. Code § 48.46.060 – discrimination – HMOs may not
cancel or fail to renew enrollment or transfer from group to individual
basis solely on the basis of health status.
Consumer Participation
Wash. Rev. Code §§ 48.46.020 (definition), 48.46.030 –
policy making – HMOs must be governed by a board elected by enrollees,
or otherwise provide enrollees with a “meaningful role in policy
making,” meaning “a procedure approved by the [insurance] commissioner
which provides consumers or elected representatives of consumers
a means of submitting the views and recommendations of such consumers
to the governing board of such organization coupled with reasonable
assurance that the board will give regard to such views and recommendations.”
Selected Benefit Mandates
*Wash. Admin. Code 284-46-500 – alternative care – HMOs must include
substitution of home health care in lieu of covered hospitalization
or other institutional care at equal or lesser cost (may include
coverage for DME which permits the insured to stay at home); substitution
of less expensive or intensive services may be made only with the
consent of the insured and upon the recommendation of the attending
physician/provider that such services will adequately meet the patient’s
needs; coverage may be limited to no less than the maximum benefits
which would be payable for hospital or other institutional expenses.
Wash. Rev. Code § 48.46.272 – diabetes – applies to HMOs (and
risk-bearing provider groups under § 48.44.315); standard provision.
Wash. Rev. Code § 48.46.350 – chemical dependent treatment
– applies to HMO group agreements (and risk-bearing provider groups
with group contracts under § 48.44.240).
Wash. Rev. Code § 48.46.510 – PKU – applies to HMOs (and risk-bearing
provider groups under § 48.44.440); requires coverage of medically
necessary medical foods.
Wash. Rev. Code § 48.46.520 – neurodevelopmental therapies
– applies to HMO employer-sponsored group contracts (and risk-bearing
provider groups with employer-sponsored group contracts under §
48.44.450); permits use of utilization and cost controls.
Miscellaneous
Wash. Rev. Code § 48.43.105 – immunity for comparison documents
– a public or private entity that exercises due diligence in preparing
a document that compares health carriers is immune from civil liability
from claims based on the document, provided it includes a specified
disclaimer.
Return to Top of Page
West Virginia
Access
W. Va. Code Ann. §§ 33-42-1 – 33-42-7 – OB/GYNs – direct
access at least annually to a women’s health care provider.
Complaints/UR
W. Va. Code Ann. § 33-25A-12 – grievances – HMO must designate
grievance coordinator and establish toll-free number; each level
of procedure must have some person with problem solving authority
to participate; formal grievances must be processed through all
phases of the procedure in a reasonable length of time, not to exceed
60 days (any grievance in which time is of the essence must be handled
on an expedited basis, “such that a reasonable person would believe
that a prevailing subscriber would be able to realize the full benefit
of a decision in his or her favor”); the procedure must state that
the subscriber has the right to appeal to the state insurance commissioner;
physicians must be involved in reviewing medically related grievances;
HMOs may not establish time limits of less than one year from the
date of occurrence for the subscriber to file a formal grievance;
copies of grievances and responses must be available to the commissioner
and public for inspection for 3 years.
W. Va. Code Rules §§ 114-51-2 – 114-51-4 – UR – UR programs
must have written UR protocols based on reasonable medical evidence;
HMOs must make review criteria available to participating physicians
upon request and establish mechanisms for checking the consistency
of application and updating criteria on a periodic basis; a licensed
physician must conduct a review of medical appropriateness on any
denial of medical services, with a physician consultant specially
trained in the area available during the review process; decisions
must be made in a timely manner; HMOs must establish medically appropriate
timeframes for urgent, emergency and planned care cases; in case
of denial, a written notice must be sent immediately to all involved
parties, and must include the reason for denial and an explanation
of the appeal process; HMOs must have mechanisms to evaluate the
effects of the program.
Disclosure
W. Va. Code Ann. § 33-25C-3 – disclosure – all managed care
plans (HMOs and prepaid plans) must give subscribers notice of certain
rights including: the ability to pursue grievance and hearing procedures
without reprisal, the right to privacy and confidentiality, the
right to be informed of plan policies and any charges; the ability
to obtain evidence of medical credentials of providers, the right
to have coverage denials reviewed by appropriate medical professionals.
Emergency Care
W. Va. Code Ann. §§ 33-25A-8d (HMOs), 33-15-21, 33-16-3i
(insurers), 33-24-7e (corporations) – emergency care – prudent layperson
standard for emergency medical condition; preauthorization or precertification
may not be required for emergency services (stabilization); excludes
employer-sponsored plans. (applies through 6/30/2000)
Nondiscrimination
W. Va. Code Ann. § 33-25A-14 – discrimination – HMOs may not
discriminate in enrollment policies or quality of services on the
basis of health status, among other things, subject to proviso that
differences in rates based on valid actuarial distinctions will
not be considered discrimination.
Prohibition of Incentives
W. Va. Code of Reg. § 114-53 – incentives – payments as an
inducement to deny medically necessary services are prohibited.
Consumer Participation
W. Va. Code Ann. § 33-25A-6 – policy and operation – HMO enrollees
must be afforded an opportunity to participate in matters of policy
and operation.
Selected Benefit Mandates
W. Va. Code Ann. §§ 33-15C-1, 33-16-16 – diabetes – standard
provision.
Return to Top of Page
Wisconsin
Consumer/Patient Protections
Access
*Wis. Stat. Ann. § 609.22(8) – access – applies to managed
care plans (= plan that creates incentives to use selected providers);
plans must develop an access plan to meet the needs, with respect
to covered benefits, of enrollees who are members of underserved
populations.
*Wis. Stat. Ann. § 609.22(4) – standing referral/specialists
as PCPs –a plan must establish a procedure by which an enrollee
may apply for a standing referral to a specialist (but the plan
may restrict secondary referrals); the specialist, in agreement
with the enrollee and the enrollee’s PCP, may provide primary care
services in accordance with procedures established by the plan.
*Wis. Stat. Ann. § 609.22(5) – second opinions – plans must
provide enrollees with coverage for a second opinion from another
participating provider.
*Wis. Stat. Ann. § 609.24(1) – continuity of care – if a plan
represents that a provider is or will be a participating provider
in marketing materials distributed during an open enrollment periods
or at coverage renewal, then it must cover services of that provider
(a) until the end of the plan year or (b) if an enrollee is undergoing
a course of treatment with a non-PCP participating provider whose
participation is terminated (but not for misconduct), for the remainder
of the course of treatment or 90 days after termination or until
the end of the plan year, whichever is shorter.
Complaints/UR
*Wis. Stat. Ann. §§ 609.84, 632.855 – experimental treatment
– limited service health organizations, PPOs and managed care plans
that limit coverage of experimental treatment must define and disclose
limits including who is authorized to make a determination and the
criteria to be used; a plan must issue a decision within 5 working
days after receiving a require; denials must be given in a letter
than includes the specific medical and scientific reasons and a
description of the appeal procedure.
Disclosure
Wis. Stat. Ann. § 609.30 – gag clauses – a plan may not contract
with a participating provider to limit the provider’s disclosure
of information, to or on behalf of an enrollee, about the enrollee’s
medical condition or treatment options.
Emergency Care
Wis. Stat. Ann. §§ 609.22(6), 609. 82, 632.85 – emergency
care – adopts prudent layperson definition of “emergency medical
condition”; plans may not impose prior authorization requirements
for coverage of emergency services.
Formularies
*Wis. Stat. Ann. §§ 609.83, 632.853 – drugs and devices
– limited service health organizations, PPOs and managed care plans
that use formularies must develop a process through which a physician
may present medical evidence to obtain an individual patient exception
for coverage of a prescription drug or device not routinely covered
by the plan; the process must include timelines for both urgent
and non-urgent review.
Provider Protections
Wis. Stat. Ann. § 609.30 – gag clauses/nonretaliation – a plan
may not contract with a participating provider to limit the provider’s
disclosure of information, to or on behalf of an enrollee, about
the enrollee’s medical condition or treatment options; a plan may
not penalize a provider for making referrals to other participating
providers or discussing medically necessary or appropriate care
with or on behalf of an enrollee.
Selected Benefit Mandates
Wis. Stat. Ann. §§ 609.78, 632.895(11) – TMJ – disability
policies, limited service health organizations, PPOs and managed
care plans must cover up to $1250 annually.
Wis. Stat. Ann. §§ 609.81, 632.895(9) – HIV/AIDS – disability
policies, limited service health organizations, PPOs and managed
care plans that provide coverage of prescription medication must
cover drugs approved by the FDA for treatment of HIV, including
INDs in or post-phase 3 clinical investigation, if prescribed by
the insured’s physician for HIV-related treatment.
Miscellaneous
Wis. Stat. Ann. § 609.36(2) – confidentiality – plan must establish
written policies and procedures consistent with state law for the
handling of medical records and the enrollee communications to ensure
confidentiality.
Return to Top of Page
Wyoming
Consumer/Patient Protections
Wy. Stat. Ann. § 26-34-117 – gag clauses/nonretaliation
– HMOs are prohibited from refusing to contract with or compensate
an otherwise eligible provider solely because the provider has in
good faith communicated with patients regarding the HMO’s products
as they related to the those patients’ needs; HMOs may not prohibit
or restrict providers from disclosing to subscriber any medically
appropriate health care information regarding treatment, the decision
of any plan to authorize or deny services, or the UR process.
Miscellaneous
Wy. Stat. Ann. § 26-34-108 – although Wyoming is bereft of
the usual protections, it does have a fairly detailed legislative
provision setting forth minimum standards for HMO quality assurance
programs.
Return to Top of Page
"Legal Protections for People with Disabilities" is one of six research
projects of the Research and Training Center on Managed Care and
Disability (RTC-MC&D). Partners in the RTC are the National
Rehabilitation Hospital Research Center (NRH-RC) in Washington,
D.C. and ILRU (Independent Living Research Utilization) in Houston,
TX. The Health Law and Policy Institute, based at the University
of Houston and ILRU are collaborating on the "Legal Protections"
project. The Center is funded by the National Institute on Disability
and Rehabilitation Research (NIDRR), an agency of the Department
of Education, under grant #H133B70003 to disseminate the results
of this research project. NIDRR is not an enforcement agency. Any
information contained on this Web site is intended solely as informal
guidance and is not a legal interpretation of any rights or responsiblities
conveyed by the legislation addressed here, nor is it binding on
NIDRR.
|